Professional Documents
Culture Documents
studentite.bg.2024.07.09.11.13.29
studentite.bg.2024.07.09.11.13.29
• Recording growth:
o UK-WHO growth charts for children aged 0-4.
▪ Ethno-specific growth charts
• Tall = Dutch, Afro-Caribbean Height/ weight/ OFC
• Short = Gujurati, Urdu, Punjabi should not be further than
o On the growth chart, plot: 2 centile marks apart, i.e.
▪ Head circumference: 9th/ 25th/ 50th/ 75th.
• OFC (occipital-frontal circumference)
• 33-35cm at birth
• 1cm/ month for first year.
▪ Length/ height:
• Height at birth + 2cm a month
• 0-2yo: lying naked infant with head and feet held
• Head → HEEL.
• >2yo: wall mounted stadometer. Shoes and socks off. Eyes at ear level.
▪ Weight:
• Naked on scales
• Normal = 3.5kg at term
• <2.5kg = low birth weight
o <1.5kg = very low
o <1kg = extremely low
• Small for gestational age = <10th centile.
o Weight gain:
▪ Normal to lose <10% of weight in 2 weeks after birth.
▪ X2 at 6mo; x3 at year.
▪ Normal rates of weight gain:
• 1st 3 mo: 30g/ day
• 3-6 mo: 20g/day
• 6-12 mo: 15g/ day
o BEWARE of centile crossing: can indicate pathology
▪ E.g. head circumference → hydrocephalus?
Growth predictions
• Mid-parental centile comparator:
o Can use special chart where you mark the mother’s on one side, and the father’s on the other,
and draw a line between. Mid parental percentile = where it crosses the line in the middle.
o Most children are ±2 centiles of mid-parental centile.
• Mid-parental height:
o Boys: [Mother’s height + father’s height]/2 +6.5cm
o Girls: [Mother’s height + father’s height]/2 -6.5cm
• Target range = MPH ± 10cm.
SHORT STATURE
• = height <3rd percentile. (MU-PLOVIDV <2nd percentile) ≤2nd percentile = -2SD
• Correct for height using MPH. ≥98th percentile = +2SD
• Causes:
o Familial
o Constitutional delay in growth and puberty
o Psychological neglect (→GH)
o IUGR Short stature is NOT
o Other endocrine: associated with
▪ Hypothyroidism prematurity.
▪ Cushing’s
▪ GH deficiency: bitemporal homonymous hemianopia. DO insulin tolerance test: should
cause a rise.
• At birth → neonatal hypoglycaemia + jaundice
• Doll-like face.
• Grow normally for first 12 months
• MARKEDLY REDUCED BONE AGE
o Dysmorphic syndromes:
▪ Turner’s
▪ Noonan
▪ Down’s
o Coeliac
o Chronic renal failure
o Chronic inflammatory disease:
▪ IBD
▪ Rheumatic disease
o Other chronic disease:
▪ Asthma
▪ HF
o Skeletal dysplasia:
▪ Achondroplasia (AD dwarfism)
▪ Hypochondroplasia
o Metabolic disease:
▪ X-linked hypophosphataemic rickets
o Malnutrition.
• Ix:
o U&E
o FBC and CRP For GH:
o Calcium and phosphate - Initial scree: IGF-1 (will be low)
o Karyotype - Then do insulin tolerance test,
o TFTs measuring GH and IGF-1 after 2h.
o Serum IGF-1
o Coeliac Ab screen
o Urinalysis.
TALL STATURE
• Height >97th percentile
• Majority = inherited.
• Other causes:
o Early puberty
o Obesity
o Endocrine disorders:
▪ Precocious puberty
▪ GH excess
▪ Pituitary adenoma
▪ Androgen excess
▪ CAH
▪ Hyperthyroidism
▪ Aromatise enzyme deficiency
▪ Oestrogen receptor defects
▪ Primary hyperinsulinaemia
o Kleinefelters (XXY)
o Marfan’s
o Homocysteinuria
o Soto syndrome: large head, characteristic facies and LD
o Beckwith-Wiedemann syndrome
o Maternal DM
• Ix:
o Karyotype
o TFTs
o Serum IGF-1
o Sex hormones/ LH/ FSH
o Androgen levels
o OGTT → test GH levels (should be suppressed).
• Mx: low dose sex steroids can be given to fuse growth plates, but usually avoided as major SEs.
• Findings AT BIRTH:
o Caput seccadenium: normal. Crosses suture lines.
o Chignon: from ventouse
o Cephalohaematoma: does not cross suture lines.
OBESITY
• Overweight = BMI ≥85th percentile (BMI >25)
• Obese = BMI ≥95th percentile (BMI >30)
• Exogenous causes rare: Hypothyroid, Cushings & Prader-Willi
• Associated with: Asian, female, tall children.
• Complications:
• Ortho: SUFE/ tibia vara/ abnormal foot structure & function
• Benign intra-cranial HTN
• Hypoventilation syndrome: daytime somnolence; sleep apnea; snoring; hypercapnia; HF
• Gall bladder disease
• PCOS/ DM2/ HTN
• Psychological sequelae
• Mx:
• Lifestyle changes
• Healthy eating/ exercise/ ↓periods of inactivity
• Success enhanced with family support.
BMI centiles: where weight and height centiles cross, follow line up.
Teeth
Formula for approximately how
many teeth they might have:
Age in months - 6
- 4 major areas:
o Gross motor
o Fine motor/ vision Screening
o Speech (language and hearing) - Newborn check
o Social (emotional and behavioural). - Newborn hearing
- Isolated delay = 1 of these domains. - 6 week check
- Global delay = ≥2. - Parental concerns.
- Biological RFs:
o Prematurity
o Low birth weight (<2.5kg)
o Birth asphyxia
o Chronic illness
o Visual/ hearing impairment
- Environmental RFs: poverty/ low parental education/ parental mental illness/ social isolation.
- N.B. bladder and bowel training during day should be by about 3yo.
- DELAY IN WALKING:
o Should walk by 18 months.
o Causes:
▪ Cerebral palsy
▪ Duchenne muscular dystrophy (X-linked)
▪ Congenital myopathy
▪ Spinal cord lesion, e.g. spina bifida
▪ Global neurodevelopmental delay
▪ Congenital dislocation of the hip.
o Bum shuffling is a normal variant to crawling; genetically linked.
RISK FACTORS
- Use of drugs, alcohol, cigarettes
- Previous pregnancy
o Still birth, neonatal death, premature, congenital malformations, neonatal jaundice,
- Current pregnancy
o Bleeding, STD, preeclampsia, poly/oligohydramnios, acute illness, genetic disease, twins
- Delivery
o Premature, late, nuchal cord, caesarean section, forceps use, etc.
DISTRIBUTION
- Countries with the LOWEST child mortality rate:
1. Luxemburg, Sweden, Japan, Finland
2. EU, Israel, USA, Canada, Australia, NZ
- Countries with the HIGHEST child mortality rate
o Africa and South Asia
RATES
- 0-1yrs have the highest mortality rates, then 1-4, 5-9, 10-14yrs
- Child mortality has been reducing worldwide for 100yrs
- Neonatal causes
o Premature birth
o Infections
- Infant causes
o Premature, anoxia, neonatal diseases
o Malformations
o Respiratory infections→ Pneumonia
- 1-4yrs causes
o Congenital
o Infectious disease
o Cancer
- 1-14yrs causes
o Accidents, poisoning
o Respiratory infections
o Cancer
o Neuro disorder
4. NUTRIITION
- Initiate breast feeding within 1st hour after birth
o Newborns drink 60-90ml/ feeding milk over 6-9 feeds/24hrs
▪ Most infants will wake for a middle-of-the-night feeding until 3–6 wk of age
o After a week – 3months ~150ml/kg/24h (30ml=1oZ) over 4-6 feeds
- Exclusive breast feeding is recommended until the infant is 6 months of age
o On-demand feeds are recommended
- 7–12 months needs an average volume of human milk plus the average amount of complementary foods
- Milk secretion is stimulated by regular emptying of breast
- 0-6months infant requires more protein per unit of body weight than the adult → ~1.5 g/kg/24 hr
- Human milk protein and all proteins used in infant formulas contain adequate amounts of all essential
amino acids
ELECTROLYTES, MINERALS AND VIATMINS
- Healthy newborn infants typically have sufficient stores of iron for 4–6 months
o These stores and the absorption of iron is variable → iron deficiency is common during infancy
- If protein intake is adequate, vitamin deficiencies are rare
- If infant formulas were not supplemented with vitamin D → hypovitaminosis D
- Routine perinatal administration of vitamin K is recommended as prophylaxis against haemorrhagic
disease of the newborn → Vit K deficiency is uncommon unless child is receiving prolonged antibiotics
and those with conditions associated with fat malabsorption
- WATER → absolute requirement is ~150ml (newborn) - 100ml (1yr old) /kg/24 hr
ADVANTAGES OF BREASTMILK
- Always at right temperature
- Requires no preparation time
- Fresh and free of contaminating bacteria → GI disturbances
- feeding difficulties related to allergy/ intolerance
- Contains bacterial and viral antibodies, including IgA (protects the intestinal mucosa from pathogens)
- Macrophages in milk synthesize complement, lysozyme, and lactoferrin
o Lactoferrin – iron-binding protein that has an inhibitory effect on growth of E.coli in intestines
- Lowers pH of stool → aids favourable intestinal flora → helps protect against infections
- Contains bile salt-stimulated lipase → kills Giardia lamblia and Entamoeba histolytica
- Psychologic advantages of breast-feeding for both mother and infant → bonding
- Helps uterus return to its normal size sooner and help mother return to pre-pregnancy weight sooner
** Main benefits for infant: obesity/ T2DM, SIDS, Chest infection/gastroenteritis, Allergies
** Main benefits for mother: breast/ ovarian cancer and PPH
DISADVANTAGES OF BREASTMILK
- Lower vitamin D
- Low iron content but most healthy term infants have sufficient stores and breast milk is well absorbed
- Low vitamin K → haemorrhagic disease → Parenteral administration of 1 mg Vit K1 at birth
- Transmission of HIV by infected mothers
- Transfer of Cytomegalovirus (CMV), Human T-cell lymphotropic virus type 1, Rubella virus, Hepatitis B
virus (mostly transmitted through delivery, immunization needed in 1st 24hrs), and Herpes simplex
virus (avoid if lesions on nipple)
CONTRAINDICATIONS OF BREAST-FEEDING
- HIV+ve mothers, Active TB, Typhoid fever,
Malaria, Septicemia
- Breast cancer
- Mastitis
- Acute maternal infection → breast may be
emptied and milk given to infant via bottle
- Substance abuse and severe neuroses/
psychoses
- Infants with galactosemia and
phenylketonuria
- Amiodarone, Anti-metabolites, Thyroxine,
Opiates
BREAST FEEDING TECHNIQUE
CHIN:
o Close to mother, chin to breast first
o Head free to tilt back
o In line
o Nose to nipple
- Positive signs: Mouth wide open, No pain, Rhythmic sucks, sleeps 2–4 hr between feedings, gains weight
** Can assess intake by weight gain, urine/ stool output, and condition of nipple
PHYSIOLOGY: Stimulation of lactation
- Prolactin (anterior pituitary) → stimulates milk secretion by cuboidal cells in acini or alveoli of breast
- Oxytocin (posterior pituitary) → contraction of the myoepithelial cells surrounding the alveoli deep in
the breast → squeezes milk into the larger ducts, where it is more easily available to the sucking infant
ADVICE
- Infants can empty a breast in 5-20min
- Infant should not be pulled from the breast
- Afterwards place infant over shoulder or on her lap, with or without gentle rubbing or patting of the
back to assist in expelling swallowed air/ burping
- Infant should empty at least 1 breast at each feeding; otherwise, the breast will not be stimulated
sufficiently to refill
- Both breasts should be used at each feeding during the early weeks to encourage maximal milk
production
PROBLEMS
- Breast engorgement – better technique & regular expressing breast milk
- Breast abscess – advise to continue feeding if possible + flucloxacillin ± surgery (drainage)
- Sore nipples: optimize attachment & moist wound healing not by resting except in emergency
- If entirely breast fed, give vit A, C, D supplements from 6 months, + eat 500kCal extra
DRUGS OK IN BREAST FEEDING: APE AHEAD
- Asthma: salbutamol, theophyllines
- Psychiatric drugs: TCAs, antipsychotics** (Avoid clozapine)
- Endocrine: glucocorticoids (avoid high doses), avoid levothyroxine*
- Antibiotics: penicillins, cephalosporins, trimethoprim
- Hypertension: beta-blockers, hydralazine, methyldopa
- Epilepsy: sodium valproate, carbamazepine
- Anticoagulants: warfarin, heparin
- Digoxin
DRUGS TO BE AVOIDED IN BREAST FEEDING: PACT SAC (make a pact to your sac not to take these drugs)
- Psychiatric drugs: SC lithium, benzodiazepines
- Amiodarone
- Carbimazole/ cytotoxics
- Tetracyclines/ doxycycline
- Sulphonylureas, sulphonamides
- Aspirin
- Ciprofloxacin, chloramphenicol
PREMATURITY
- Breast milk best, give unheated via a tube, add vit D & K ± phosphate
o Term babies also at risk of rickets/ hypocalcaemia if exclusively breastfed so use vit supplements
BOTTLE FEEDING
- Cross cut teats – more content than standard teats
- Standard infant formulas: humanized cow’s milk – whey based protein
- Follow-on formula milk (6-24mo) – casein-based protein component – delays stomach emptying and
allows less frequent feeds
- Soya milks – no longer recommended, contain high levels phyto-oestrogens – may affect immunity/
thyroid & hormones especially in boys
- Quanitiy during 1st week = (x-1)х70 daily → (x= no. days post partum); or 800 ml daily at 2 months,
for every week below this age – 50 ml less, for every month above this age 50 ml more
** Hydrolyzed formula: Cows milk formula where protein is hydrolyzed into short peptides. Normal for stool to
turn green → Indications = cow’s milk allergy
WEANING
- Intro solids at 4-6months → puree
- Solid foods from 6months
o Vegetable puree – 4 months
o Vegatable-meat puree and eggs’ yolk – 6 months
o Soup – 7 months
- Avoid foods with high allergenic potential (cow's milk, eggs, fish, nuts, soybeans)
- Avoid honey until 1 year → risk of infantile botulism
- At the proper age, encourage a cup rather than a bottle
- Introduce 1 food at a time
- Iron-containing foods (meat, iron-supplemented cereals) are required
- Zinc intake should be encouraged with foods such as meat, dairy products, wheat, and rice
- Breast milk should continue to 12 months
- Reducing milk production:
o Use of a tight breast binder and application of ice bags
o Restriction of the mother's fluid intake and small doses of oestrogen for 1–2 days also may help
decrease milk production
MANAGEMENT
- Mealtime observations and food diaries
- Health visitors to assess and support families to improve feeding and increase calorie intake
- Paediatric dietician to recommend food and strategies
- Key outcome → rise up weight centiles; usually begins 4 weeks to 8 weeks after intervention
- Severe cases require hospital admission
MALNUTRITION
- Worldwide is responsible for 1/3rd of all deaths of children under 5 years
- Is often a consequence of war and social disruption, famine and natural disasters
- In developed countries → results from poverty, parental neglect or poor education, restrictive
diets, and in children with feeding disorders, chronic illness, or anorexia nervosa
ASSESSMENTS
- Evaluation involves:
o Assessment of past and present dietary intake → recorded by parents over several days
o Anthropometry
o Laboratory assessments
- Skinfold thickness from triceps reflects subcutaneous fat stores and can be measured with calipers
- In children from 6 months to 5 years → MUAC →relates to skeletal muscle mass
SEVERE MALNUTRITION
- Is a major problem in many low and middle-income countries
- Severe protein-calorie malnutrition is classified as:
o Marasmus
o Kwashiorkor
o Marasmickwashiorkor
MARASMUS
- Child has a wasted, wizened appearance, Oedema is NOT present
- Affected children are often withdrawn and apathetic
KWASHIORKOR
- Generalized oedema as well as severe wasting
o Because of the oedema, the weight may not be as severely reduced as in marasmus
o In addition, there may be sparse and depigmented hair, skin rash, angular stomatitis, distended
abdomen, enlarged liver (fatty infiltration), and diarrhoea
- It is unclear why some children with protein-energy malnutrition develop kwashiorkor and others
develop marasmus
SEVERE ACUTE MALNUTRITION
- Severe acute malnutrition is defined as the presence of any of the following:
o Weigh- height → more than 3 standard deviations below the median on the standard WHO
growth chart
o MUAC < 115 mm in children 6 months – 5 years old
o Bilateral oedema
MANAGEMENT
- Most children with severe acute malnutrition have an appetite, are alert and can be managed within
community by ready-to-use therapeutic food (RUTF) → mix of peanut butter, milk, vitamins,
minerals, etc.
- Children with no appetite, severe oedema, a medical complication or are less than 6 months old have
complicated severe acute malnutrition and require hospital in-patient care
o In addition to protein and energy deficiency, there is electrolyte and mineral deficiency
(potassium, zinc and magnesium) as well as micronutrient and vitamin deficiency (Vit A)
- Children with long-term disorders who are malnourished will grow better if given supplemental
nutritional support, which may be provided by the enteral or parenteral route
- ENTERAL N → used when GI tract is functioning; feeds are given nasogastrically, by gastrostomy or
occasionally via a feeding tube in the jejunum (e.g. if there are problems with vomiting)
o If long-term, gastrostomy is preferred as prevents constant replacing of NG tube
- PARENTAL N → Energy is given as glucose together with a fat emulsion (usually derived from soya
bean oil, sometimes combined with fish oil, medium chain triglycerides and olive oil), whereas
nitrogen is supplied as synthetic amino acids in a combination resembling egg protein. Electrolytes
and a full range of vitamins, micronutrients, and trace elements are also given
o Common reasons for long-term PN → short bowel syndrome (e.g. major loss of bowel from
complicated gastroschisis, or a volvulus), enteropathies (often with onset of severe diarrhoea
in very early life), or a motility disorder such as long-segment Hirschsprung disease
WHO 10 STEPS FOR ACUTE MANAGEMENT:
- STABILIZATION → Treat Hypoglycaemia (1), Hypothermia (2), Dehydration (avoid fluid overload →
HF) (3), correct Electrolyte imbalances (4), treat Infections (broad spectrum antibiotics- fever and
other signs maybe absent) (5), correct Micronutrient deficiencies (6), Initiate feeding (small
frequent volumes) (7)
- REHABILITATION → Achieve catch-up growth (8), provide Sensory stimulation and emotion
support (9), provide follow-up after recovery (10)
BMI = Kg / (m)2
6. OBESITY 18.5 → Underweight
- Is the most common nutritional disorder affecting children and 18.5–24.9 →Normal weight
adolescents in high-income countries and is rapidly becoming a major 25–29.9 →Overweight
problem in low and middle-income countries as well 30–34.9 →Obese
- Overweight is a BMI >91st centile, and Obese is a BMI >98th centile 35–39.9 →Moderately obese
- Has important short and long-term complications; and these people 40–49.9 →Morbid obesity
are likely to be obese as adults ≥50 →Super morbid obesity
COMPLICATIONS
o Orthopaedic – slipped upper femoral epiphysis, tibia vara (bowlegs), abnormal foot structure
and function
o Idiopathic intracranial hypertension (headaches, blurred optic disc margins)
o Hypoventilation syndrome (daytime somnolence, sleep apnoea, snoring, hypercapnia, heart
failure)
o Non-alcoholic fatty liver disease
o Gall bladder disease/gallstones
o Polycystic ovarian syndrome
o Type 2 diabetes mellitus ; Hypertension ; Abnormal blood lipids
o Other medical sequelae, e.g. asthma, changes in left ventricular mass, increased risk of certain
malignancies (endometrial, breast, and colon cancer)
o Psychological sequelae – low self-esteem, teasing, depression
ETIOLOGY
- Dysregulation of caloric intake and energy expenditure; involving both genetics and environment
- EXOGENOUS CAUSES
o Increased prevalence is due to changes in behaviour relating to diet and physical activity
o Energy-dense foods are widely consumed, including high-fat fast foods and processed foods
o More time is spent with video games, mobiles and TV
▪ Reduction in time spent in front of screens is most effective factor for prevention
o Children from low socioeconomic homes are more likely to be obese
- ENDOGENOUS CAUSES → rare
o Overnutrition accelerates linear growth and puberty → therefore they are relatively tall and
will usually be above the 50th centile for height
o If child is obese and SHORT → look for endogenous cause, i.e. hypothyroidism and Cushing
syndrome
o If obese and with learning disabilities or who are dysmorphic → an underlying syndrome
may be present
▪ Most common of these is Prader–Willi (obesity, hyperphagia, poor linear growth,
dysmorphic facial features, hypotonia, and undescended testes in males
o If severely obese children > 3 years → gene defects, e.g. leptin deficiency, are possible causes
** First predictor of overweight is high birthweight, probably linked to maternal obesity or maternal diabetes
** Paradoxically, lower birthweight appears to place people at risk for later central obesity
*** Children who are overweight are more likely to be over weight as adults
Tx
- Unless there is an endogenous cause or complication, most obese children can be managed in primary
care
- Weight maintenance is a more realistic goal than weight reduction and will result in a demonstrable
fall in BMI on their centile chart as height increases
- Successful management requires sustained changes in lifestyle, with healthier eating, increased
physical activity and reduction in physical inactivity (i.e. decreased TV time)
- Drug treatment can be used in children >12 years who have extreme obesity (BMI > 40 kg/ m2) or
have a BMI over 35 kg/m2 and complications of obesity
o Orlistat → lipase inhibitor which reduces the absorption of dietary fat and thus produces
steatorrhoea
▪ It should not be used for children under 12 years, but may be indicated if there are
comorbidities (e.g. orthopaedic, sleep apnoea) or severe psychological disturbance
- Bariatric surgery → laparoscopic adjustable gastric banding → not considered in children or young
people unless they have almost achieved maturity, have very severe or extreme obesity with
complications, e.g. type 2 diabetes or hypertension and all other interventions have failed
Leptin deficiency child!
7. VITAMIN D DEFICIENCY
PATHOGENESIS
- Deficiency results from inadequate UVB exposure, deficient intake or defective metabolism → low
serum Ca2+ → secretion of parathyroid hormone → normalizes serum Ca2+ but demineralizes the bone
Parathyroid hormone causes renal losses of phosphate and consequently low serum phosphate levels,
further reducing the potential for bone calcification.
RICKETS
- Inadequate mineralisation of bones before growth plates have fused
o Osteomalacia = after growth plated have fused
- vitamin D → calcium and phosphate → 2o hyperparathyroidism
- Food sources: oily fish, liver, egg yolks, fortified margarine, cereal
RISK FACTORS:
o Dark skin living in UK
o sunlight/ intake
o Premature babies (vit D stores build up in womb)
o Drug induced, e.g. phenytoin
o Genetic disorders, e.g. hypophosphataemic rickets (kidneys and bone deal abnormally with
phosphate)
CLINICAL FEATURES
o EARLIEST SIGN → a sensation similar to pressing a ping-pong ball elicited by pressing firmly
over the occipital or posterior parietal bones (cranio- tabes)
o Wrists (especially in crawling infants) and ankles (in walking infants) may be widened
o Severe: signs of hypocalcaemia, e.g. seizures, spasm/ tetany
o Bony deformity: bowed legs, prominent costochondral joints (rachitic rosary), soft skull,
easily fractured
o Harrison’s sulcus → indentation of softened lower ribcage at site of attachment of diaphragm
o Reluctant to weight bear: waddling gait
o Impaired growth, poor weight gain
o respiratory infections due to rachitic lung (expansion and muscular weakness), rachitic
rosary
Dx
o 1,25-dihydroxyvitamin D assay
o plasma calcium and phosphate / alkaline phosphatase and PTH
o Wrist X-ray (required for diagnosis):
▪ Osteopenia/ widening
▪ Cupping and fraying of metaphyses
Fraying occurs at
the METAPHYSIS
(growth plate).
Tx
o Education: dietary advice and referral to dietician
o Sunlight exposure
o Calciferol PO (ergocalciferol/ cholecalciferol) – vitamin D
o Monitor Vit D/ cholecalciferol/ PTH 3-4 monthly
Dx
- Physiological neonatal jaundice is a diagnosis of exclusion → laboratory tests should first rule out all
pathological causes of neonatal jaundice
1. Physical examination for icterus → all neonates should be assessed very ~8-12 hours
2. Bilirubin tests → should be performed in neonates with signs of jaundice
a. Transcutaneous bilirubin measurement (TcB)
i. device that measures the degree of yellow discoloration in the skin with a light signal
b. Serum bilirubin measurement
i. Measured if transcutaneous bilirubin measurement yields a high value or if jaundice
arises within the first 24 hours of life
1. Total serum bilirubin (TSB) measured
2. Differentiation of direct (conjugated) and indirect (unconjugated) bilirubin
3. Other laboratory tests
a. Complete blood count (including reticulocyte count)
b. Blood grouping Red flags:
c. Direct and indirect Coombs' test (Rh incompatibility) - <24h/ >14 days
d. Markers of inflammation - Rapidly rising serum
e. Liver enzymes bilirubin (>100um/L/24h)
i. Increase in the levels of AST, ALT, alkaline phosphatase - Fails to respond to
(ALP), or γ-GT may indicate an underlying hepatic phototherapy
disease (e.g., hepatitis). - Jaundice in sick neonate
f. Total serum protein and serum albumin - Pale stools and dark urine
i. Total protein and albumin levels in serum provide (i.e. conjugated)
information about the nutritional status of a neonate
g. fT4 (free T4)
i. To rule out central hypothyroidism in the case of prolonged neonatal jaundice
h. G6PD activity (in the case of G6PD deficiency)
Tx
- Bilirubin chart: plot a concentration vs age chart to dictate
treatment:
o Different charts are used for each different gestational age
- If under 1st line and –ve tests → supportive Tx
- 1st line: PHOTOTHERAPY:
o Baby subjected to certain light wavelengths which
convert non-conjugated bilirubin → soluble isomer →
this bilirubin levels
- 2nd line: EXCHANGE TRANSFUSION:
o Required if the bilirubin rises to levels that are considered potentially dangerous
o Replace baby’s blood with warm blood 2x through umbilical venous catheter entry) paired with
an arterial line (removal) → to ensure volume balance
o Complications: HR, apnoea, platelets/ glucose/ Na+/ Hb/ O2 sats
- IVIg can also be used in jaundice caused by ABO/ Rhesus incompatibility (i.e. haemolytic disease of the
newborn)
o Acts as a competitive inhibitor to auto-Abs
9. Congenital Newborn Infections
- Congenital infections are caused by pathogens transmitted from mother to the embryo/fetus/newborn
either during pregnancy (transplacentally) or delivery (peripartum) → Vertical transmission
- Vertically transmitted infections that are capable of significantly influencing fetal and neonatal
morbidity and mortality
o Generally, the earlier TORCH infection occurs during pregnancy, the more severe complications
- The acronym TORCH stands for the causative pathogens of congenital infections:
o Toxoplasma gondii
o Others (including Treponema pallidum, Listeria, Varicella, and Parvovirus B19)
o Rubella virus
o Cytomegalovirus (CMV)
o Herpes simplex virus (HSV)
- Primary prevention includes:
o Vaccination for varicella and rubella (prior to pregnancy)
o Hygiene measures (washing hands and avoiding certain foods)
o Screening for syphilis during pregnancy, etc.
- Several other pathogens can also be vertically transmitted during pregnancy and have detrimental
effects on the fetus and/or newborn. These include:
o HIV in pregnancy
o West Nile virus
o Perinatal hepatitis B
o Adenovirus
o Group B Streptococci
o Measles virus
o E. coli
o Enterovirus
o Gonococcal infections
o Zika virus
o Chlamydial infections
CONGENITAL TOXOPLASMOSIS
- Pathogen: Toxoplasma gondii(parasite)→ Asymptomatic in healthy individuals but pregnancy and
immunocompromised are at risk!
- Transmission:
o To Mother from:
▪ Cat faeces ** 4Cs:
▪ Raw or insufficiently cooked meat - Cerebral Calcifications
▪ Unpasteurized milk (especially goat milk) - Chorioretinitis
o To foetus → transplacental transmission - HydroCephalus
- Clinical features: - Convulsions
o Classic triad
▪ Chorioretinitis
▪ Hydrocephalus
▪ Intracranial calcifications (ring-enhancing lesions)
o Petechiae and purpura (blueberry muffin rash)
- Sequelae of congenital toxoplasmosis
o Epilepsy
o Intellectual disability
o Visual disabilities (chorioretinitis → increased risk of retinal lesions, cataracts, and glaucoma)
- Dx
o Foetus: PCR for T. gondii DNA in amniotic fluid
o Newborn
▪ CT/MRI: intracranial calcifications, hydrocephalus, ring-enhancing lesions
▪ T. gondii-specific IgM antibodies (CSF, serum)
▪ PCR for T. gondii DNA (CSF, serum)
- Tx
o Pyrimethamine, sulfadiazine, and folinic acid
- Prevention
o Avoidance of uncooked meat
o Avoidance of handling cat faeces
o Spiramycin → prevention of foetal toxoplasmosis in acute maternal toxoplasmosis infection
CONGENITAL SYPHILIS
- Pathogen: Treponema pallidum
- Transmission ** Hutchinson triad:
o Foetus: Transplacental transmission from infected mother Interstitial keratitis,
o Neonate: Perinatal transmission during birth Sensorineural hearing loss,
- Clinical features Hutchinson teeth
o EARLY congenital syphilis
▪ Onset < 2 years of age
• The majority of newborns with congenital syphilis are asymptomatic at birth
and go on to develop symptoms in the first few months following birth
▪ Hepatomegaly and jaundice
▪ Rhinorrhea with white or bloody nasal discharge (which contains spirochetes)
▪ Maculopapular rash on palms and soles
▪ Skeletal abnormalities (e.g., metaphyseal dystrophy, periostitis)
▪ Generalized non-tender lymphadenopathy
o LATE congenital syphilis
▪ Onset > 2 years of age
• Features are due to continued inflammation and scars in infected tissues
▪ Facial features: saddle nose, frontal bossing, short maxilla
▪ Dental findings: Hutchinson's teeth (notched, widely spaced teeth); Mulberry molars
▪ Eyes and Ears: interstitial keratitis, sensorineural hearing loss
▪ Skin: Gummas
▪ Skeletal: Saber shins (anterior bowing of the tibia), painless arthritis in knees/ joints
▪ Neurologic: cranial nerve palsies (e.g., CN VIII defect causing deafness), intellectual
disability, hydrocephalus
- Dx
o Fetus: Repeated US (placentomegaly, hepatomegaly, ascites, and/or hydrops fetalis)
o Newborn and mother
▪ Initial test: RPR or VDRL (serum)
▪ Confirmatory test: dark-field microscopy or PCR of lesions or bodily fluids
- Tx
o 14 days of IV penicillin G
- Prevention
o Maternal screening in early pregnancy
▪ Penicillin G for mother in early pregnancy → transmission is usually after first trimester
CONGENITAL LISTERIOSIS
- Pathogen: Listeria monocytogenes
- Transmission
o Mother
▪ Contaminated food: especially raw milk products
▪ Other possibilities: fish, meat, industrially processed vegetables (e.g. ready-made salads)
o Fetus
▪ Transplacental transmission from an infected mother
▪ Direct contact with infected vaginal secretions and/or blood during delivery
- Clinical features
- Intrauterine transmission
o Increased risk of spontaneous abortion or premature birth
o Meningitis→ Infection later in pregnancy→ 3rd most common cause of meningitis in newborns
o Sepsis
- Transmission during birth or postnatally (via contact with the mother or contaminated environment)
o 5 days to 3 weeks after birth: Listeria meningitis/encephalitis
- Dx
o Bacterial culture from blood or CSF samples (pleocytosis)
- Tx
o IV ampicillin and gentamicin (for both mother and newborn)
- Prevention
o Avoidance of unpasteurized dairy products
o Avoidance of cold deli meats
CONGENITAL VARICELLA INFECTION
- Pathogen: Varicella-zoster virus (VZV)
- Transmission: Transplacental transmission from an infected mother
- Clinical features
o IUGR, premature birth
o Chorioretinitis, cataract→ Can cause blindness
o Hypoplastic limbs
o Cicatricial skin lesions in a dermatomal distribution
o Encephalitis/CNS abnormalities
o Pneumonia
- Dx
o Foetus: PCR for VZV DNA (in fetal blood, amniotic fluid) and US to detect abnormalities
o Newborn and mother
▪ Usually clinical diagnosis is confirmed by appearance of skin lesions
▪ Direct fluorescent antigen test or PCR of fluid from blisters or CSF
▪ Serology
- Tx
o For pregnant women or newborns with (severe) infection: acyclovir
o Administer postexposure prophylaxis in newborns if mother displays symptoms of varicella < 5
days before delivery: IgG antibodies (varicella-zoster immune globulin, VZIG)
o Caesarean section if lesions are present at delivery
o Encouraged breastfeeding for possible protective effect of antibodies in breast milk
- Prevention
o Immunization of seronegative women before pregnancy
o VZIG in pregnant women without immunity within 10 days of exposure
UNDERSTANDING SEROLOGY
- Positive IgM and negative IgG: very recent infection → refer to specialist
- Positive IgM and IgG: acute infection → refer to specialist
- Positive IgG and negative IgM: maternal immunity → reassurance
- Negative IgG and negative IgM: no maternal immunity → counselling
CONGENITAL RUBELLA INFECTION
- Pathogen: Rubella virus
- Transmission
o Foetus: Transplacental from infected mother
o ~90% transmission if infected in first trimester; but ~0% if at >20 weeks
- Clinical features
- Miscarriage, preterm birth, foetal growth restriction (especially likely if infection occurs during the first
trimester)
- Congenital rubella syndrome
o Triad of congenital rubella syndrome → CCC
▪ Cataracts
▪ Cochlear defect: Bilateral sensorineural hearing loss
▪ Cardiac defect: most common defect (e.g., patent ductus arteriosus, pulmonary artery
stenosis)
o Additional nonspecific clinical features
▪ Hepatosplenomegaly, jaundice
▪ Haemolytic anaemia, thrombocytopenia
▪ Petechiae and purpura (blueberry muffin rash)
▪ CNS defects: microcephaly, intellectual disability, panencephalitis
- Dx
o Newborn and mother
▪ PCR for rubella RNA (throat swab, CSF)
▪ Serology (abnormally high or persistent concentrations of IgM and/or IgG antibodies)
▪ Viral culture (nasopharynx, blood)
o Foetus
▪ IgM antibody serology (chorionic villi, amniotic fluid)
▪ PCR for rubella RNA (chorionic villi, amniotic fluid)
- Tx
o Intrauterine rubella infection
▪ < 16 weeks: Counsel to terminate pregnancy
▪ > 16 weeks: reassurance
o Congenital rubella syndrome: supportive care (based on individual disease manifestations) and
surveillance (including monitoring for later complications)
- Prevention
o Most mothers have been vaccinated, so congenital infection is rare
o Immunization of seronegative women before pregnancy
CONGENITAL CMV INFECTION
- Pathogen: Cytomegalovirus
- Transmission
o Mother: via CMV-contaminated blood, urine, saliva, and genital secretions
o Fetus: Transplacental transmission from an infected mother
o Newborn: During birth or postnatal via breastmilk from infected mother
- Clinical features
o Subclinical infection (∼ 90%): ∼ 10% go on to develop a late complication (most commonly
hearing loss).
o Symptomatic infection at birth (∼ 10%): ∼ 70-80% go on to develop a late complication.
o Fetal infection
▪ Risk of fetal demise, IUGR, Oligohydramnios or polyhydramnios, placental abnormalities
o Sequelae of fetal and newborn infection
▪ Jaundice, hepatosplenomegaly
▪ IUGR
▪ Chorioretinitis
▪ Sensorineural deafness
▪ Periventricular calcifications
▪ Petechiae and purpura (blueberry muffin rash)
▪ Microcephaly
▪ Seizures
- Dx
o Foetus and newborn: US → hydrocephalus, periventricular calcifications, or intraventricular
haemorrhage
o Newborn and mother
▪ CMV IgM antibodies (blood)
▪ Viral culture or PCR for CMV DNA (urine, saliva)
o Foetus
▪ Viral culture or PCR for CMV DNA (amniotic fluid)
▪ CMV IgM antibodies (foetal blood)
- Tx
o Foetus
▪ Severe anaemia: intrauterine blood transfusions
▪ Thrombocytopenia: platelet transfusions
o Newborn
▪ Supportive therapy of symptoms (e.g., fluid/electrolyte imbalances, anaemia,
thrombocytopenia, seizures, secondary infections)
▪ Ganciclovir, valganciclovir, or foscarnet
o Mother: valacyclovir is the only therapy approved during pregnancy
- Prevention
o Frequent hand washing, especially after contact with bodily secretions of small children (e.g.,
diaper changing)
o Avoidance of food sharing with children
o Avoidance of kissing small children on the mouth
Congenital toxoplasmosis may manifest with symptoms similar to those of congenital CMV infection!
CONGENITAL HERPES SIMPLEX VIRUS INFECTION
- Pathogen: Mainly herpes simplex virus 2 (HSV-2); in rare cases HSV-1
- Transmission
o Foetus: Transplacental transmission from an infected mother (rare)
o Newborn: perinatal transmission during birth
- Clinical features
o Intrauterine HSV infection (congenital herpes simplex virus infection)
▪ Foetal demise, preterm birth, IUGR
▪ Microcephaly, hydrocephalus, and other CNS defects
▪ Microphthalmia, chorioretinitis
▪ Vesicular skin lesions
o Perinatal and postnatal transmission
▪ Skin, eye, and mouth disease
• Vesicular skin lesions
• Keratoconjunctivitis‚ cataracts, chorioretinitis
▪ CNS disease
• Meningoencephalitis (manifesting with fever, lethargy, irritability, poor feeding,
seizures, bulging fontanelle)
▪ Disseminated disease
• Features similar to those of sepsis, with multiple organ involvement
• Vesicular skin lesions (may not appear until late in disease course)
- Dx
o Foetus: ultrasound may show CNS abnormalities
o Newborn (and mother)
▪ Standard: viral culture of HSV from skin lesions, conjunctiva, oro/nasopharynx, or
rectum
▪ Alternative: PCR for HSV DNA (CSF, blood)
- Tx
o Newborn and mother: IV acyclovir or valaciclovir
o Additionally in newborns: supportive therapy of fluid/electrolyte imbalances, SIRS, septic
shock, seizures, secondary infections, etc.
- Prevention
o Antiviral therapy (acyclovir) beginning at 36 weeks of gestation for individuals with a known
history of HSV lesions
o Caesarean section in women with active genital lesions or prodromal symptoms (e.g., burning
pain)
HSV should be considered in infants up to 6 weeks of age with vesicular skin lesions, persistent fever
with negative cultures, and/or symptoms of meningitis, encephalitis or sepsis. A high index of
suspicion is warranted in neonatal HSV. Skin, eye, and mouth disease has a good prognosis if detected
and treated early!
INFECTIOUS DISEASE If <4 weeks, temperature
reading should be
Monospot = heterophile Ab test measured in the axilla.
In all febrile children, should record: Do not give anti-pyretics in a child with
- Temperature the sole aim of reducing temperature or
- RR for the prevention of febrile convulsions.
- HR ONLY give anti-pyretics if they are
- Cap refill. distressed and unwell.
Scoring
GREEN AMBER RED
Colour Normal Pallor reported by carer Pale/ mottled/
ashen/ blue
Activity Awake, smiling, No smile, wakes after No response
strong normal prolonged stimulation, Does not wake if
cry decreased activity roused
Weak, high-
pitched
continuous cry
Respiratory Nasal flaring Grunting
Tachypnoea RR >60
Sats <95% Chest indrawing
Crackles
Circulation Normal skin Tachycardia skin turgor
Moist Cap refill >3
membranes Dry membranes
Poor feeding
UO
Other Fever for ≥5 days <3mo and >38oC
Swelling of a limb Non-blanching
Rigors rash
Not using an extremity Bulging
<6mo and >39oC fontanelle
Neck stiffness
Status/ seizures/
focal signs
ACTION Reassure and Safety net and book f/u Admit urgently
send home appointment
HSV1 and 2
Presentations:
• Cold sores
• Genital lesions
• Gingivostomatitis:
o Commonest HSV in 10mo-3yo
o Vesicular lesions on tongue, lips, palate →
ulceration and bleeding
o High fever
o Pain eating and drinking
o Mx: symptomatic, but severe disease may require
acyclovir + chlorhexidine mouthwash.
• Eczema herpeticum: give acyclovir
• Herpetic whitlow: white pustules on skin
• Dendritic ulcer
• Neonatal:
o risk in mothers with infected genital tract
o Present in first few weeks with herpetic lesions round eye or
encephalitis
o Mx:
▪ Elective C-section ONLY if mother has primary disease at
delivery
▪ Avoid foetal blood sampling, scalp electrode, instruments.
▪ If primary infection in within 6 weeks of giving birth: give
acyclovir PO until delivery, then elective CS.
• If born vaginally, give mother IV acyclovir
intrapartum and high dose acyclovir for neonate.
CMV
• Transmission via bodily fluids (inc. Breast milk)
• Normally asymptomatic
• May have viral illness with splenomegaly, liver function, abnormal
lymphocytes, pharyngitis, lymphadenopathy
• IN UTERO: growth restriction, hepatosplenomegaly, jaundice,
thrombocytopenia, microcephaly
o LT: sensorineural hearing loss
• If immunocompromised, can cause:
o Retinitis
o Pneumonitis
o BM failure
o Hepatitis, colitis, oesophagitis
o Encephalitis
• Can be treated with ganciclovir/ foscarnet.
EBV
• Associated with Burkitt’s, lymphoproliferative disease and NP carcinoma.
• Tropism for B cells and epithelial cells of pharynx.
• Older children:
o Lymphadenopathy, dysphagia, pain
o Petichiae on soft palate
o Splenomegaly, hepatomegly
o Maculopapular rash
o Jaundice
• Ix:
o Monospot test (heterophile Ab). May be –ve in very young.
o Paired sera (for IgM and IgG).
• Mx:
o Avoid contact sports and alcohol
o Paracetamol
o Systemic corticosteroids if serious tonsillar enlargement/
haemolytic anaemia
o Ampicillin/ amoxicillin → rash.
ΔΔ = Kawasaki
Measles→ RubeOLA
• Droplet infection
• RNA paramyxovirus
• Incubation = 7-12 days
• Disease:
o Prodrome:
▪ Cough, coryza, conjunctivitis,
febrile, irritable
o Rash – florid. Becomes blotchy and
confluent→ Descending from head.
o Koplik’s spots:
▪ Prodromic viral exanthema of measles – they precede the
rash
▪ White lesions on buccal mucosa
▪ Often fade as rash appears
• Complications (more common in<5yo/ >20yo):
o Otitis media = MOST COMMON
o Pneumonia = most common cause of DEATH.
o Encephalitis (can lead to LT seizures, deafness, LD)
o Subacute sclerosing panencephalitis: develops 7-14 years after
primary infection. Progressive myoclonus,
choreoathetosis, dystonia, dementia, coma and
death.
o risk of appendicitis
o In immunocompromised: giant cell pneumonia
• Diagnosis: specific serum samples (IgM) taken 3 days
after appearance of rash.
• If unvaccinated child has a contact → offer vaccine
within 72h
• Vit A has been shown to ↓ risk of complications
Mumps
• 14-21 day incubation
• Transmission by droplet
• Features:
o Fever, malaise
o Parotitis swelling (→ earache/ pain on eating)
o Muscular pain
o Orchitis (unilateral enlarged testicle 1 week after parotitis).
Fertility may be impaired.
• Ix: amylase due to pancreatic involvement.
• Complications:
o PANCREATITIS
o Aseptic meningitis
o Meningitis
o fertility from orchitis/ oophritis
o Deafness
o Cerebellar ataxia
Rubella (German measles)
• Incubation period = 14-21 days
• Childhood disease = mild. Main problem is maternal infection → foetus.
• Foetal rubella syndrome:
o Heart: PDA, pulmonary stenosis
o Eyes: cataracts, glaucoma, retinopathy Rubella starts on
o Ears: sensorineural deafness face; scarlet fever
o Hepatosplenomegaly, growth retardation spares face
• In adult:
o Low grade fever followed by pink-red maculopapular rash which
starts on the face then spreads to the rest of body.
o Generalised lymphadenopathy
o Suboccipital/ post-auricular lymphadenopathy
• Precautions:
o All women screened for rubella at booking
o Women found to be seronegative on antenatal screening should be
immunised after delivery→ Vaccine is live hence why
o Pregnant women exposed to rubella should be screened for IgM/
IgG REGARDLESS of previous immunisation Hx.
Scarlet fever
• Streptococcal antigen
• Droplet infection → incubation 2-4 days
• Fever followed by rash
• Presentation:
o Rash:
▪ Fine, red and rough textured (sandpaper-like)
▪ Chest, axilla, behind ears
▪ Spares face, palms and soles→ Peri-oral
Scarlet fever:
pallor
Spares face
▪ Sloughs off after 6 days
Sandpaper-like
o Fever
Sloughs off
o Sore throat – tonsillitis
Strawberry tongue
o Pastia’s lines (lines in skin creases)
o Strawberry tongue (red and furry)
• Treat with penicillin (PenA → azithromycin)
• Consider rheumatic fever if chorea.
• Complications: rheumatic fever, Sydenham’s chorea, acute
glomerulonephritis.
TSS (Toxic Shock Syndrome)
• GAS or Staph aureus.
• Toxin → superantigen.
• Presentation:
o Temperature
o Hypotension
o Diffuse, sunburn-like rash
o Desquamation on soles and palms 1-2 weeks later
o Multi-organ dysfunction
o Mucositis
o GI vomiting/ diarrhoea
o Clotting abnormalities + thrombocytopenia
• Mx:
o → take to ITU.
o Debride areas of infection
o Ceftriaxone + clindamycin
o IVIg may also be used to neutralise toxin
Enterovirus
• =:
o Polio
o Coxsackie viruses A & B
o Echovirus.
• Faecal-oral transmission.
• Virus replicates in gut → spreads to other organs.
• Classic clinical syndromes:
o Hand, foot and mouth (coxsackie A16):
▪ Painful vesicular lesions on hands,
feet, mouth, tongue and buttocks
• (ΔΔ VZV if haven’t yet had)
▪ Mild systemic features
▪ Subsides in a few days
▪ Does not require school exclusion.
o Herpangina (coxsackie):
▪ Vesicles on back of throat
▪ Sore throat, loss of appetite, headache, neck pain
▪ Ulcerated lesions of soft palate
o Meningitis/ encephalitis:
▪ There may be a skin rash present – difficult to distinguish
from meningococcal
TB
• Very low bacterial load in children, thus can be hard to diagnose.
• Must treat according to sensitivity. Isolates from:
o Sputum
o Gastric lavage
o Excised tissue.
• If CXR/ mantoux negative but high index of clinical suspicion → TB.
Malaria
• Parasitaemia in <7days old implies transplacental transmission
• Babies:
o Fever, irritability, refuse feeds
o Anaemia, jaundice
o Hepatosplenomegaly
• Do an LP in cerebral malaria to rule out meningitis, or in those with
malaria + febrile seizures.
• Mx:
o Quinine (CI in G6PD)
▪ Widespread falciparum resistance
o Chloroquine
▪ Used in pregnancy
o Mefloquine
o Artemether - particularly effective vs resistance
• Longer course for vivax/ ovale → must make sure dormant hypnozoites
are also killed.
Threadworms
• Enterobius vermicularis
• Infestation occurs after swallowing eggs that are present in the
environment
• Presentation:
o 90% = asymptomatic
o Peri-anal itching
o Girls may have vulval Sx
• Dx: sellotape to peri-anal area → lab
• Mx: mebendazole single dose to WHOLE HOUSEHOLD, + hygiene advice.
Immunisation schedule
Routine immunisations
• 0 weeks:
o BCG:
▪ Offered to high risk groups (>40/100,000)
o Hepatitis B (IV) (first dose):
▪ To children with +ve mothers
▪ (Also give IVIg if mother HBeAg +ve)
• [4 weeks:
o Hepatitis B (alternative time to give first dose)]
• 8 weeks:
o Hepatitis B (second dose)
o DTaP(5) (diphtheria, tetanus, pertussis)/ IPV (inactivated polio
virus - IV)/ HiB.
▪ 5 in one. 5 in 1:
▪ IV DTaP/ IPV/ HiB
o Pneumococcus (conjugate, IV)
o Rotavirus (PO)
o Men B (new in 2015)
• 12 weeks:
o DTaP(5)/ IPV/ HiB
o Men C
o Rotavirus
• 16 weeks:
o DTaPV/ IPV/ HiB
o Pneumococcus
• 12 months:
o Hepatitis B (third dose)
• 12-13 months:
o HiB/ Men C (1 injection)
o Pneumococcus
o MMR
• 2 years:
o Influenza (given every year 2→17: herd immunity; to stop spread to
grand parents rather than to protect children). Nasal spray; LIVE
vaccine
Nasal flu vaccine CI if:
• 3 – 5 years:
- Egg allergy
o DTaP(5)/ IPV/ HiB pre-school booster
- Immuncompromised
o MMR booster
- Current febrile illness/
• 12-13 years:
blocked nose
o HPV for girls
- Wheeze
• 14 years: - Taking aspirin (e.g. for
o Diphtheria/ tetanus/ IPV booster Kawasaki’s → Reye’s
o Men C booster syndrome)
• 65 years:
o Influenza annually
o Pneumococcus
• 70-80 years:
o Varicella zoster.
(Pneumococcal)
Men B
Men C
Men B
Men B & C
Men ACWY
Distribution
• Not required by law but offered.
• All recommended vaccines are free on NHS.
• Vaccination must reach cost effectiveness to be recommended.
Meningicoccus
• Serogroups: A, B, C, Y, W135
• Outcomes: 5% die, 10% have severe/ moderate disabilities, amputations,
cerebral palsy, deafness, brain damage
• Vaccine = fragment of bacterium (conjugated with polysaccharide
antigen)
• Schedule:
o 1 dose Men C given at 12 weeks
o 2nd dose Men C given with HiB at 12-13 months
o Booster at 13-14yo.
MMR
• Injection
• 1st dose at 12 mo
• 2nd dose pre-school
• Both required for herd immunity, as some do not react for first dose.
• Live attenuated.
• IF NOT INITIALLY IMMUNISED:
o Can give MMR, with a repeat dose in 3 months.
• CIs:
o Severe immunosuppression
o Allergy to neomycin
o Children who have received another live vaccine within 4 weeks
o IVIg within past 3mo (may be no response to measles).
• SEs: fever, malaise and rash 5-10 days after.
• Pregnancy should be avoided for 1mo.
Illness Incubation Period School/nursery exclusion
(days) infectiousness
Chicken pox 10-23 -2→+5d Until 5 days after onset of rash
Enterovirus (non-polio, 2-7 Not known 24h from last diarrhea except for
non-hand foot & mouth) E.coli – 2 –ve stools
Gastroeneteritis (viral) 1-10 1-3wks dep on
organism
School exclusion
Advice Condition
No exclusion Conjunctivitis
Fifth disease
Roseola infantum
Infectious mononucleosis
Head lice
Threadworms
24h after starting ABx Scarlet fever
4d from onset of rash Measles
5d from onset of rash Chickenpox
5d after starting ABx Whooping cough
5d from onset swollen glands Mumps
Until symps have settled for 24h D&V
Until lesions have crusted over Impetigo
Until treated Scabies
Until recovered Influenza
11. BIRTH INJURIES
- Infants may be injured at birth, particularly if they are malpositioned or too large for the pelvic outlet
- Severe injuries are now rare due caesarean deliveries for difficult births
SOFT-TISSUE INJURIES
- CAPUT SUCCEDANEUM– bruising and oedema of the presenting part extending beyond
the margins of the skull bones; resolves in a few days → Due to pressure against cervix
- CEPHALHAEMATOMA – Haematoma from bleeding below the periosteum, confined
within margins of the skull sutures. Usually involves the parietal bone. Resolves over
several weeks
- CHIGNON – oedema and bruising from Ventouse delivery (vacuum-assisted vaginal delivery)
- BRUISING – on face, genitalia or buttocks depending on delivery position; more common in preterms
- ABRASIONS – from scalp electrodes applied during labour or from accidental scalpel
incision at caesarean section
- SUBAPONEUROTIC HAEMORRHAGE – diffuse boggy swelling of scalp, blood loss may
be severe and can lead to hypovolaemic shock and coagulopathy
HUMERUS/FEMUR FRACTURE
- Usually midshaft, occurring at breech deliveries, or fracture of the humerus at shoulder dystocia
- Presents as deformity, reduced movement of the limb and pain on movement
- Heals rapidly with immobilization
12. HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Perinatal asphyxia = compromised gas exchange (placental or pulmonary) → Hypoxia, hypercarbia and
respiratory acidosis → CO → tissue perfusion → hypoxic ischaemic injury to brain and other organs
- Hypoxic-ischaemic injury causing encephalopathy usually occurs antenatally or during labour or
delivery, or may occur postnatally, BUT the encephalopathy may sometimes be caused by another
neonatal condition (not asphyxia), e.g. inborn error of metabolism or kernicterus
ETIOLOGY
- Inadequate maternal placental perfusion:
o Maternal hypotension
o Maternal HTN
- Failure of placental gas exchange:
o Prolonged uterine contractions Infants at most risk are
o Placental abruption those >42 weeks who try
o Ruptured uterus normal vaginal delivery
- Interruption of umbilical blood flow: (NVD) and get stuck
o Cord compression, e.g. from shoulder dystocia
o Cord prolapse
- Comprised foetus:
o Anaemia
o IUGR
- Failure of cardiorespiratory adaptation at birth: pressure in the pulmonary circulation is higher in
utero, but must drop after birth to allow perfusion of the lungs
SEVERITY - Clinical manifestations start immediately or up to 48 hours after asphyxia, and can be graded:
- MILD:
o Irritable, staring eyes, excessive response to stimulation, hyperventilation, impaired feeding
o Complete recovery can be expected
- MODERATE:
o Marked abnormalities of tone and movement, can’t feed, may have seizures
o If normal feeding by 2 weeks = good prognosis
o If issues persist = full recovery unlikely
- SEVERE:
o No normal spontaneous movements/ response to pain
o Tone in limbs may fluctuate between hypo-/ hypertonia
o Seizures: prolonged and refractory
▪ ΔΔ: infection, IV haemorrhage, structural lesion, metabolic disturbance/ disorder
o Multiple organ failure
o Mortality 30-40% without cooling therapy (mainly available in high-income countries)
▪ 80% of survivors will have neurodevelopmental disorders, especially cerebral palsy
o Neuronal damage can be:
• 1o: immediate neuronal death
• 2o: delayed (reperfusion injury)
Therapeutic hypothermia:
- Has become standard therapy in the UK and many countries if moderate or severe
o Not used in middle- or low-income countries
Criteria:
o A) In term infants, >1.8kg and <6h old:
▪ Apgar ≤5/ continued need for resuscitation for 10 mins
▪ Cord acidosis pH <7
o B) Altered level of consciousness + 1 of the following:
▪ Hypotonia
▪ Abnormal reflexes
▪ Clinical seizures
o If A) and B) are met → assessment on CFAM: if this shows abnormal background activity/
seizures → criteria met.
o N.B. if CFAM not available but A) and B) met, discuss with senior → may start
Process:
o Cool to 33-34oC (rectal temp) within 6h of incident
o Maintain for 72hrs, before warming up
o Monitor rectal temperature throughout
o Also monitor via:
▪ Cranial USS
▪ Blood gases
▪ Ventilator
** The diagnosis ‘birth asphyxia’ has potentially serious medicolegal implications; it has been recommended that
infants who have the clinical features of HIE should only be considered to have birth asphyxia if there is:
- Evidence of severe hypoxia antenatally or during labour or at delivery
- Resuscitation needed at birth
- Features of encephalopathy
- Evidence of hypoxic damage to other organs such as liver, kidney or heart
- No other prenatal or postnatal cause identified
13. NEONATAL SEIZURES
Causes
- Hypoxic-ischaemic encephalopathy (due to birth asphyxia/respiratory distress etc)
- Infection (meningitis/encephalitis)→ Sometime congenital infections
- Intracranial haemorrhage/infarction
- Structural CNS lesions (focal cortical dysplasia/tuberous sclerosis)
- Metabolic disturbance (Hypoglycaemia; Hyocalcaemia; Hypomagnesaemia; Hypo/Hypernatraemia;
Hyperbilirubinemia (Kernicterus)
- Metabolic disorders (urea cycle disorders/amino acid metabolism)
Dx
- Can be difficult as there may only be subtle clinical signs of seizures
o May miss seizures referable to the brainstem, e.g. nystagmus, conjugate eye movements,
posturing, sucking movements, lip smacking, etc. Grand mal is rare
- Cerebral ultrasound is performed to identify haemorrhage or cerebral malformation
- MRI scans of brain is need for some cerebral ischaemic lesions or cerebral malformations
- EEG is used to confirm seizure activity
Tx
- ABC
- Turn on the side
- Rule out or treat reversible causes such as hypoglycaemia and electrolyte disorders
o Hypoglycaemia and meningitis need to be excluded or treated urgently
- Start on empirical antibiotics, if possible sepsis
- Investigate to find cause of seizures
- If prolonged or repeated seizures consider anticonvulsants
o Firstline: Phenobarbital IV
o Secondline: Phenytoin IV
- Metabolic abnormalities are treated with metabolic approaches; don’t rely on conventional
anticonvulsants
https://www.youtube.com/watch?v=
Igj1HBT6oCQ
14. HAEMORRHAGIC DISEASE OF THE NEWBORN (VITAMIN K DEFICIENCY BLEEDING)
- Vitamin K deficiency bleeding of the newborn (VKDB) refers to spontaneous bleeding in a newborn
caused by a deficiency of vitamin K dependent-coagulation factors
- As vitamin K does not cross the placental barrier, is not present in breast milk, and is not synthesized in
the sterile gut of a newborn, vitamin K levels are low in all neonates
- VKDB is rare in industrialized countries because most children receive a vitamin K injection at birth
ETIOLOGYY
- The underlying cause is always a deficiency of vitamin K, which can be due to various factors:
o Vitamin K deficiency in the mother (e.g., because of anticonvulsant therapy)
▪ Most important in early-onset VKDB; maternal malnutrition
o Exclusive breastfeeding: low vitamin K levels in breast milk
▪ Most important in late-onset VKDB
o Underdeveloped intestinal flora (which produces vitamin K), e.g., due to premature birth
o Long-term antibiotic treatment in newborns
▪ Impairment of the vitamin K-producing bacterial flora
o Low liver storage capacity
o Cholestatic diseases (e.g., biliary atresia)→ Common for Late onset-VKDB
CLINICAL FEATURES
- Bleeding is usually Subgaleal, intracranial, Nasal, Gastrointestinal
- VKDB is categorized as
o Early-onset (within 24 hours after birth)
▪ Bleeding at sites related to trauma at birth
▪ Intracranial bleeding is common
o Classic (within 4 weeks)
▪ Intracranial bleeding is rare
▪ Bleeding: GI, Skin and Mucous membranes, prolonged bleeding after trauma
o Late-onset (between 2–8 months)
▪ Intracranial bleeding is common → long-term cranial disability
▪ Often caused by undiagnosed cholestasis → malabsorption of vitamin K
▪ Greatest morbidity/ mortality
Dx
- Coagulation studies:
o Normal bleeding time
o Decreased Vit K dependant coagulation Factors II, VII, IX, and X → vitamin K dependent
factors→ 2,7,9,10 ASWELL as Decrease Anti-thrombotic factors→ Protein C & S
▪ Increased Prothrombin time (PT) (I, II, V, VII, X)
▪ Normal or Increased activated partial thromboplastin time (aPTT)→ Extrinsic pathway
(I,II,V,VIII,IX,X,XI,XII)
Tx
- Vitamin K IM should be given to all newborn infants to prevent haemorrhagic disease of the newborn
o Parents may request oral vitamin K as an alternative
▪ IM may cause a haematoma as they are deficient of clotting factors
- Mothers on anticonvulsant therapy should receive oral prophylaxis from 36 weeks gestation and the
baby should be given intramuscular vitamin K
Thrombin once produced will produce negative feedback system to inhibit the over clotting→ Produces:
- Plasmin (from plasminogen) which directly breaks down the stable clot
- Anti-thrombin→ Inhibits Factor Xa and factor itself (factor IIa)
Activated Protein C (APC) production is induced by thrombin → APC inhibits factor Va and VIIIa
- Protein S acts as a cofactor to activate protein C
- Thrombomodulin inhibits thrombin directly and stimulates APC
15. Allergy
Hx
- Feeding and weaning: recent change in milk? Bottle fed from day 1?
- Diet and nutrition
- FHx – maternal atopy?
Dennis+
- PMHx: atopy, allergy, asthma, eczema Morgan
- SHx: pets, recreational drugs, smoking Freeman
O/E
- Dennie-Morgan folds (extra folds under eyes from oedema) → marker for atopic dermatitis (Allergy)
- ‘Allergic salute’ – nose-wiping with hand (can leave a permanent crease across the top of your nose)
- Enlarged cervical LNs
- Pale and swollen nasal turbinates (bones inside the nose)
- Mouth breathing.
Food allergy
- Can be:
o Immunological reaction:
▪ IgE mediated
▪ Non-IgE mediated
o Non-immunological (i.e. food intolerance).
- Can occur the 1st time a food is ingested.
- Commonest causes:
o Infants: milk, cow’s milk protein, peanut, egg Live influenza
o Older children: peanut, tree nut, fish, shellfish. (nasal), some
injected influenza
- IgE mediated (IMMEDIATE, type I): and yellow fever
o E.g. anaphylaxis, asthma, rhinitis, acute food allergy vaccines should not be
o Very soon after ingestion: given to children with
▪ Urticaria, face swelling, anaphylaxis egg allergies.
▪ Sneezing, bronchospasm
▪ Oral pruritis
▪ Nausea, colicky abdominal pain, D&V
o Can be:
▪ 1o: allergic from first ingestion (more common)
▪ 2o: initially tolerate, and then become allergic due to cross reactivity of antigens in
fresh fruit/ veg and pollens.
o Diagnosis:
▪ Skin prick test:
• Size of reaction does not correlate with severity
• Good for ruling allergens out
• Many false +ves
• Must stop anti-histamines before.
▪ RAST test (RadioAllergoSorbentTest):
• Blood test for food-specific IgE levels.
• No need to stop anti-histamines before.
- Non-IgE-mediated (DELAYED, type IV):
o Delayed onset (48h-1 week)/ variable clinical course
o May feature eczema/atopic dermatitis, enterocolitis, reflux, colic, FTT.
o Typically involves the GI tract:
▪ GORD
▪ Loose/ frequent stools
▪ Blood and mucus in stools
▪ Abdominal pain, colic, constipation
▪ Food refusal/ aversion
▪ Perianal redness, pallor, tiredness
o Diagnosis:
▪ There is no diagnostic test
▪ Dietary exclusion→ Stop 6 wks= no Sx// Start again= symptoms start
▪ ± gut biopsy
This is not cow’s milk
- Food intolerance:
protein allergy.
o Experiencing digestive problems to certain foods even though the
immune system is not responding (not the cause)
o E.g. transient lactose intolerance following gastroenteritis
o Previously well child
o Develops diarrhoea and vomiting → watery diarrhoea continues for 4-6 weeks then resolves.
o Features in older child: flatulence, cramps, diarrhoea.
o If persisting, lactose (reducing sugar) can be detected in the stool using Clinitest method.
- A food challenge test is the only Ix which can predict the severity of a reaction following exposure→
Food is eaten gradually in increasing amounts under the supervision of a medical profession until
symptoms of intolerance develop.
Allergic rhinitis
- Presentation:
o Coryza and conjunctivitis
o Cough variant rhinitis due to post-nasal drip
o Mainly due to airborne pollens/ spores
- Management:
o 1st = Anti-histamines: loratidine, cetirizine
o 2nd = intranasal steroid spray = beclometasone
o Course of oral corticosteroids may occasionally be needed
- Children have a ~5 URTIs per year in the first few years of life
- Some toddlers and primary school-aged children have as many as 10–12 per year
- ~ 80% of all respiratory infections involve only the nose, throat, ears or sinuses
- URTIs may cause:
o Difficulty in feeding in infants as their noses are blocked and this obstructs breathing
o Febrile seizures
o Acute exacerbations of asthma.
SINUSITIS
- Infection of the paranasal sinuses may occur with viral URTIs
- Occasionally, there is secondary bacterial infection, with pain, swelling and tenderness over the
cheek from infection of the maxillary sinus
- As the frontal sinuses do not develop until late childhood, frontal sinusitis is uncommon in the first
decade of life
- Antibiotics and analgesia are used for acute sinusitis.
STRIDOR
- Stridor is a musical noise heard in inspiration from partial obstruction at the larynx or large airways
- Stertor is an inspiratory noise like snoring, coming from pharynx obstruction (commoner in obese)
- Children’s airways are narrower and more readily deformed than adult airways, so obstruction happens
faster and more dramatically
- Signs: swallowing difficulty/drooling, pale/cyanosed, using accessory muscles of respiration;
downward plunging of the trachea with respiration (tracheal tug); all are grave signs and mean
impending obstruction
Causes
- Congenital: Laryngomalacia, web/stenosis, vascular rings.
- Inflammation: Laryngitis, epiglottitis, laryngotracheobronchitis, anaphylaxis
- Tumours: Haemangiomas or papillomas (usually disappear with onset of immunity—but may require
laser treatment before)
- Trauma: Thermal/chemical—or from intubation.
- Miscellaneous: Airway or oesophageal foreign body; vocal cord paralysis.
- Leading causes to be distinguished are viral croup, bacterial tracheitis and epiglottitis (rare in the
UK since haemophilus vaccination), and inhaled foreign body
- Investigations: This is a clinical diagnosis; lateral neck X-ray may show an enlarged epiglottis, but this
wastes time at a dangerous and critical time
Laryngotracheobronchitis/croup
- The leading cause of stridor with a barking cough (much commoner than epiglottitis)
- Age: <6yrs Epidemics: Autumn
- Pathology: Subglottic oedema, inflammation, and exudate
- Causes: Parainfluenza virus (1, 2, 3), respiratory syncytial virus, measles (rare)
o Bacteria (klebsiella; diphtheria) & fungi are rare.
- Signs: Stridor, barking cough, hoarseness from obstruction in the region of the larynx
o If there is cough and no drooling, croup is almost always the diagnosis
- Is classified into mild/moderate and severe disease
- Usually self-limiting; treat at home (± antibiotics)
- Mild/moderate may be sent home if settles with dexamethasone, 0.15mg/kg PO or prednisolone 1–
2mg/kg
- In hospital: Aim for minimal interference and careful watching (TPR; SAO2) by experienced nurses.
Watch for severe signs: Restlessness; cyanosis (give O2); sternal retractions; rising pulse/respiratory
rate; tiredness
- Admit ITU if severe
o CXR may show ‘steeple sign’ of a tapering trachea
o Give antibiotics, humidified O2, + nebulized adrenaline (5mL 1:1000, may buy time in severe
disease needing ventilating), and dexamethasone PO or budesonide nebulized
▪ NB! volume of stridor is a factor of flow; in severe disease, stridor will be very soft
- Failure to improve with steroids / nebulized adrenaline should prompt the consideration of →
Bacterial tracheitis→ S.aureus
o This is defined by the presence of thick mucopurulent exudate and tracheal mucosal sloughing
that is not cleared by coughing, and risks occluding the airway
o There is often a history of a viral infection (such as croup) with an acute deterioration
o Pronounced tracheal tenderness may be present
o Tx - early intubation and cefotaxime + flucloxacillin→ Same as breast abcess (S.aureus)
o Hydrocortisone may be given but isn't of proven value
Acute epiglottitis → D’s = respiratory distress, drooling, dysphagia, dysphonia
- Rarer than croup, but mortality is higher → is an emergency as respiratory arrest can occur
- Often, history is short, septicaemia is rapid, and cough is absent
- Signs: sore throat, fever, dyspnoea, dysphonia, dysphagia, drooling (head forward tongue out) →
prefers to sit→ TRIPOD POSITION, refusal to swallow→ THUMB SIGN on CXR
- Typical cause: Haemophilus (vaccination has reduced prevalence); Strep pyogenes
- Managing suspected epiglottitis:
o Stay calm! Avoid examining the throat → may precipitate obstruction
o Do not bleed the patient or upset him, and quickly summons the most experienced anaesthetist
to make the diagnosis by laryngoscopy → epiglottitis (a cherry-red, swollen epiglottis) →
Intubate before obstruction occurs
o Since cause is usually H.influenzae type b → treat with 3rd generation cephalosporin
o Hydrocortisone may be given but isn't of proven value
DIPPHTHERIA
- Corynebacterium diphtheria → grey pseudo-membrane formation over nose/ pharynx/ larynx
- Systemic disease → myocarditis and neurological manifestations
- Treat with diphtheria anti-toxin and erythromycin
- Now essentially eradicated because of vaccine
17. WHEEZING AND PNEUMONIA
- Stridor = upper airway = inspiratory
o Croup
o Epiglottitis
- Wheeze = lower airway = expiratory
o Asthma
o Viral LRTIs
o Bronchiolitis
o Foreign bodies
o Tracheo-oesophageal fistula
o GORD
o CF
Pre-school wheeze
- Generally classed as:
o Episodic viral wheeze:
▪ Only occurs following URTI
▪ Tx:
• 1st = SABA
• 2nd = montelukast/ inhaled steroids if there is a Hx of atopy.
▪ No increased risk of asthma.
o Multi-trigger wheeze:
▪ Triggered by URTI, exercise, allergens, cigarettes.
▪ Tx: inhaled steroids or montelukast
▪ risk of asthma later on.
BRONCHIOLITIS
- Most common serious respiratory infection of infancy; usually in winter months
o 90% are aged 1–9 months; highest risk group = <6 months
- Typical cause: Winter respiratory syncytial virus (RSV) – 80% cases
o Others: Mycoplasma, parainfluenza, adenoviruses.
o Co-infection with more than one virus is possible = RSV + metapheumovirus
- Premature infants who develop bronchopulmonary dysplasia or with other underlying lung disease
(e.g. CF) are at greatest risk from severe infection
Presentation
- Coryzal symptoms precede a dry cough and increasing breathlessness
- Low fever, tachypnoea, wheeze, inspiratory crackles, intercostal recession ± cyanosis
- Recurrent apnoea is a serious complication
Ix
- Pulse oximetry in all suspected cases
- No other investigations are routinely recommended
o CXR or blood gases are only indicated if respiratory failure is suspected
- Hospital admission is indicated if any of the following are present:
o Apnoea (observed or reported)
o Severe respiratory distress – grunting, marked chest recession, or a RR >70 breaths/min
o Persistent oxygen saturation of < 90% when breathing air
o Inadequate oral fluid intake (50–75% of usual volume)
Mx
- Humidified oxygen is either delivered via nasal cannula or using a head box
o Stop O2 when SpO2 >92%
- Nasogastric feeds
o Fluids may need to be given by nasogastric tube or intravenously
- 5% need ventilating
- NO EVIDENCE for reducing severity or illness duration using mist, nebulized hypertonic saline,
antibiotics, corticosteroids or nebulized bronchodilators
- Most infants recover from the acute infection within 2 weeks. However, as many as half will have
recurrent episodes of cough and wheeze
PNEUMONIA
Age Pathogens
Neonates - Organism from the mother's genital tract, particularly group B streptococcus
- Also can be:
o E Coli
o Chlamydia trachomatis
o Listeria monocytogenes
Infants - Respiratory viruses e.g. RSV (most common); adenovirus
- Strep pneumoniae
- Haemophilus influenzae
- Bordetella pertussis
Children >5 - Strep pneumoniae
years - Haemophilus influenzae
- Group A strep.
- Mycoplasma pneumoniae = MOST COMMON in school-aged children
** TB SHOULD BE CONSIDERED FOR ALL AGE GROUPS
- RFs:
o Low birthweight, vitamin A deficiency, bottle fed.
- Presentation:
o Similar to that in adults Wheeze: think RSV and bronchiolitis
o Wheeze = viral more likely
o Pain = pleural irritation = bacterial
o ABDOMINAL PAIN is a common presentation of pneumonia in children
o *Dullness to percussion/ signs of consolidation often absent in children
- Ix:
o CXR/FBC/blood and sputum cultures
▪ Nasopharyngeal secretions for viral PCR
- Mx:
o ABx: Viral LRTI is more
▪ Mild → amoxicillin common than
▪ Severe → co-amoxiclav bacterial infection in
▪ PenA = erythromycin children <2, so those
▪ If mycoplasma possible → add in macrolide with mild symptoms
o O2 to maintain sats >92% can typically be
o Admit if:
discharged without
▪ Sats <90% in <6months
antibiotics
▪ Signs of respiratory distress
▪ Suspected MRSA
▪ Concerns about observation at home
- PREVENTION:
o Prevanar-13: conjugate vaccine vs 13 common serotypes of streptococcus pneumonia
▪ 8 weeks, 12 weeks, 12 months
o HiB: given as part of the 5 in 1 at: 8/ 12/ 16 weeks, and with MenC booster at 12-13 months
18. Chronic lung infections. Cystic fibrosis
- Any child with a persistent cough that sounds ‘wet’ or is productive requires further investigations
- Could be due to:
o Persistent bacterial bronchitis → common organisms are Haemophilus influenzae and Moraxella
catarrhalis → precursor to bronchiectasis if Ix and Tx are not instituted
▪ Bacterial growth from sputum or bronchial lavage is consistent with the Dx
▪ Tx is with a high dose of antibiotic such as co-amoxiclav, coupled with physiotherapy
o Bronchiectasis (permanent dilatation of the bronchi)
▪ Can be generalized or restricted to a single lobe
▪ Generalized bronchiectasis may be due to cystic fibrosis, primary ciliary dyskinesia,
immunodeficiency, or chronic aspiration
▪ Focal bronchiectasis is due to previous severe pneumonia, congenital lung abnormality,
or obstruction by a foreign body
• CXR may show gross bronchiectasis, but often it is not possible to identify it →
best identified on CT
• For focal disease, bronchoscopy is usually indicated to exclude a structural cause
CYSTIC FIBROSIS
- Autosomal recessive
- 1/25 carry the gene
o Thus 1/2500 live births. Sweat test:
- Mutation in CFTR gene (CF Transmembrane conductor Regulator) Pilocarpine administered,
on chromosome 7 chloride content of the sweat
o luminal Cl secretion and Na absorption is measured.
o secretions.
o In sweat glands, Na and Cl reabsorption → salty sweat.
- Features:
o Neonate:
▪ FTT (failure to thrive)
▪ Recurrent persistent chest infections with purulent sputum
▪ Nature of sputum predisposes to infection by:
• S.aureus
• H.influenzae
• Pseudomonas later in life.
▪ Meconium ileus: contents of meconium not broken down due to pancreatic insufficiency
→ firm plug of meconium and distended loops of bowel.
▪ Rectal prolapse (due to bulky stools).
o 0-2:
▪ Extended period of neonatal jaundice
▪ Steatthorea
o Children 2-8:
▪ Nasal polyps, sinusitis
▪ Resp:
• Wheeze, cough/ haemoptysis, infections
• Bronchiectasis
• Pneumothorax
• Cor pulmonale
o 8+:
▪ GI:
• Pancreatic insufficiency → DM, steatorrhoea
• Distal intestinal obstruction syndrome
• Gallstones
• Cirrhosis
▪ Cor pulmonale
▪ Pneumothorax
▪ Male infertility
▪ Delayed puberty
▪ Vasculitis
▪ Osteoporosis (due to fat→ vit D)
- Signs:
o Clubbing
o Cyanosis
o Bilateral coarse crepitations (bronchiectasis)
- Respiratory organisms:
o Early:
▪ S.aureus
▪ H.influenzae
o Later:
▪ Pseudomonas
▪ Burkholderia
- Diagnosis:
o Part of newborn blood spot test using immunoreactive trypsinogen (enzyme produced by
pancrease and ↑ in CF) (IRT) with the aim of early diagnosis to preserve lung function.
o GOLD STANDARD = Sweat test:
▪ Na and Cl >60mM
▪ False +ves: atopic eczema/ adrenal insufficiency/ ectodermal dysplasia/ hypothyroid/
glycogen storage disorder/ first day of birth
▪ False –ve: oedema.
o Genetic screening for common mutations (although there are many)
o Faecal elastase:
▪ Tests pancreas exocrine function
▪ Absence = dysfunction.
▪ Not all children have pancreatic involvement → not 100% reliable
- Other Ix:
o Bloods: FBC, LFTs, clotting, ADEK levels, glucose TT
o Sputum MCS
o CXR → bronchiectasis
o Abdo US: fatty liver, cirrhosis, pancreatitis
o Spirometry: obstructive defect
o Aspergillus serology/ skin test (20% develop ABPA).
- Management:
o MDT
o Chest:
▪ Physio: postural drainage, forced expiratory techniques
▪ ABx:
• Oral flucloxacillin in first 2 years of life, as particularly prone to Staph
infections→ Same Abx as mastitis/tracheatis
▪ Mucolytics: DNase, e.g. dornase alpha or hypertonic saline
o Nutritional:
▪ Pancreatic enzyme replacement (creon): amylase, lipase, protease → CRAYON!!!!!!!
▪ ADEK supplements
▪ Insulin if impaired glucose tolerance
▪ Omeprazole
▪ High calorie high fat diet
o Management of complications, e.g. DM.
o DEXA osteoporosis screen.
CFTR is a protein in the membrane of (epithelial) cells found in lungs, pancreas, vas deferens etc→ The protein is
responsible for transport of Cl- in/out of cells.
- In lungs→ The epithelial cells cannot secrete Cl- into the lumen hence Na+ follows the Cl- and water follows
Na+ leaving behind a thick/mucoid secretion in the lungs airways (in lumen)
- In sweat→ Cl- cannot be re-absorbed from the sweat hence Na+ follow Cl- and salt (NaCl) is lost in sweat
DawnASE Alpha
19. TUBERCULOSIS
- Pathogen: Mycobacterium Tuberculosis → Synonymous with acid-fast bacilli
- Incidence and mortality in developed countries has declined, however, there’s an increased incidence in
HIV patients, and emergence of multidrug-resistant Mycobacterium tuberculosis strains (MDR-TB)
- Infection depends on the exposure and efficiency of person’s immune system
- Close proximity, a large infectious load in the index case, and underlying immunodeficiency enhance the
risk of transmission → children typically acquire TB from an infected adult in same household
o Transmission → respiratory droplets → can become droplet nuclei which can remain
suspended in the air for hours
o Children are generally not infectious, because their disease is typically paucibacillary
▪ Also they rarely produce sputum, and they lack tussive forces necessary to project
and suspend infectious particles
- Latent TB is more likely to progress to active TB in infants and young children compared with adults
Dx
- Sputum samples are generally unobtainable → children < 8 years swallow sputum
o Gastric washings and sample extraction via NG tube on 3 consecutive mornings → acid–fast
bacilli (Ziehl–Neelsen stains or auramine stains) and cultures → check of MDR-TB
▪ PCR can also be used in parallel to mycobacterial cultures
- Urine, lymph node tissue, CSF, and radiological examinations should also be performed
- Tuberculin skin test (TST; Mantoux test) → injecting purified protein derivative of tuberculin into
forearm (0.1 ml intradermal injection, read after 48 – 72 hours as induration measured in millimetres)
o TST may be positive from past BCG vaccination
o New guidelines in UK = Induration of 5 mm or more should be considered to be positive,
regardless of prior BCG vaccination
▪ Other countries use different cut-offs (typically 10 mm)
- Interferon-gamma release assays (IGRAs) → blood-based tests for TB
o Assess response of T cells to in vitro stimulation, with a small number of antigens expressed by
M. tuberculosis but not by BCG
o Positive results = TB infection rather than BCG vaccination
o Negative IGRA does not reliably rule out TB infection
- Neither IGRA nor TST can distinguish between latent and active TB
- In advanced immunocompromised both TST and IGRA can be false negative
DDx
- Avoid making incorrect diagnosis of TB on CXR alone, as lymphoid interstitial pneumonitis can have
a similar appearance and occurs in 20% of HIV-infected children
o All individuals with TB should be tested for HIV, and vice versa
Tx
- Triple or quadruple therapy (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol), unless MDR-TB is
strongly suspected (e.g. when a household member has been recently diagnosed with MDR-TB)
o Then decrease to Rifampicin and Isoniazid alone after 2 months
- Tx for uncomplicated pulmonary TB or TB lymphadenitis is usually for 6 months; longer treatment
courses are required for osteoarticular TB, TB meningitis, or disseminated disease
- In adolescents, pyridoxine is given weekly to prevent peripheral neuropathy associated with isoniazid
therapy → a complication that does not occur in young children
- In tuberculous meningitis, dexamethasone is given initially → decreases risk of long-term sequelae
- Asymptomatic children who are Mantoux or IGRA positive and therefore latently infected should also
be treated (e.g. with rifampicin and isoniazid for 3 months or isoniazid alone for 6 months) →
decreases risk of reactivation (i.e. conversion to active TB) later in life
Prevention
- BCG immunization (not 100% effective) → BCG-vaccinated children can still acquire TB infection)
o In the UK, BCG is recommended at birth for high-risk groups
- BCG, which is a live vaccine, should not be given to HIV-positive or other immunocompromised
children due to the risk of severe local reactions and dissemination
- Essential to screen other family members for TB infection
- Children < 2 years who had close contact with a sputum smear-positive pulmonary TB person should
be started on prophylactic isoniazid; if the TST and the IGRA are negative at 6 weeks, isoniazid should
be discontinued, and the BCG vaccine should be given (unless previously immunized with BCG)
CLINICAL FEATURES
- Active TB is often nonspecific → prolonged fever, malaise, anorexia, weight loss, or focal signs of
infection (e.g. lymph node swelling in TB lymphadenitis)
- Majority (~3/4) of cases are with active TB have pulmonary TB; extrapulmonary disease is less
common and includes TB lymphadenitis, osteoarticular TB, genitourinary TB, and TB meningitis
20. ASTHMA
- The most common chronic respiratory disorder in childhood in the developed world
- Diagnosing in preschool children is often difficult → ~ half of all children wheeze at some time during
the first 3 years of life → generally, there are 3 patterns of wheezing:
• Viral episodic wheezing – wheeze only in response to viral infections
▪ Typically, preschool children with episodic wheezing during infections
• Multiple trigger wheeze – in response to multiple triggers and which is more likely to develop
into asthma over time → seen in both preschool and school aged children
• Asthma → more common in children with a personal or family history of atopy
PATHOPHYSIOLOGY
CLINICAL FEATURES
HISTORY
- Wheeze, cough, chest tightness
• Widespread polyphonic (multiple pitch) wheeze
• Asthma should be suspected with wheezing on more than one occasion, particularly if there are
interval symptoms
- Certain pattern/ triggers → Sx worse at night or early morning; occurs in intervals
- Symptoms worse at night
- Exercise induced
- Family history of atopic disease
- Positive response to asthma therapy
OBSERVATIONS
- No clubbing; wet cough or sputum production
- ENT for allergic rhinitis
- Eczema
- Chest is normal between attacks; though might be hyperinflated in long-standing asthma
Dx
- Usually diagnosed by history and examination alone → parental description and response to Tx
- Sometimes specific tests are needed to confirm the diagnosis, or determine the severity and phenotype
in more detail
• Skin-prick testing for common allergens
• CXR → usually normal unless other condition is present
- If there is uncertainty in the diagnosis or disease severity needs to be monitored, peak expiratory flow
rate (PEFR) or spirometry (FEV1) is performed → used for children >5 years
• Increased variability in peak flow = poorly controlled asthma
• Bronchodilator test = improvement of >12% confirms reversibility → characteristic of asthma
- UK Dx criteria
• FEV1 ≥15% AND 200ml with bronchodilators
• FEV1 ≥15% after 15 mins of exercise
• PEF varies by >20% during the day on ≥3days/ week for 2 weeks
MANAGEMENT
<5yo >5yo
1 Salbutamol (SABA) inhaler PRN
2 Salbutamol PRN Salbutamol PRN
Beclometasone BD (Max. 400 – inhibits growth) Beclometasone BD
[OR montelukast mouth dissolving capsule ON if steroids
CI]
3 Salbutamol PRN Salbutamol PRN
Try other one to whichever of becometasone/ montelukast Beclometasone BD
was tried before (NOT LABA) Salmetarol BD- if not working, stop and
Refer to paediatrician if <2yo beclometasone dose
4 Refer to paediatrician Trial of montelukast/ theophylline
5 Prednisolone PO
Salbutamol SEs
• Tremor
• heart rate → myocardial ischaemia → lactate
• K+
• If SEs become too much, can change → terbutaline.
If on high dose inhaled steroids:
• Must monitor growth, as they can growth and cause adrenal suppression
• Transient growth depression may occur; catch up will occur though.
• Consider adrenal insufficiency ± Addisonian crisis if on many steroids and suddenly
consciousness, vomiting, abdominal pain etc.
EMERGENCIES
Most reliable sign for assessing severity = O2 sats.
SEVERE LIFE-THREATENING
• Too breathless to speak/ feed • Pallor, cyanosis, poor respiratory
• PEFR <50% if 5-12 effort, fatigue, agitated, silent chest
• Sats <92% • PEFR <33%
• RR:
o >40 if <5yo
o >30 if >5yo
o >25 if >12yo
• HR:
o >140 if <5yo
o >120 if >5yo
o >110 if >12yo
Management
All children with an exacerbation of asthma should have a 3 day course of prednisolone (regardless of severity).
• MODERATE:
o PEFR (if >5yo) = >50%
o Wheeze
o Sats 92-95%
o Tx
▪ 10 puffs of salbutamol
▪ Repeat after 15-20 mins if necessary
▪ Discharge with 3 day course of prednisolone
• SEVERE/ LIFE-THREATENING:
o OSHSIM:
o O2
o Salbutamol neb
o Ipratropium neb
o IV salbutamol
o Prednisolone fluid/ hydrocortisone IV
o Magnesium sulphate/ aminophylline IV
• In an acutely unwell asthmatic who shows initial improvement but then deteriorates suddenly →
tension pneumothorax.
o Hypotension
o Respiratory distress
o Hypoxia.
21. Respiratory failure
Definition: failure of the lungs to maintain adequate gas exchange due to alveolar hypoventilation, diffusion
impairment, intrapulmonary shunting or ventilation-perfusion mismatch.
Long standing type 1 RF results in hypoxia and eventual organ failure I.e. cardiac arrest.
Long standing type 2 RF results in hypercapnia and this depresses the CNS leading to respiratory arrest.
Diagnosis
• Clinical assessment:
o Take history
o Physical examination
▪ Pallor or cyanosis, assess respiratory rate and pattern, assess chest wall movement, mental
state. Auscultation of breath sounds and note added sounds e.g. wheezes, crackles, stridor
etc. Measure heart rate.
• Investigations:
o Pulse oximetry
o Oxygen saturation (SpO2)
o Arterial blood gases: PaO2, PaCO2, assessment of acid-base status
o Full blood count, electrolytes, glucose and blood cultures
o CXR: for diagnosis of pneumonia or assessment of complications e.g. pulmonary oedema and
pneumothorax
Monitoring
• Pulse oximetry, continuous ECG, blood pressure, temperature, fluid balance and consciousness level
Treatment
• First aid—>ABC and intubation
• Treat underlying cause
• Mask ventilation
• Oxygen therapy
• Mechanical ventilation
• Exogenous surfactant in case of neonatal respiratory distress syndrome
• Extra corporeal life support for neonates
22. Vomiting
• Vomiting is an active process, composed of 3 linked activities : Nausea, retching and active propulsion of
stomach contents
• Control of vomiting by 2 anatomic centers in the medulla —> Chemoreceptor trigger zone (CTZ) and central
vomiting center.
Diagnosis
• History:
o Note age of patient, onset, duration and frequency of vomiting, determine if associated with food
intake, nature of vomiting (projectile, non-projectile, bilious or non-bilious, fecal content, digested or
non-digested food and colour). Note associated symptoms e.g. fever, pain, diarrhoea, constipation,
dysphagia.
o Ask about symptoms according to systems
o Ask about past medical history e.g. inborn errors of metabolism
o Drug and allergy history
• Physical examination
o Assess patient’s weight before and after illness, consciousness (GCS)
o Hydration status—> sunken fontanelle, sunken and tearless eyes, dry mucous membrane, prolonged
capillary refill time, reduced skin turgor, tachycardia and tachypnea
o Abdominal examination: distension, peristalsis, masses, bowel sounds, hepatosplenomegaly
o CNS examination: muscle tone, strength and reflexes, vision changes and fundoscopy.
o Otoscopy
• Investigations and imaging
o FBC, serum creatinine, blood glucose, blood gases, urinalysis
o CXR, plain abdominal x-ray, barium meal, cranial CT and upper GI endoscopy
Treatment
• Treat cause
• Rehydrate and correct electrolyte imbalance
Pathophysiology of pain
• Visceral pain has an aching and dull character and is poorly localised. Can be due to mechanical factors e.g.
stretching or chemical factors.
• Parietal pain is sharp and well-localised
• Referred pain is pain perceived at a location other than the site of the painful stimulus/origin. This is due to
many somatic and visceral afferent fibers converging and entering the spinal cord close to each other.
Localisation of pain
• Bilateral – most GI tract, midline pain
• Unilateral – kidney, ureter, ovary, somatic
Acute appendicitis
• Most common cause of abdominal pain in
childhood. Requires surgical intervention.
• Can occur at any age but typically seen in children under 3 years of age.
• Clinical features: Anorexia, Vomiting, Abdominal pain: initially periumbilical colicky pain which then localises
to the the RLQ (McBurney’s point). Fever and Persistent tenderness with guarding in RLQ (maybe absent if
appendix is retrocecal or pelvic)
• Perforation is more rapid in children due to a less well developed omentum which fails to contain the
inflammation
• Treatment: appendectomy. If complicated by abscess or perforation: give IV antibiotics and fluid
resuscitation prior to laparotomy with appendectomy.
Mesenteric adenitis
• Large mesenteric nodes seen at laparoscopy and whose appendix is normal, but there is doubt whether this
condition truly exists as a diagnostic entity.
Intussusception
• Invagination of proximal bowel into a distal segment. Most commonly ileum into caecum through ileocecal
valve. Common in 3 months – 2 year. May be complicated by constriction and venous and arterial
obstruction. This results in engorgement of bleeding of mucosa, perforation, peritonitis and gut necrosis.
• Clinical features:
o Paroxysmal severe colicky pain with pallor, refuses feeds, bile stained vomit, palpable sausage-
shaped mass in abdomen, passage of red current jelly stools (blood stained mucus), abdominal
distension and shock.
• Abdominal x-ray: distended small bowel and absence of gas sin the distal colon or rectum
• Abdominal US: target/doughnut sign is seen
• Treatment: Reduction by Rectal air insufflation or operative reduction
Meckel diverticulum
• 2% of individuals have Meckel’s diverticulum, 2% of those get symptomatic, 2 inches from ileocecal valve,
2inches long, men are 2X more likely to be affected and 2 types of tissues are present (Gastric/Pancreatic)→
which is a remnant of the vitello-intestinal duct. It contains ectopic gastric or pancreatic tissue.
• Usually asymptomatic but may present with severe red rectal bleeding
• May be complicated by severe bright red rectal bleeding, Obstruction (e.g. intussusception, volvulus),
Diverticulitis (mimics appendicitis), Perforation and tumours.
• Technetium scan will demonstrate uptake by ectopic gastric mucosa.
• Treatment: surgical resection.
Malrotation
• During rotation of the small bowel in fetal life, if the mesentery is not fixed at the duodenojejunal flexure or
in the ileocecal region, its base is shorter than normal, and is predisposed to volvulus. Ladd bands are
peritoneal bands that may cross the duodenum, often anteriorly. Risk of necrosis due to compromised blood
supply.
• Clinical features: Obstruction due to volvulus—>
bilious vomiting in first few days of life, weight
loss, no stools/bloody stools and abdominal
distension
• Diagnosis—> abdominal x-ray shows distended
stomach and duodenum with excess air whereas
distal bowel has little to no air. Upper
gastrointestinal contrast study with barium will
show corkscrew pattern of contrast in region of
malrotation.
• Treatment—> emergency laparotomy and surgical
correction (cecum on left!). Appendectomy is
done to avoid diagnostic confusion if child
presents with symptoms suggestive of appendicitis.
Abdominal migraine
• Abdominal migraine is often associated with attacks of
midline abdominal pain in addition to headaches,
vomiting and facial pallor. Usually there is personal or
family history of migraine. Long periods with no symptoms (e.g. weeks) and shorter period (12-48h) with
pain. Treatment with anti-migraine medication if it causes school absence.
Eosinophilic oesophagitis
• Inflammatory disease of esophagus due to activation of eosinophils within the mucosa and submucosa.
Assumed to be linked to allergy – more common in children with atopy.
• Presents with pain, vomiting and dysphagia.
• Diagnosis: upper endoscopy shows trachealisation of the oesophagus (rings inside the esophagus similar to
rings of tracheal cartilage). Biopsy shows infiltration of eosinophils.
• Treatment: swallowed corticosteroids e.g. Fluticasone and Budesonide.
Gastroenteritis
• Etiology:
o Viruses: Rotavirus (upto 60% of cases in <2 year olds), Adenovirus, Norovirus, Calicivirus,
Coronavirus and Astrovirus
o Bacteria: Campylobacter jejuni (most common), Shigella, Salmonella, Cholera and Enterotoxigenic
E. Coli. Bacterial infection typical for developing countries – ask about recent travel.
o Protozoan parasites: Giardia and Cryptosporidium
• Symptoms: sudden change to loose or watery stools accompanied by vomiting. Blood and pus in stools with
tenesmus for Shigella and Salmonella. Profuse and rapidly
dehydrating diarrhoea with enterotoxigenic E.Coli and
Cholera.
• Dehydration leading to shock is the most serious
complication. Infants have the greatest risk due to greater
surface area to weight ratio which leads to greater
insensible water losses as well as immature renal tubular
reabsorption. Dehydration is assessed by measuring the
degree of weight loss during the diarrheal disease.
• Diagnosis: stool culture if child appear septic. Plasma
electrolytes, urea, creatinine and glucose. Blood culture.
• Treatment:
o Fluids:
▪ No signs of dehydration—> encourage fluid intake to compensate for GI losses and
supplement with oral rehydration solutions (ORS)
▪ Signs of clinical dehydration (loss of 5-10% of BW)—> start with ORS, if no improvement
then give IV fluids (0.9 NaCl w/ or w/o 5% glucose) over at least 48h to limit cerebral
oedema. Monitor electrolytes.
▪ Signs of shock (Loss of >10% of BW)—> IV fluids. Monitor electrolytes.
o Antidiarrhoeal drugs—> Loperamide
o Antibiotics—> usually only indicated if there is suspected sepsis, patient is <6 months old,
malnourished or immunocompromised, or for specific bacterial or protozoan infection.
Metronidazole/Tinidazole for Giardia. Trimethoprim-sulfamethoxazole for E. Coli.
Amoxicillin/Ceftriaxone/Trimethoprim-sulfamethoxazole for Salmonella.
• Anti-rotavirus vaccine available for prophylaxis
Causes of malabsorption
• Due to digestive failure
o Pancreatic insufficiency —> cystic fibrosis, chronic pancreatitis and carcinoma of pancreas
o Bile salt insufficiency —> obstructive jaundice and pseudo-obstruction due to bacterial overgrowth
• Due to structural defects
o Inflammatory bowel diseases e.g. Crohn’s disease (damages terminal ileum leading to impaired bile
acid and vitamin b12 absorption)
o Gastrectomy and gastro-jejunostomy—> lack of intrinsic factor for vitamin B12 absorption
o Short bowel syndrome
o Post-radiation syndrome
• Due to mucosal abnormality
o Coeliac disease
o Specific transport defects e.g. glucose-galactose malabsorption and Acrodermatitis enteropathica
o Food allergy and intolerance e.g. milk protein intolerance
• Due to enzyme deficiencies
o Lactose intolerance
• Due to impaired transport
o Abetalipoproteinemia (Bassen-Kornzweig syndrome)—> defect in microsomal triglyceride (TG)
transfer protein, a protein critical to chylomicron and very-low-density lipoprotein (VLDL)
formation
o Intestinal lymphangiectasia
• Due to infective agents
o Whipple’s disease, Intestinal TB, Tropical sprue, Giardia lamblia and HIV
TREATMENT
• Treat underlying disease
• Supplemental digestive enzymes e.g. pancreatic enzymes in CF
• Nutritional supplements to correct deficiencies
• Parenteral nutrition if malabsorption is severe or slow to recover
25. Chronic non-specific diarrhoea. Inflammatory bowel disease
Crohn’s disease
• This form of IBD can affect any segment of the gastrointestinal tract from the mouth to the
anus. It is a transmural inflammatory disease which can be focal, subacute or chronic.
There are skip lesions (regions of inflamed bowel are interspersed with regions of
unaffected bowel). Commonly affects the distal ileum and proximal colon. There periods of
acute inflammation I.e. relapse and periods of remission. Following acute inflammation
there is formation of fissures, strictures and fistulae with adjacent loops of bowel, skin,
vagina or bladder.
• Clinical presentation:
o Growth failure
o Puberty is delayed
o General ill health: Fever, lethargy and weight loss
o Classic presentation (25%): abdominal pain, diarrhoea and weight loss
o Extra-intestinal manifestations: oral lesions or perianal skin tags, uveitis, arthralgia
and erythema nodosum
Ulcerative colitis
• Recurrent inflammatory and ulceration disease involving the mucosa of the colon only.
• Clinical presentation: rectal bleeding, diarrhoea and colicky pain. Weight loss and growth
failure may occur but less common than CD. Extraintestinal complications – erythema
nodosum and arthritis.
Diagnosis of IBD
• GI endoscopy, МRI-enterography, Enteroscopy, Video-capsule enteroscopy and Double-
balloon enteroscopy.
• Biopsy shows non-caseating epitheloid cell granulomata for CD whereas there is crypt
damage and ulceration with UC.
• Investigations: No laboratory test is specific enough to adequately and definitively establish
the diagnosis of IBD. Inflammatory markers: Leukocytosis, Anemia, Thrombocytosis, ESR,
CRP and Calprotectin.
o Antibodies important for IBS: pANCA (Perinuclear antineutrophil cytoplasmic
antibodies), ASCA (anti-Saccharomyces cerevisiae antibodies) and ANA (anti-Nuclear
antibodies)
▪ pANCA (-) and ASCA (+) have high specificity for CD
▪ pANCA (+) and ASCA (-) have high specificity for UC
Treatment
• CD:
o Nutritional therapy I.e. whole protein modular feeds (polymeric diet) for 6-8 weeks
o Systemic steroids
o Immunosuppressants to prevent relapse e.g. methotrexate, azathioprine or
mercaptopurine. Anti-TNF therapy.
o Long term enteral nutrition in case of growth failure
o Surgery to correct complications e.g. obstruction, fistulae and abscess
• UC:
o Aminosalicylates for induction and maintenance therapy in mild disease
o Topical steroids if confined to rectum and sigmoid colon.
o Systemic steroids for acute exacerbation
o Immunomodulatory therapy with/without low dose steroids to
maintain remission. If not effective use biological therapy e.g.
Ciclosporin
o Colectomy with ileostomy or ileorectal pouch is indicated for
severe fulminating disease.
TRANSMURAL
• This is the infrequent passage of dry, hardened faeces often accompanied by straining or pain and bleeding
• Normal frequency of defecation: 1st week of life – 4x/day and by 1 year of age 2x/day.
• Breast fed infants may not pass stools for several days and be entirely healthy.
• Etiology
o Organic causes: Hirschsprung’s disease, anal disease (infection, stenosis, fissure and hypertonic
anal sphincter), coeliac disease, spinal cord injury, tumour masses, chronic dehydration e.g.
diabetes insipidus, hypothyroidism, hypercalcaemia, food hypersensitivity, drugs (anticholinergics
and opiates) etc.
o Functional causes I.e. voluntary withholding of stool—> Lack of privacy, insufficient water intake,
uncontrolled pain with defecation (anorectal, bone or cancer pain), sexual abuse etc
• Clinical presentation:
o Straining and/or infrequent stools
o Anal pain on defecation
o Fresh rectal bleeding (anal fissure)
o Abdominal pain
o Anorexia
o Involuntary soiling or spurious diarrhoea (liquid faeces
passes around solid impaction)
o Flatulence
o Decreased growth
o Abdominal distension
o Palpable abdominal or rectal faecal masses
o Abnormal anal tone w/DRE (DRE is not usually
indicated)
o RED FLAG SYMPTOMS
• Investigations:
o FBC, coeliac antibody screen, thyroid function tests,
serum Ca, RAST testing, abdominal x-ray, rectal biopsy
(for Hirschsprung’s disease), anal manometry, spinal
imaging (for neurological causes)
• Treatment
o Encourage adequate oral fluid intake
o Encourage good toileting habits
o Medication:
▪ Disimpaction (emptying the rectum)—> give stool softener e.g. Polyethylene glycol 3350 and
electrolytes for 1-2 weeks. If not effective then add stimulant laxative e.g. Sodium
picosulphate and senna or osmotic laxative e.g. lactulose.
▪ Maintenance—> this ensures ongoing pain-free defectation e.g. Polyethylene glycol with or
without stimulant laxative for minimum of 6 months.
o Last resort: enemas e.g. Micralax or phosphate enemas
Different classes of constipation medications exist→ Stool softners, Bulk laxatives (↑ in fibre content), Osmotic
laxative(attract water to colon to help passage), stimulants (muscle contractions which cause stool to pass)
27. Chronic liver diseases
These are liver diseases which last more than 6 months.
• Etiology: Chronic hepatitis (after viral hepatitis B, C and D), biliary tree
disease (e.g. biliary atresia), toxin-induced (e.g. paracetamol, alcohol),
alpha-1 antitrypsin deficiency, autoimmune hepatitis, Wilson’s disease,
Cystic Fibrosis, Alagille syndrome or non-syndrome paucity of bile ducts,
tyrosinaemia, primary sclerosing cholangitis, parental nutrition-induced
and Budd-Chiari syndrome.
• Clinical presentation—>
Galactosaemia
• Rare disorder characterised by the lack of galactose metabolism.
• Symptoms: poor feeding, vomiting, jaundice and hepatomegaly when fed milk. Liver failure, cataracts and
developmental delay are inevitable if untreated.
• Dx: measuring enzyme galactose-1-phosphate uridyl transferase in RBC. Galactose in urine.
• Treatment: galactose-free diet
CHRONIC HEPATITIS
Presents as fatigue, malaise, loss of appetite and occasional bouts of jaundice. Large tender liver and some will have
splenomegaly.
Viral hepatitis
• There are 5 types of viral hepatitis (Hepatitis A-E) but only HBV, HCV and HDV causes chronic hepatitis.
• Dx: LFT (high enzymes), FBC, DBC, detection of HBV antigens or antibodies via serology or PCR
• Hepatitis B virus
o This is a DNA virus which causes acute and chronic hepatitis. High prevalence in Sub-Saharan Africa.
o Transmission: vertical (perinatal), horizontal (breast-feeding), parenteral (transfusion) and sexual
o Infants who contract HBV perinatally are asymptomatic but at least 90% will become chronic
carriers (HBsAg in the serum). Older children who contract HBV will be asymptomatic or have
features of acute hepatitis but 5-10% will become chronic carriers.
o Approx 30-50% of asymptomatic carrier children will develop chronic HBV liver disease which may
progress to cirrhosis in 10%. There is a long term risk of hepatocellular carcinoma.
o Treatment of chronic HBV: interferon or pegylated interferon, oral antiviral therapy e.g. lamivudine,
adenovir.
o Prevention: antenatal screening for HBsAg in pregnant women. Babies of all HBsAg-positive mothers
should receive course of HBV vaccination course with/without Hep B immunoglobulin.
• Hepatitis C virus
o This is a RNA virus. High prevalence in IV drug abusers.
o Transmission: vertical (6% of transmissions from infected mothers but twice as common if there is
confection with HIV)
o Majority of infected children will be chronic carrier. 20-25% risk of cirrhosis or hepatocellular
carcinoma.
o Treatment: not undertaken before 3 years of age as HCV may resolve spontaneously following
vertically acquired infections. Interferon A +/- Ribavarin.
• Hepatitis D virus —> A defective RNA virus that depends on HBV for replication. It occurs as coinfection with
HBV or as a superinfection causing an acute exacerbation of chronic HBV infection.
o Cirrhosis develops in 50-70% of those who develop chronic HDV infection
Autoimmune hepatitis and sclerosing cholangitis
• Mean age presentation is 7-10 years. More common in girls.
• Autoimmune hepatitis:
o May present as acute hepatitis, fulminant hepatic failure or chronic liver disease with autoimmune
feature like skin rash, arthritis, haemolytic anaemia or nephritis.
o Dx: elevated total protein, hypergammaglobinemia (IgG >20 g/l), positive autoantibodies (anti-
smooth muscle, anti-nuclear antibodies and liver-kidney microsomal antibodies), low serum
complement (C4) and typical histology.
• Sclerosing cholangitis:
o Fatigue, Pruritus, jaundice, upper abdominal pain, malabsorption of fat and fat soluble vitamins
(osteoporosis, bleeding and steatorrhea), gallstones/bile duct stones.
o Dx: US, magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde
cholangiopancreatography (ERCP). Anti–smooth muscle antibodies and pANCA are positive.
Antimitochondrial antibody is characteristically negative. Liver biopsy.
• May be in isolation or with inflammatory bowel disease, coeliac disease and other autoimmune disease.
• Treatment: Prednisolone and Azathioprine for autoimmune hepatitis. Ursodeoxycholic acid for sclerosing
cholangitis.
Cystic fibrosis
• Liver disease is the 2nd most common cause of death after respiratory disease. Typically presents as hepatic
steatosis (fatty liver), protein malabsorption and biliary fibrosis (due to abnormal bile concentration).
Cirrhosis and portal hypertension occurs in 20% of children in mid-adolescence. Dx: sweat test. Family
history.
• Treatment of liver complications involves Ursodeoxycholic acid endoscopic treatment of varices and liver
transplantation.
Wilson disease
• Autosomal recessive disorder. Mutations in ATP7B gene result in a combination of reduced synthesis of
ceruloplasmin (copper binding protein) and defective excretion of copper in the bile which leads to an
accumulation of copper in the liver, brain, kidney and cornea. Rarely presents in children <3 years
• Sx: In childhood—>acute hepatitis, fulminant hepatitis, cirrhosis and portal hypertension. Kayser-Fleischer
rings (copper in cornea). From 2nd decade—> neuropsychiatric problems like change in school performance,
behaviour/mood changes, ataxia, tremor and dysarthria. Renal tubular dysfunction with vitamin D resistant
Rickets.
• Dx: low serum copper and ceruloplatsmin. Increased 24h urinary copper excretion. Molecular genetic
testing to prove mutation. Liver biopsy shows copper deposits. Slit-lamp examination for Kayser-Fleischer
rings
• Treatment: lifelong chelation therapy with Penicillamine. Zinc to decrease copper absorption. Pyridoxine to
prevent peripheral neuropathy. Liver transplantation for end-stage liver failure.
Diagnosis
• Antenatal diagnosis
o Screening at 18 and 20 weeks of gestation can reveal congenital heart defects of the fetal heart.
Fetal echocardiography
o If there is a family history or previous child with congenital heart defect—> strong indication for
screening
o Early diagnosis allows parents to choose termination of pregnancy
• History —> determine age, onset and nature of symptoms, prenatal and natal period, developmental history
(age of walking, talking etc), family history (hereditary diseases), allergies, medications etc
• General assessment of the patient is always the first part of the examination with specific attention:
o Cyanosis (nail beds, lips, tongue and other mucous membranes)
o Poor growth/failure to thrive
o Chest wall abnormalities
o Evidence of respiratory distress e.g. use of accessory muscles, retractions etc
o Observe any presence of thrill
• Physical examination
o Measurement of height and weight—> used to determine if there is poor growth
o Cyanosis e.g. patent ductus arteriosus (PDA) will present with differential cyanosis—>blue lower
extremities and pink upper extremities→ ↓oxygenation of blood in distal aorta compared with
proximal aorta (Before the left subclavian artery)→ Patient also have clubbing on toes but not the
finger nails!!
o Hepatomegaly and occasionally splenomegaly
o Peripheral oedemas (sign of heart failure)
o Evaluate character of pulses e.g. large bounding pulses (feel like palpitation) are seen in PDA
o Blood pressure—> measure in all 4 limbs
o Auscultation of the heart sounds—> assess
if with sinus rhythm or arrhythmia and
determine heart rate and presence of
murmurs. Must note the characteristics of
murmurs:
▪ Loudness: according to grades I-IV
▪ Timing in the cardiac cycle: diastolic,
systolic, early, mid or late
▪ Pitch: high or low
▪ Quality: blowing, musical or rough
▪ Location where best heard
▪ Radiation
• Investigations:
o Chest x-ray—> cardiac size (cardiothoracic index should <0.55), pulmonary vessel shadows,
pulmonary oedema, associated lung and thoracic anomalies
o ECG—> detect arrhythmias
o Echocardiography with Doppler ultrasound—> assess cardiac structure, kinetics of heart chambers,
stenosis/regurgitation of valves, blood flow, pressure gradients etc. Echocardiography also assists
with implementing pericardiocentesis, balloon atrial septostomy, ASD/VSD closures and endocardial
biopsy.
o MRI/MRA (angiography)—> useful for emulating children with congenital heart diseases
o CT—> especially for evaluating the pulmonary arteries, anomalies in systemic and venous return and
great vessel anomalies e.g. coarctation of the aorta
o Diagnostic interventional Cardiac catheterisation—> indicated for diagnosis of complex congenital
heart lesions, for cases in which other imaging studies are inconclusive, for patients with critical
haemodynamic assessment and for myocardial biopsy (for diagnosis of cardiomyopathy).
o Blood tests—> FBC, electrolytes, urea, creatinine, liver function tests, thyroid function tests and
arterial blood gas.
Eisenmenger syndrome
• This is the consequence of untreated congenital heart diseases with left to right shunts. These diseases
cause high pulmonary blood flow which if left untreated, will result in thickening of pulmonary artery walls
and therefore increased resistance to flow. This decreases the shunt and these children become less
symptomatic. However when these children enter their teenage years,
the shunt reverses and the teenager turns blue – this is Eisenmenger
syndrome. These patients will die of right HF in 4th-5th decade of life.
• Treatment: early therapeutic intervention for left-to-right shunt heart
diseases.
31. Cardiac disorders outflow obstructions
Aortic stenosis
• Partial fusion of the aortic valve leaflets giving a restrictive exit from the left ventricle.
• There may be 1-3 aortic leaflets.
• Usually accompanied with mitral stenosis and coarctation of the aorta
• Clinical features: Asymptomatic murmur but if AS is severe: reduced exercise tolerance, chest pain on
exertion or syncope
• Physical examination:
o Pulsus parvus (↓volume/weak pulse), slow rising pulses – Pulsus tardus
o Carotid thrill (always)
o Ejection systolic murmur – best heard at upper right sternal edge. Radiating to the neck.
o Delayed and soft aortic S2
o Apical ejection click
• CXR: normal or prominent left ventricle. Post-stenotic dilation of of ascending aorta
• ECG: may have LV hypertrophy
• Echocardiography: shows AS and determines pressure gradients
• Treatment:
o Early treatment is palliative
o Interventions:
▪ Balloon valvotomy—> for children with symptoms on exercise or with high resting pressure
gradient (>64 mmHg) across aortic valve. Balloon is expanded to widen the stenosis. Safe in
older children but more risky for neonates.
▪ Aortic valve replacement—> for most neonate and children with significant AS. Initially there
is palliative treatment until child is old enough for surgery.
Pulmonary stenosis
• Pulmonary valve leaflets are partly fused together giving a restrictive exit from the right ventricle
• Clinical features: Asymptomatic but if PS is critical—> cyanosis
• Physical examination:
o Ejection systolic murmur best heard at upper left sternal edge; thrill may be present
o Ejection click best heard at upper left sternal edge
o Severe PS: right ventricular impulse (heave)
• CXR: normal or post-stenotic dilatation of the pulmonary artery
• ECG: RV hypertrophy (upright T wave in V1)
• Treatment: Transcatheter balloon dilatation—> indicated for patients with markedly increased pressure (>64
mmHg) across pulmonary valve.
Patient is at ↑↑ risk of
subarachnoid haemorrhages due to
↑ Bp proximal to the narrowing
Coarctation of the aorta – infantile type
• 10% of all congenital heart defects
• This is due to the arterial duct tissue encircling the aorta just at the point of insertion of the duct. When the
duct closes, the aorta also constricts, causing sever obstruction to the LV outflow.
• N.B! Infantile type the coarctation occurs PRIOR (Paediatric) to ductus arteriosus→ Duct is PATENT!!
• The constriction can be discrete or severe.
o Discrete juxtaductal coarctation:
▪ Ascending aortic blood flows through the narrowed segment
to reach the descending aorta.
▪ Left ventricular hypertrophy occurs
▪ In first few days of life, the PDA provides temporary relief
from the obstruction.
▪ Net left-to-right ductal shunting occurs in acyanotic infants.
o Severe juxtaductal coarctation (i.e. transverse arch hypoplasia):
▪ Right ventricular blood is ejected through the ductus to
supply the descending aorta.
▪ Perfusion of the lower part of body is dependent on
right ventricular output.
▪ Ductal right-to-left shunting is manifested as differential
cyanosis→ upper extremities are pink (perfused) and
lower extremities are blue.
• Clinical manifestations
o Infants→ symptoms occur when ductus arteriosus closes approx
2 days after birth
▪ Poor feeding, Respiratory distress and Shock→ develop before 2 weeks of age
▪ Metabolic acidosis
▪ Femoral pulses weaker and delayed compared with radial pulses
▪ Lower BP in lower extremities
▪ No murmur but S3 is present
o Older children:
▪ Usually asymptomatic
▪ Leg discomfort with exercise
▪ Headache
▪ Epistaxis
▪ Decreased or absent lower extremity pulses
▪ Hypertension in upper extremity
▪ Murmur of coarctation – best heard in left interscapular area of back
▪ If significant collaterals have developed, continuous murmur may be heard throughout the
chest
• Imaging and ECG:
o Infants:
▪ ECG and CXR show RV hypertrophy with marked cardiomegaly and pulmonary oedema.
▪ Echocardiography shows site of coarctation and associated lesions
o Older children:
▪ ECG and CXR show LV hypertrophy and mildly enlarged heart.
▪ Rib notching may be seen in children >8 years with large collaterals
• Echocardiography shows site and degree of coarctation, presence of left ventricular hypertrophy, aortic
valve morphology and function.
• Treatment:
o In infants:
▪ IV infusions of prostaglandin E1→ chemically opens the ductus arteriosus
▪ Inotropic agents
▪ Diuretics
▪ Balloon angioplasty especially in critically ill infants
▪ Surgical repair is required.
o In older children:
▪ Surgical repair
Interruption of the aortic arch
• Uncommon congenital heart disease. There is a gap between the ascending
aorta and descending aorta so the cardiac output is dependent on the right-
to-left shunt via the ductus arteriosus.
• It is usually associated with VSD
• Clinical presentation—> shock in neonatal period following ductus arteriosus
closure, absent femoral pulses and absent left brachial pulse.
• Treatment
o Surgical correction is performed in the first few days of life
• Congenital arrhythmias may occur in structurally normal or abnormal hearts. They may be secondary to
myocardial disease e.g. rheumatic fever, myocarditis or exposure to toxins, drugs or surgery to the heart.
Children with suspected arrhythmia requires a detailed history, examination and ECG. Do echocardiography
to exclude congenital heart disease.
• Sinus arrhythmia is normal in children and is detectable as a cyclical change in heart rate with respiration
there is acceleration during inspiration and slowing on expiration (HR changing by up to 30 beats/min)
Supraventricular tachycardia
• Most common childhood arrhythmia. HR is rapid, between
250-300 beats/min.
• It can cause poor cardiac output and pulmonary oedema.
• Typically presents with symptoms of heart failure in the in
the neonate or young infant.
• It is a cause of hydrops fetalis and intrauterine death
• It is due to re-entry where a circuit of conduction is set up with premature
activation of the atrium via an accessory pathway. Usually involves the AV
node.
• Investigation with ECG:
o There is narrow complex tachycardia of 250-300 beats/min. QRS
complex <0.08 msec
o In case myocardial ischaemia: T wave inversion in lateral precordial
leads
o If Wolf-Parkinson-White syndrome is present: short PR interval and
delta wave
• Treatment:
o Restore sinus rhythm:
▪ Circulatory and respiratory support —> tissue acidosis is corrected; positive pressure
ventilation
▪ Vagal stimulating procedures e.g. carotid sinus massage or cold ice pack to the face (80%
success)
▪ IV adenosine – treatment of choice! This induces a AV block after bonus injection.
▪ Electrical cardioversion with a synchronised direct current shock (0.5-2 J/kg body weight) if
adenosine fails.
o Maintenance therapy:
▪ E.g. Flecainide or Sotalol
▪ Digoxin can be used if there is no overt pre-excitation I.e. delta wave. If there is pre-
excitation combine with propranolol.
o Treatment is stopped after 1 year of age because 90% of children will have no further attacks.
Children with WPW syndrome will be treated with atrial pacing in teenage years. If there is relapse
then percutaneous radio frequency ablation or cryoablation of the accessory pathway is performed
Atrial fibrillation, atrial flutter, ectopic atrial tachycardia and ventricular fibrillation can occur in children but all are
rare. They are most often seen in children who have undergone surgery for complex congenital heart disease.
33. Infective endocarditis. Myocarditis/cardiomyopathy
Infective endocarditis
• Children with congenital heart diseases (except secumdum ASD) are at risk of infective endocarditis. Also
previous rheumatic heart disease, preceding dental, urinary or intestinal procedures, IV drug abuse, central
venous catheter and prosthetic heart valves.
• Etiology:
o Bacterial IE: staphylococcus aureus (most common acute IE), Streptococcus viridans group (most
common subacute IE), enterococcus and Pseudomonas aeruginosa. HACEK [Haemophilus,
Actinobacillus, Cardiobacterium, Eikenella, Kingella] group
o Non-bacterial IE: viruses, fungi
• Symptoms:
o Fever, anaemia and pallor, dyspnea, malaise, splinter haemorrhages in nailbed, clubbing of fingers
(late sign), necrotic skin lesions, splenomegaly, neurological signs from cerebral infarction, retinal
infarcts, arthritis/arthralgia and microscopic haematuria. Heart failure, new or changing murmurs
and arrhythmias. Embolic phenomena - Roth spots (retinal), petechiae, Osler nodes, and CNS lesion
• Laboratory Tests
o Positive blood culture – low grade bacteremia
o Elevated ESR,
o C-reactive protein
o Leukocytosis
o Immune complexes
o Rheumatoid factor
o Hematuria
o Echocardiographic evidence of valve vegetations
• Therapy
o I.V. Penicillin, Ceftriaxone, Vancomycin, Tienam, Linezolid for 4 to 8 weeks.
o Surgery of valves is indicated
▪ unsuccessful medical treatment
▪ unusual pathogen
▪ myocardial abscess formation
▪ refractory heart failure
▪ serious embolic complications
▪ refractory prosthetic valve disease
• Prophylaxis
o Good dental hygiene and avoid body piercings and tattoos
o Antibiotic prophylaxis for dental treatment or abdominal/urological surgeries where there is risk of
bacteriemia.
Myocarditis
• Acute or chronic infection of the myocardium. Results in inflammatory cell infiltration of myocardium and
myocyte degeneration/necrosis.
• Etiology:
o Viral (e.g., coxsackievirus, mumps, Epstein-Barr virus, influenza, parainfluenza, measles, varicella,
HIV)
o Rickettsiae (e.g., psittacosis, Coxiella,
o Bacterial (e.g., diphtheria, Mycoplasma, meningococcus, leptospirosis, Lyme disease)
o Parasitic (e.g., Chagas disease, toxoplasmosis, Loa loa) → John shagged the cat & got myocarditis
• Symptoms:
o Fever, severe heart failure, respiratory distress, cyanosis, distant heart sounds, weak pulses,
tachycardia out of proportion to the fever, mitral insufficiency caused by dilatation of the valve
annulus, a gallop rhythm, acidosis, and shock.
o Evidence of viral hepatitis, aseptic meningitis, and an associated rash may be present.
▪ In the most fulminant form, death may occur within 1–7 days of the onset of symptoms.
oThe chest x-ray demonstrates an enormously enlarged heart (dilated cardiomyopathy) and
pulmonary edema.
o The ECG reveals sinus tachycardia, reduced QRS complex voltage, and ST segment and T-wave
abnormalities. Arrhythmias may be the first clinical manifestation
o Onset of congestive heart failure or a sudden onset of ventricular arrhythmias. In these patients, the
acute infectious phase has usually passed and an idiopathic dilated cardiomyopathy is present
• Diagnosis:
o ESR, heart enzymes (creatine phosphokinase, lactate dehydrogenase), and brain natriuretic peptide
(BNP) are elevated
o Serum viral titers
o PCR of ventricular biopsy and serum samples (viral genome
routinely present in cardiac samples yet absent in peripheral
blood)
o Echocardiography - poor ventricular function and often a
pericardial effusion, mitral valve regurgitation, and the absence
of coronary artery or other congenital heart lesions.
o Endomyocardial biopsy - during cardiac catheterization
• TREATMENT
o For severe congestive heart failure or cardiogenic shock
▪ Intravenous immunoglobulin (IVIG) 2 g/kg
▪ Prednisone (2 mg/kg daily, tapered to 0.3 mg/kg daily
over a period of 3 mo)
▪ Antiviral drugs- enterovirus (pleconaril), Epstein-Barr
virus (acyclovir)
Cardiomyopathy
• Primary disorder of the heart muscle. There are 3 types: dilated CM,
hypertrophic CM and restrictive CM.
o Dilated CM is more common in children. Hypertrophic and
restrictive CM are more rare.
Arthritis: disease that causes painful inflammation and stiffness of the joints.
• Joints are typically swollen or 2/4 of the following signs are present: ↑ local temperature, erythema (redness of
skin and mucous membranes due to hyperaemia;↑ local blood flow), pain and ↓ range of movement.
• 1-5% of children have joint symptoms.
• Monoarthritis (1 joint), oligoarthritis (2–4 joints) and polyarthritis (≥ 5 joints). Gout, septic arthritis,
osteoarthritis and reactive arthritis commonly present as a monoarthritis/oligoarthritis.
The commonest chronic inflammatory joint disease in children and adolescents. Defined as persistent joint swelling
(>6 months duration) presenting in < 16 yrs of age in the absnce of infection or any other define cause.
Classification: clinically based on the # of joints affceted in the 1st 6 months of disease, there are 7 different subtypes
of JIA.
1. Oligoarthritis persistant (49% of JIA cases): age of onset (AOO) is 1-6 yrs, female to male gender ratio (F:M) is
5:1. It affects 1-4 joints, most commonly the knee, followed by ankle and wrists. Patients have swelling, limping
and inability to extend rather than pain. ● ANA(+) with a ↑ risk of chronic uveitis (pain andblurred vision).
2. Oligoarthritis extended (8%): AOO 1-6 yrs. 5F:1M. > 4 joints affected after the 1st 6 months of disease,
assymetrical distribution of the affected joints. ANA (+), chronic uveitis and assymetrical growth.
3. Polyarthritis, rheumatoid factor (RF) negative (16%): AOO 1-6 yrs. 5F:1M. > 5 joints affected (large and small).
Affects joints of the digits, cervical spine and the temperomandibular joint. Low grade fever, uveitis and late
reduction of growth rate. IgM RF negative.
4. Polysrthritis RF posisitve (3%): AOO 10-16 yrs. 5F:1M. Chronic, symmetrically affected both smal and large joints
(> 3months). Marked finger involvement, rheumatoid nodules, morning stiffess and low grade fever. Remain RF
(+) long term; 2 occasions, 3 months apart. Erosions on X-ray.
5. Systemic artritis (9%): AOO 1-10 yrs. Equa F:M. Initially starts as arthralgia and/ or myalgia, then after 6 months
may develop into oligoarthritis or polyarthritis. High daily fever, pink-salmon macular rash on the chest and
trunk. Labs→ Pancytopenia
6. Psoriasis arthrtitis (7%): AOO 1-16 yrs. Equal F:M. Rash before arthritis develops. Asymmetrical distribution of
both large (knees or ankles) and small (metacarpal phalangeal, proximal and distal interphalangeal) joints.
Dactylitis, nail pitting, chronic anterior uveitis and psoriasis.
7. Enthesitis related arthrtis (7%): AOO 6-16 yrs. 1F:4M. Lower limb and large joint arthritis or sacroiliac joint
tenderness with enthesitis (site where the ligament attaches to bone). Acute anterior uveitis, HLA B272 (+).
8. Undifferentiated arthtritis (1%): AOO 1-16 yrs. 2F:1M. Overlapping articular and extra-articular patterns
between ≥2 subtypes (insufficient criteria for sub-classification).
Clinical signs
Complications
Systemic inflammatory connective tissue disease that develops as a complicatoin to A beta - haemolytic
streptococcus infection. Disease occurs 2-4 weeks (sequelae) after initial infection (usually pharyngitis) with
rheumatologic, cardiac, and neurologic manifestations.
Clinical signs
Primary infection → latent/ incubation period of ~ 18 days → ARF onset (fever, migratory polyarthritis, carditis,
chorea and malaise). The following Jones criteria are used to diagnose ARF:
• Major manifestations:
o Carditis (50% of ARF cases)
▪ Endocarditis: significant number, valvular dysfunction.
▪ Myocarditis: may lead to heart failure and death.
▪ Pericarditis: pericardial friction rub, pericardial effusion and tamponade.
o Polyarthritis (80%): migratory, painful polyarthritis that affects the ankles, knees and wrists. Tenderness,
redness and swelling. Described as “flitting”, will last <1 week in a joint, but then migrate to another
over the next 1-2 months.
o Chorea (10%): neurological disorder, involuntary movements and emotional lability. Occurs 2-6
monthspost strep throat.
o Erythema marginatum (<5%): uncommon early manifestattuon of a rash on the trunk and limbs; pink
border macules with a faded centre.
o Subcutaneous nodules (rare): painless, pea-sized, hard on the extensor surfaces.
• Minor manifestations:
o Fever
o Polyarthralgia
o History of rheumatic fever
o Raised acute phase reactants, ESR, C-reactive protein and leucocytosis.
o Prolonged P-R interval on the ECG.
Diagnosis: 2 major, or 1 major and 2 minor criteria plus evidence of past group A strep infection e.g. ↑ ASO titre or
anti-streptococcal Abs, or positive throat culture.
*Chronic rheumatic heart - long-term damage from valve fibrosis and mitral stenosis. Sxs often don’t manifest until
late adulthood as aortic, tricuspid or pulmonoary valve diseas.
Management/ Treatment
Vasculitis is inflammation of blood vessels, often with ischemia, necrosis, and organ inflammation. Vasculitis can
affect any blood vessel—arteries, arterioles, veins, venules, or capillaries.
Classification
• Predominantly large vessel vasculitis e.g. Takayasu arteritis
• Predominantly medium sized vessel vasculitis e.g. Kawasaki disease
• Predominantly small vessel vasculitis:
o Granulomatous e.g. Wegener’s granulomatosis
o Non-granulomatous e.g. HSP
• Other vasculitides e.g. polyarteritis nodosa, lupus, dermatomyositis, scleroderma etc
Henoch-Schonlein purpura
• Occurs in ages 3-10 years. M:F =2:1. Peaks during the winter months
and often preceded by upper respiratory infection.
• Unknown cause – excess IgA and disruption in IgG—> immune
complex formation and deposition. Complexes activate complement
and promote small vessel vasculitis
• Symptoms: characteristic symmetrical palpable purpuric skin rash on
extensor surfaces of the extremities and buttocks, arthralgia,
periarticular oedema, colicky abdominal pain (may have
haematemesis, melaena and intussusception), glomerulonephritis
(with macro/microscopic haematuria and mild proteinuria)
• Diagnosis: Based on clinical features and kidney biopsy to prove
crescentic IgA glomerulonephritis (indicated when there is heavy
proteinuria, oedema, hypertension and deteriorating kidney
function)
• Investigations: FBC, renal function, dipstick urinalysis and renal
biopsy
• Treatment: typically has a benign course with resolution within 6 weeks. NSAIDs help with arthritis
symptoms. Corticosteroids for abdominal pain and arthritis.
• Follow-up for assessment of renal function
Kawasaki disease
• Affects children of 6 months to 5 years of age. Younger infants are more severely affected compared to older
children. More common in children of Japanese descent
• It is a systemic vasculitis with coronary arteritis. This is complicated by coronary artery aneurysms, coronary
thrombosis, myocardial infarction an dysarrhythmias.
• Diagnostic criteria:
o Fever (>38.5oC) present for at least 5 days without other explanation, in the presence of 4 of the 5
following criteria:
▪ Bilateral congestion of the ocular conjunctivae
▪ Changes of the lips and oral cavity with at least one of the following: dryness, erythema,
fissuring of lips, strawberry tongue, diffuse erythema of oral and pharyngeal mucosa without
discrete lesions.
▪ Changes of the extremities with at least one of the following: erythema of palms and soles,
indurative oedema, periungual desquamation of the fingers and toes
▪ Polymorphous exanthem/rash
▪ Non-suppurative cervical lymphadenopathy >1.5 cm
• Investigations:
o FBC: normocytic normochromic anaemia
o DBC: leucocytosis, thrombocytosis
o ESR and CRP are elevated
o LFT: increased liver transaminases
o ECG
o Urinalysis: monocytes in urine
o Echocardiography: pericardial effusion, poor contractility,
endocardial disease (valve regurgitation) or coronary disease with aneurysm formation which can be
giant (>8 mm in diameter). If coronary arteries are abnormal then angiography or MRI is required.
o Serology: ANA, rheumatoid factor
• Treatment:
o IV immunoglobulin —> should be administered within first 10 days to lower risk of coronary
aneurysms
o Aspirin to reduce thrombosis
o Persistent cases: corticosteroids, infliximab (mAb against TNF-alpha) or cyclosporin
36. Urinary tract infection. Urinary tract obstruction
• Hydrocalycosis—> dilatation of the calyces as a result of obstruction at the infundibulum. This can be due to
congenital anomaly, trauma and inflammation. Patient presents with symptoms of hydronephrosis and UTI.
• Fraley syndrome—> an accessory artery which compresses the lower pole of the kidney, mainly in boys.
Presents with antenatal hydronephrosis, tumour in the neonatal period, abdominal or back pain, loin
tenderness, UTI and asymptomatic haematuria after minimal trauma.
• Ectopic ureter—> ureter enters abnormal locations e.g. urethra at bladder neck (35%), urethra-vagina
septum, vagina, cervix, uterus or posterior urethral wall. Clinical picture of contact trickle of urine (in girls),
epididymitis (in boys), UTI symptoms and hydronephrosis symptoms.
• Ureterocele—> cystic dilatation of the terminal ureter, mainly in girls. Can present as hydronephrosis,
vesicoureteric reflux and UTI. Diagnosis: MCUG or IV urogram.
• Megaureter—> occurs as a result of:
o Vesicoureteric reflux
o Obstruction
▪ congenital anomaly (ectopic ureter, ectopic ureterocele)
▪ secondary (neurogenic bladder, urethral calculosis and post-surgery)
o Non-refluxing, non-obstructive
▪ Infection, diabetes insipidus, persistent after surgical correction of vesicoureteric reflux
• Obstruction of the bladder neck—> always secondary – ectopic ureterocele, bladder calculosis and pelvic
tumour.
• Posterior urethral valve – only in boys
o Bilateral hydronephrosis with abnormally large bladder on antenatal ultrasound
o Neonates – poor urinary flow, large palpable bladder
o Infants – uraemia and/or sepsis
o Milder stenosis presents in early childhood with UTI or enuresis
o Dx: catheterisation and MCUG.
• Urethral atresia—> only boys
• Urethral hypoplasia—> only boys. Bilateral hydronephrosis and large bladder
• Obstructed urethra—> in boys: secondary due to catheterisation, trauma, surgery. Presents with poor
urinary flow, dysuria and haematuria. In girls: extremely rare because the location of the urethra protects it
from trauma.
• Urinary tract stones
o Boys are affected more often than girls
o Most common stones are phosphate stones, calcium stones, uric acid stone and oxalate stone.
Cysteine and xanthine stones are rare.
o Formed as a result of:
▪ increased urine concentration of stone-forming substances e.g. hypercalciuria
▪ presence of chemical or physical factors that facilitate stone formation e.g. UTI
▪ Insufficient amount of inhibiting factors – magnesium, citrate
o Causes:
▪ Family history of hypercalciuria, cystinuria, glycinuria, hyperoxaluria and xanthinuria
▪ Hypervitaminosis A and D, medication e.g. allopurinol, furosemide, fluids rich in Ca/oxalate,
hyperparathyroidism etc
▪ Congenital anomalies e.g. pelviureteric junction obstruction and megaureter.
▪ Chronic UTI with Proteus (predisposes to stag horn calculus), Pseudomonas, Klebsiella etc
o Clinical presentation:
▪ Acute severe pain/renal colic, typically irradiating along the path of the ureters to the labia
or scrotum
▪ Haematuria (less frequent compared to adults)
▪ Symptoms of UTI
▪ Dysuria, frequency, urgency and difficulty in passing urine
▪ Accidental x-ray finding
o Diagnosis: clinical features, FBC, U&E (calcium, phosphate, uric acid), dipstick test, urine microscopy
and culture, parathyroid hormone US, plain x-ray, CT, IV urogram
o Treatment: high fluid intake to promote spontaneous passage of stone. If no passage, lithotripsy or
surgery (ureteroscopy and stone extraction). Antibiotics for underlying UTI.
37. Proteinuria
Nephrotic syndrome
• Comprised of:
o Proteinuria (>3.5g/24h)
o Hypoalbuminaemia (<2.5g/dL)
o Hyperlipidemia (cholesterol >200mg/dL)
o Oedema
• Etiology:
o Primary: congenital nephrotic syndrome, minimal change disease (85%), focal segmental
glomerulosclerosis, membranoproliferative glomerulonephritis, and membranous
glomerulonephritis.
o Secondary: Henoch-Schonlein purpura, SLE, infections e.g. malaria or allergens e.g. bee sting
• Signs:
o Periorbital oedema
o Scrotal or vulval, leg and ankle oedema
o Ascites
o Dyspnea due to pleural effusions and abdominal distension
o Infection e.g. peritonitis, septics arthritis or sepsis due to loss of protective immunoglobulins in the
urine→ Urine may be frothy white indicating lipids in urine
• Investigations: urinalysis/dipstick, urinary protein:creatinine ratio, 24h urinary protein, FBC, plasma albumin
• Steroid sensitive nephrotic syndrome
o Mainly due to minimal change disease (>95%)
o 85-90% of children with nephrotic syndrome, the proteinuria resolves with corticosteroid therapy
(steroid sensitive nephrotic syndrome). These children do not progress to CKD.
o Features suggesting steroid-sensitive nephrotic syndrome: age between 1-10 years, no macroscopic
haematuria, normal BP, normal complement and normal renal function.
• Steroid-resistant nephrotic syndrome
o Accounts for 10-15% of cases.
o Same features as steroid-sensitive nephrotic syndrome only that it is not well treated with steroids.
• Congenital nephrotic syndrome
o Presents in 1st 3 months of life. Rare autosomal recessive condition. High mortality with very severe
proteinuria which is treated with unilateral nephrectomy followed by dialysis. Requires renal
transplantation when child is old enough.
• Treatment
o Management of steroid sensitive nephrotic syndrome: Oral corticosteroids e.g. 60mg/m2/day of
Prednisolone. Then after 4 weeks reduce dose to 40mg/m2 on alternate days for 4 weeks. Then
wean off.
o Management of steroid resistant nephrotic syndrome: first with calcineurin inhibitors (Cyclosporin
or tacrolimus). Diuretics (loop Diuretic), ACE inhibitors and NSAIDs
o Salt restriction
o Antibiotic e.g. oral penicillin V
• Complications of nephrotic syndrome:
o Hypovolemia—> due to oedema there is reduced volume of the intravascular compartment. Body
compensates with sodium retention by the kidneys and peripheral vasoconstriction. Hypovolemia is
presented by low urinary sodium (<10mmol/l) and high haematocrit. Treat with IV fluids and
albumin infusion if severe.
o Thrombosis—> urinary losses of antithrombin III, high haematocrit and increased clotting factors
promotes a hypercoagulable state.
o Infection—> especially with encapsulated bacteria like pneumococcus. Immunise with
pneumococcal vaccine/antibiotic prophylaxis e.g. Penicillin V.
o Hypercholesterolaemia—> not well understood but correlates inversely with serum albumin.
o Acute kidney injury.
• Prognosis
o 30% single relapse, 30% occasional relapses, 30% steroid dependence
o Children with steroid sensitive nephrotic syndrome are prone to relapse.
o Management of relapse: Levamisole, alkylating agents (Cyclophosphamide), calcineurin inhibitors
(Cyclosporin) and immunosuppressants (Mycophenolate mofetil)
38. Haematuria
• Haematuria = blood in the urine I.e. 10 or more RBC per high-power field is abnormal.
o Macroscopic (gross) haematuria: any discoloured urine visible to the human eye I.e. >10 RBC
o Microscopic haematuria: >5 RBC under microscopy in 3 consecutive centrifuged specimen of urine at
least 1 week apart.
• Classification of haematuria:
o Macroscopic or microscopic
o Symptomatic or symptomless/asymptomatic
o Transient or Persistent
• Causes:
o UTI e.g. cystitis, tuberculosis
o Tumour e.g. Wilm’s tumour
o Trauma e.g. accident, catheter
o Inflammation: glomerulonephritis, Henoch Schonlein purpura, IgA nephropathy, polyarteritis nodosa
o Structural: calculi (renal, bladder, ureteric)
o Haematological: coagulation disorders
o Toxins: sulphonamides, NSAID
o Other: genital bleeding, child abuse, menstruation
• DDX of ‘dark urine’—> Haemoglobinuria (dipstick positive but no red cells on microscopy), myoglobinuria,
foods (e.g. beetroot), drugs (e.g. Rifampicin), Urate crystals, Bilirubinuria (obstructive biliary disease) and
External source e.g. menstrual blood.
• Haematuria can be:
o Glomerular—> renal (IgA nephropathy, Alport syndrome, thin GBM disease, post-infectious GN and
MPGN) and multi-system (SLE nephritis, HSP, Wegener syndrome, goodpasture syndrome, HUS)
o Extraglomerular but renal—> pyelonephritis, papillary necrosis , nephrocalcinosis, thrombosis,
malformation and tumour.
o Extrarenal —> cystitis, urethritis, urolithiasis, trauma, coagulopathy, heavy exercise, ureteropelvic
obstruction and ureterocele
• Glomerular haematuria is suggested by brown urine, deformed RBC, casts and proteinuria.
• Lower urinary tract haematuria is usually red and occurs at the beginning or end of the urinary stream, blood
clots and is not accompanied by proteinuria.
• Isolated haematuria (microscopic)
o No other urinary abnormalities, no renal insufficiency and no evidence for systemic disease.
o Incidence (school-aged children): 4-6% single urine examination; 0.5-1% repeated testing over 6-12
months
• Isolated gross recurrent haematuria
o Asymptomatic patient—> IgA nephropathy, Alport syndrome and hypercalciuria
• History:
o UTI: fever, frequency, dysuria
o Renal stones: renal colic
o Sore throat/rashes (post-streptococcal GN)
o Easy bruising
o Trauma
o Family history: haematuria, deafness (Alport’s), sickle cell disease
• Clinical presentation
o Episode of macroscopic haematuria
o Incidental finding of microscopic haematuria
o Family screening and routine urinalysis
• Investigations
o Urine microscopy (with phase contrast) and culture with protein:creatinine rate, protein and calcium
excretion, US, plasma urea, electrolytes, creatinine, calcium, phosphate, albumin, FBC, platelets,
coagulation screen, complement, ASO titre and sickle cell screen.
o For Alport syndrome: Urinalysis of mother’s urine and perform hearing test in infant
• Treatment
o Treat underlying cause e.g. UTI, urinary tract stones
Common causes of haematuria:
Nephritis
• Most common cause of glomerular injury. It is a disturbance of the glomerular structure with inflammatory
cell proliferation
• This leads to oliguria, uraemia/azotemia, haematuria and hypertension
• Causes: post-infectious GN, vasculitis (e.g. HSP, SLE), IgA nephropathy, mesangiocapillary GN, Goodpasture
syndrome
• Post-Streptococcal glomerulonephritis nephritis
o >3 years
o Occurs 1-3 weeks after streptococcal sore throat or skin infection by Group A beta haemolytic
streptococcus
o Sx: oedema, gross haematuria like cola/tea, oliguria and hypertension
o Diagnosis: throat or skin culture of organism, raised ASO titre/anti-DNAse B titres, Streptozyme test
and low complement C3. Urinalysis: RBC casts, hyaline and/or epithelial casts.
o C3 level returns to normal after 3-4 weeks
o Renal biopsy indicated when haematuria or proteinuria >1 year, low C3 for >3 months.
o Histological findings:
▪ Light microscopy—> glomerular tufts appear enlarged and swollen often filling Bowman
space
▪ Immunofluorescent microscopy—> granular deposits of IgG and C3 along the capillary walls
▪ Electron microscopy—> electron-dense deposits (humps) in the sub epithelial space
o Complications of PSGN: hypertensive encephalopathy, seizure, heart failure, hyperkalaemia,
hyperphosphataemia, hypocalcaemia, acidosis and renal failure
o Treatment
▪ Symptomatic—> Antibiotics, antihypertensives and diuretics
▪ Complete recovery in 95%
o Duration of haematuria/proteinuria
▪ Gross haematuria: few weeks
▪ Microscopic haematuria: 18 months
▪ Proteinuria: decreasing over 18 months
• IgA nephropathy
o Episodes of macroscopic haematuria commonly in association with upper respiratory tract infections
o Histological findings and management are as for Henoch Schonlein purpura which may be a variant
of the same pathological process but not restricted to the kidney.
o Prognosis in children is better than that in adults
• Familial nephritis
o The most common familial nephritis is Alport syndrome. This is an X-linked recessive disorder that
progresses to end stage chronic kidney disease by early adult life in males and is associated with
nerve deafness and ocular defects.The mother may have haematuria.
o The differential diagnosis is thin basement membrane disease which also requires long-term follow-
up to detect proteinuria and chronic kidney disease which rarely develops in later life
• See essay 35 for HSP and SLE nephropathy; see essay 36 for urinary tract stones
39. Acute kidney injury. Haemolytic uraemia syndrome
AKI
• This is acute renal failure where there is a sudden, potentially reversible reduction in renal function. Oliguria
(<0.5 ml/kg/hr) is usually present.
• AKI is divided into 4 phases: onset/initiation phase, oliguric/anuria phase, diuretic phase and recovery
phase
• Causes:
o Prerenal—> most common in children
▪ Hypovolemia e.g. gastroenteritis, burns, sepsis,
haemorrhage and nephrotic syndrome
▪ Circulatory failure e.g. peripheral vasodilation in
sepsis, congestive HF, drugs I.e. ACE inhibitors
o Renal:
▪ Vascular e.g. haemolytic uraemic syndrome,
vasculitis, embolus and renal vein thrombosis
▪ Tubular e.g. acute tubular necrosis, ischaemic,
toxic (drugs like aminoglycosides, NSAIDs, IV
contrast) and obstructive
▪ Glomerular e.g. glomerulonephritis
▪ Interstitial e.g. interstitial nephritis and
pyelonephritis
o Postrenal (obstruction)
▪ Congenital e.g. posterior urethral valves
▪ Acquired e.g. blocked urinary catheter, calculi, tumours, neurogenic bladder
• History—> History of sore throat/rash (PSGN), urinary symptoms of haematuria, frequency, dysuria
(pyelonephritis), poor stream (e.g. posterior urethral valves) and history of drugs/medication.
• Symptoms
o Weight gain, peripheral edema and changes in urine output
ABB
o Symptoms of uremia may develop later as nitrogenous products accumulate. E.g. Anorexia, Nausea,
BUN/UREMIA
Ca2+/Phosphate Vomiting, Weakness, Myoclonic jerks, Seizures, Confusion and Coma
D VitD o Asterixis and hyperreflexia may be present on examination.
Electrolyte
Fluid
o Uraemic pericarditis: Chest pain, pericardial friction rub, and findings of pericardial tamponade..
o Fluid accumulation in the lungs may cause dyspnea and crackles on auscultation.
• Investigations
o Urine—> urinalysis with microscopy (casts are present), culture, osmolality, Na, creatinine,
fractional excretion of Na, protein:creatinine ratio, myoglobin and urine calcium/oxalate.
o Blood—> urea, electrolytes, creatinine, Ca, phosphate, albumin, glucose, bicarbonate, plasma
osmolality, FBC, blood film, blood cultures, uric acid, creatine kinase (for myoglobinuria)
▪ For suspected nephritis: complement, ASO titre, anti-DNAseB, ANA, ANCA and anti-dsDNA
antibodies
o Throat swab
o Imaging: US of kidneys and bladder. CXR to prove fluid overload
• Treatment:
o Prerenal failure: correct hypovolemia with fluid replacement and circulatory support.
o Renal failure:
▪ For circulatory overload→ restrict fluid intake and give diuretics.
▪ High calorie normal protein feed for decreasing catabolism, uraemia and hyperkalemia.
▪ Metabolic acidosis→ Sodium bicarbonate
▪ Hyperphosphatemia→ calcium carbonate and dietary restriction
▪ Hyperkalemia→ calcium gluconate (if ECG changes), Salbutamol (nebuliser or IV), calcium
exchange resin, glucose with insulin, dietary restriction or dialysis
o Postrenal failure:
▪ Relief from obstruction by nephrostomy or bladder catheterisation. Surgery can be
performed when electrolyte disturbances are corrected.
o Dialysis → this can be peritoneal dialysis or haemodialysis→ indicated when there is failure of
conservative management, Hyperkalemia, Severe hyponatraemia or hypernatraemia, pulmonary
oedema or severe hypertension (due to volume overload), severe metabolic acidosis and multi
system failure
Haemolytic uraemic syndrome (HUS)
• This is a triad of:
o Acute renal failure,
o Microangiopathic haemolytic anaemia
o Thrombocytopenia
• Etiology:
o E. coli (O157:H7)
o Miscellaneous e.g. drugs, pregnancy, systemic scleroderma, tumours
o Other infections e.g. Shigella, other ETEC/EHEC, pneumococcus, HIV/EBV
• Types of HUS:
o Typical HUS which has a diarrheal prodrome due to infection
o Atypical HUS which is not associated with diarrheal prodrome
• Typical HUS:
o This is secondary to GI infection with verocytotoxin (aka Shiga-like toxin)-producing E. Coli O157:H7
which is acquired through contact with farm animals or eating uncooked beef or less often Shigella
(via Shiga toxin).
o The toxin from these organisms enters the GI mucosa and preferentially localises to the endothelial
cells of the kidney where it causes intravascular thrombogenesis. Coagulation cascade is activated
and clotting is normal (unlike DIC). Platelets are consumed in this process and microangiopathic
haemolytic anaemia results from damage to RBC as they circulate through the microcirculation,
which is occluded. Other organs such as the brain, pancreas and heart may also be involved.
• Atypical HUS:
o It has no diarrhoeal prodrome, may be familial and frequently relapses.
o Associated with mutations in complement regulatory proteins. Results in inappropriate
complement activation, endothelial injury and thrombosis.
• Clinical presentation:
o Typical HUS follows prodrome of bloody diarrhoea: 3-12 days of watery/bloody diarrhoea in 6
month-5 year old child.
o Atypical HUS without prodrome.
o Pallor due to sudden decrease in Hct and platelets
o Oliguria – can be masked by diarrhoea
o Neurological symptoms: weakness, confusion and seizures
o GI: haemorrhaging colitis, abdominal pain, nausea and vomiting. Pancreatitis.
o CV: arrhythmias
• Investigations
o FBC – thrombocytopenia and anaemia. High bilirubin and low haptoglobin
o Blood film - Fragmented RBCs (schistocytes)
o Urinalysis, microscopy
o Prove bacteria - blood cultures, stool culture and microscopy and ELISA of bacteria.
o Biochemistry- urea, electrolytes, high LDH
o Coagulation screen
o Direct Coombs test – negative in HUS
• Diagnosis—> Clinical features w/ or w/o Stool testing for organism
• DDX:
o Thrombotic thrombocytopenia purpura (has decreased ADAMTS13 activity unlike HUS)
o DIC syndrome
o Immune thrombocytopenia purpura (has positive Coombs test)
• Recovery: renal function returns in 3-12 days. Platelet increase indicates recovery. 50% need haemodialysis.
• Treatment:
o Supportive - Monitor electrolyte balance, monitor fluid balance, nutrition, blood transfusion and
treat hypertension. Haemodialysis. NO antibiotics!
o For atypical HUS—> Eculizumab (monoclonal anti-terminal complement antibody).
▪ Plasma exchanges is still used especially in cerebral atypical HUS.
• Typical HUS has good prognosis with early supportive therapy including dialysis.
• Long term follow-up is required assessment of persistent proteinuria, hypertension and progressive CKD in
subsequent years.
40. HYPERTENSION
Hypertension (HTN) in children is defined as having an average blood pressure (BP) > the 95th percentile for their
respective age, gender and height on at least 3 different occasions.
* Accurate BP measurements are taken anuualy in children < 3 y/o, width of the cuff should be between 50-75% of
the circumference of the childs arm. Must correlate with BP tables for age, gender, height and weight plus take a
complete family hx of HTN.
AETIOLOGY
Primary (essential) HTN: HBP with an unknown cause – most common amongst obese children or adolescents.
• Linked to family hx, diet (matabolic syndrome), ↓ physucal activity and ↑ stress.
Secondary HTN: HBP caused by a an known underlying primary disease – most common amongst infants with renal
disease being the most common cause, *otherwise systematic HTN is rare amongst children. Causes of secondary
HTN are as follows:
• Renal diseases:
o Congenital anomalies (renal dysplasia , obstructive uropathy)
o Structural disorders (Wilm’s tumour, polycystic kidney disease)
o Acute and chronic glomerulonephritis
o Haemolytic uraemic syndrome
• CVDs:
o Renal artery stenosis, renal vein thrombosis
o Vasculitis
o Coarction of the aorta
• Endocrine disease (endocrinopaties): Pheochromocytoma and neuroblastoma (catecholamien secreteing
tumours), Hyperthyrodism, hyperaldosteronism, hypercortisolism.
• Neurologic (↑ ICP)
• Others: illicit drugs e.g. cocaine.
Causes of HTN in the newborn: ● Umbilical artery catherterisation, ● Renal artery thrombosis.
Causes of HTN during early childhood: ● Renal disease, ● Coarctation of the aorta, ● Endocrine disorders, ●
Medication.
EPIDEMIOLOGY: HTN is uncommon in infants and young children (<1% prevalence), if present is indicative of
underlying disease (secondary HTN). Increasing prevalance of primary hiypertension with increasing school age in
parallel with the obesity epidemic.
CLINICAL FEATURES
• Most children are asymptomatic (perticularly in cases of primary HTN). Secondary HTN has BP elevations ranging
from mild to severe.
• Sxs of severe HTN include: headache, dizziness, epistaxis (nose bleeds), vomiting, seizures, high temperature and
visual changes (blurred vision, flame hemorrhage, and cotton wool spots on retinal exam).
• End organ damage in marked HTN e.g. heart failure +/- pulmonary oedema and left ventricular hypertrophy
(LVH), stroke and renal dysfunction.
• Various histories: neonatal history - low birth weight or use of umbilical artery catheter, family history of HTN,
stroke and other CVDs; and dietary history (salt, caffeine or drugs) are important.
• Specific signs: Coarctation of the aorta (abdominal bruit, diminished leg pressure and weak femoral pulse) ; renal
artery stenosis (cafe-au-lait spots); Wilm’s tumour (flank mass); pheochromocytoma ( achycardia with flushing
and diaphoresis.
DIAGNOSIS
TREATMENT
Therapeutic lifestyle changes (diet, exercise) for asymptomatic stage 1 HTN without target organ damage or systemic
disease.
• ↓ salt intake, eat low fat, balamced diet, be active, loose weight, drink less caffeine.
Medication is started for stage 2, symptomatic HTN and stage 1 HTN, which fails to respond to lifestyle changes. 1st
line tx for children includes:
PROGNOSIS: dependsonunderlying aetiology and extent of BP control. If left untx = ↑ risk of CVD, CNSD and renal
morbidity in adulthood.
Hypertensive crisis: acute increase in both SBP and DBP with end-organ damage e,g, stroke, cerebral haemorrhage,
pulmonary oedema, renal failure, hypertensive encepahlolthy, ↓ vision (hypertensive retinopathy or retinal
hamrohhrage) and seizures.
RFs: BMI > 95th percentile, pre-existing HTN and poor BP conntrol.
Pathophysiology: rapid ↑ in TPR due to increases in circulating vasoconstrictor substances e.g. NA, Ang II (possible
overactivation of RAAS) and anti-natriuretic hormone. Arteriolar fibrinoid necrosis induces severely elevated BP
→endothelial damage with resultant end organ ischemia. Ischemia could trigger the further release of vasoactive
substances, causing further vasoconstriction and myointimal proliferation.
Treatment:
• Hypertensive crisis: prompt hospitalization (ICU) and may require parenteral antihypertensive treatment with
nicardipine (CCB), labetalol (α and β-adrenergic blocker), esmolol (β-blocker), hydrazalne (direct vasdilator) or
sodium nitroprusside. Achieve controlled reuction in mean arterial presure, then once stable normalize BP with
oral antihypertesive mediaction over a period of 24-48 hours.
• Hypertensie urgency: normalize BP with oral antihypertesive mediaction over a period of 24-48 hours.
PAEDIATRIC PHYSIOLOGY
o Haematopoiesis in fetal life occurs in the LIVER and postnatally occurs in the BONE MARROW or EXTRA-
MEDULLARY HEMATOPOIESIS→ Hematopoiesis outside medulla of
bone marrow mainly in the LIVER and SPLEEN→ So
hepatosplenomegaly can not only indicate Er destruction but also
its production
o HbF has a much higher affinity for oxygen compared with HbA
hence the oxygen dissociation curve is shifted to the LEFT meaning
it doesn’t let go of oxygen as easily and delivery ↓ O2 to tissues.
o Hb of the term infant is 140-210g/L (high) to compensate low O2
concentration in fetus→ This value then falls to 100g/L (lowest
value) by 2nd month due to reduced RBC production
o Preterm babies have a steeper fall to 65 to 90g/L at 4 weeks to 8 weeks respectively.
o Normal blood volume in term infant is 80ml/kg but preterm being 100ml/kg
o Iron, folic acid and B12 stores are adequate at birth for both preterm and term infants but they deplete
more quickly by 2nd-4th month in preterm infants
o WBC in neonates are ↑ than older children at 10-25*109/L
o Platelet count at birth is within normal adult range at 150-
400*109/L
ANEMIA
o Anaemia is defined as Hb below the normal values:
o Neonate: Hb less than 140g/L
o 1 month to 12 months of age: Hb less than 100g/L
o 1 year to 12 years of age: Hb less than 110g/L
o Dx of ineffective erythropoiesis
o Diagnostic clue of ineffective erythropoiesis:
▪ Normal reticulocyte count
▪ Abnormal MCV of RBCs→ ↓ In iron deficiency and ↑ in folic acid deficiency
1) Iron deficiency
o Mainly caused by:
▪ Inadequate intake/↑requirements → ↑Fe2+ is required for ↑ in blood volume
which accompanies the growth (Puberty) and to build up the child iron stores.
• Intake is from: Breast milk, Formula milk, Cows milk and Solids at weaning
o Cow milk has ↑ Fe content but 10% is absorbed where as breast milk
has ↓ Fe content but 50% is absorbed. Don’t feed infants with just
unmodified cows milk! → Other: Meats, organs, beans etc.
• Its absorption is ↓ when ate with tanins (tea) and ↑ with VitC rich foods.
▪ Malabsorption → Celiac disease etc.
▪ Chronic blood loss→ Meckels diverticulum, older child→ IBD, menorrhagia, epistaxis
o Stages of Iron deficiency:
1) Pre-latent iron deficiency→ Normal Hb + serum iron BUT ↓serum FERRITIN
2) Latent iron deficiency→ Normal Hb BUT ↓serum iron, ↓ferritin and ↑TIBC
3) IDA→ ↓Hb, ↓Serum iron, ↓ferritin and ↑TIBC → Hypochromic Microcytic
o Clinical features→ Most are asymptomatic until Hb <60/70g/L and present with SLOW FEEDING,
pale (conjunctiva, tongue or palmer creases).
▪ Some present with PICA→ Inappropriate eating of non-food material such as soil.
o Diagnosis:
▪ Bloods→ MCV + MCH ↓↓ (Microcytic, hypochromic anemia) and ↓ serum ferritin
• DDx of microcytic anaemia→ B-thalassemia
o Mx→ Dietary advice + Oral iron supplement (Sytron, Niferex)→ Oral med continued until normal
iron levels reached then continue for additional 3 months to replenish iron stores.
▪ Supplement with ↑ dietary intake of iron also e.g. formula feeding, meat, liver etc.
2) Red cell aplasia
o Mainly caused by:
▪ Congenital red cell aplasia (Diamond-Blackfan anaemia)→ Inherited or sporadic
• Most cases present 2-3 months postpartum→ Tx w/ steroids, RBC transfuse
▪ Transient erythroblastopenia of childhood
• Triggered by viral infection→ Fixed after Tx unlike diamond blackfan anemia
▪ Parvovirus B19 infection (only affect children with inherited haemolytic anaemia)
o Diagnostic clue of red cell aplasia:
▪ Low reticulocyte count despite low Hb
▪ Normal bilirubin
▪ Negative Coombs test
▪ Absent red cell precursor on bone marrow examination
ANEMIA
- Anaemia is defined as Hb below the normal values:
o Neonate: Hb less than 140g/L
o 1 month to 12 months of age: Hb less than 100g/L
o 1 year to 12 years of age: Hb less than 110g/L
- Haemolytic anaemia is characterised by ↓ RBC lifespan which is caused by ↑ RBC destruction either in
the circulation (INTRAVASCULAR HEMOLYSIS) or Liver/Spleen (EXTRAVASCULAR HEMOLYSIS)
- Normal lifespan of a RBC is 120 days→ When haemolysis occurs, bone marrow production ↑ so
anaemia is only achieved when the destruction surpasses the production in the bone marrow
- Causes of ↑ destruction in CHILDREN is intrinsic abnormalities of the RBCs (unlike neonates→ immune
mediated haemolysis):
o Red cell membrane disorders→ Hereditary spherocytosis
o Red cell enzyme disorders → G6PD deficiency
o Hemoglobinopathies e.g. B-Thalassaemia major, sickle cell disease
- Clinical features (generally):
o Anaemia, Hepatosplenomegaly, ↑Unconjugated Br, ↑ urinary urobilinogen
- Diagnostic clues haemolysis is occurring:
o ↑ Reticulocyte count (Polychromasia), Unconjugated-Br + ↑ Urinary urobilinogen, Abnormal RBC
on film, ↑ RBC precursor in the bone marrow and (+Ve) direct antiglobulin test (only if immune
cause)
1) Disorder of RBC MEMBRANE → HEREDITARY SPHEROCYTOSIS
o Autosomal dominant inheritance (but 25% can be sporadic)→ Mutations in genes for proteins in
RBC membrane – SPECTRIN, ANKYRIN or BAND 3→ ↓Surface : Volume ratio causing it to be
spheroidal and less deformable when it passes in the microvasculature of spleen→ Haemolysis!
o Clinical features→ Family Hx, Jaundice in first few days of life/intermittent throughout childhood,
Anaemia (mild), Splenomegaly (mild/mod), Gallstone formation (↑Br), Aplastic crisis if
w/parvovirus B19 infection
o Dx→ BLOOD FILM, OSMOTIC FRAGILITY TEST
o Mx→ Pts have ↑ Folic acid requirement due to ↑ RBC destruction so supplementation with
folate, SPLENECTOMY if poor growth/severe cases (done after 7yrs old to avoid post-splenectomy
sepsis→ Before splenectomy give vaccines against HiB, S.pneumonia, meningitis C and after give
lifetime oral Penicillin prophylaxis), Blood transfusion in aplastic crisis.
▪ If gallstones become symptomatic→ Cholecystectomy
2) Disorder of RBC ENZYMES → G6PD DEFICIENCY
o X-Linked (predominantly MALES)→ Common in middle east, Mediterranean and central Africa
▪ G6PD is in the pentose phosphate pathway and essential for preventing oxidative damage
to RBC→ When Hb denaturation occurs (due to oxidative damage) → HEINZ BODIES→
Heinz beans= Acute hemolytic attack!! = it’s a joke …
▪ Affected males will have low or absent enzyme activity in their RBC’s
o Clinical manifestation:
▪ Neonatal jaundice, Acute hemolysis (caused by drugs(Table), fava beans and naphthalene
in mothballs)→ Hemolysis is mainly intravascular and is associated with FEVER, malaise,
abdominal pain and DARK URINE (Hb + Urobilinogen) → Hb↓ <50g/L in 24-48hrs
Antimalarial drugs Antibiotics Analgesics Chemicals
Quinine, Primaquine, Sulphonamides, Aspirin (↑dose) Napthalene and fava
Chloroquine Quinolones, Nitrofurantoin beans
o Dx→ Between episodes pt is completely normal, measure G6PD activity of RBC but during the
haemolytic crisis its ↑ due to reticulocyte synthesis so do a repeat assay after haemolytic crisis
o Mx→ Parents need to be aware of signs of haemolysis and avoid foods and drugs which induce it
3) Hemoglobinopathies
a. SICKLE CELL DISEASE
▪ Autosomal recessive inheritance where abnormal HbS is produced due to a point
mutation in the B-globin gene causing AA change from glutamine to VALINE. Three forms:
I. Sickle cell anaemia (HbSS)→ homozygous HbS→ No HbA and small amounts of HbF
II. HbSC disease (HbSC)→ HbS from 1 parent and HbC from other (HbC is from another
point mutation in B-globin, together with HbS there’s no normal HbA globins)
III. Sickle B-thalassaemia→ HbS from 1 parent and B-thalassemia trait from 1 parent
IV. Carriers (sickle trait) HbS from 1, normal B-globin from other parent= no symptoms
• Just screen prior to general anaesthesia in case hypoxia triggers it
▪ In ↓PO2, Dehydration and cold causes HbS to polymerize within RBCs deforming them
into sickle shape→ ↓ lifespan RBC but can also cause vessel occlusion→ Organ ischemia
▪ Clinical manifestation:
• Anaemia→ With jaundice due to chronic haemolysis
• Infection→ From encapsulated organism due to hyposplenism from
microinfarction of spleen from chronic sickling. ↑ risk of sepsis
• Painful crisis→ Vaso-occlusive crisis, Hand-foot syndrome (dactylitis), bone pain
(spine, limbs), avascular necrosis of femoral head.
• Priapism
• Splenomegaly→ Mainly in children, ↓ common in older children.
• Long-term problems→ Short stature, stroke, adenotonsilar hypertrophy, HF, CKD
▪ Dx→ Neonatally= Guthrie test (dried blood spot test)
▪ Mx
• Prophylaxis to encapsulated organisms (VACCINES)/daily oral penicillin, Folic acid
for chronic anaemia and avoid triggers such as dehydration, cold and hypoxia.
• Painful crisis (Analgesics) and exchange transfusion in priapism, acute chest
syndrome, stroke
• Hydroxycarbamide (↑HbF), Bone marrow transplant if hydroxycarbamide fails
b) B- THALASSAEMIAS
• HBB mutation on Chr 11 in autosomal recessive→ Common in Mediterranean
• 2 main types→ B-T-intermedia(mild, small amount of HbA + HbF produced) and B-
T-Major(severe, HbA cannot be produced)→ both have ↓ production of B-globin
and hence reduction in HbA (consequent) (HbA(a2B2) cannot be formed!)
• Clinical manifestations:
o Severe anaemia→ Pallor, Jaundice, faltering growth
o Extra-medullary hemopoiesis→ hepatosplenomegaly, bone marrow
expansion causing classical skull bossin with maxillary overgrowth
• Mx→Life long transfusion with RBC→ Aim to keep Hb >100g/L to reduce growth
failure and bone deformation.
o Repeated transfusion cause IRON OVERLOAD (previously was cause of death,
not the actual disease) which if left untreated cause HF, Cirrhosis, DM etc. →
To prevent this CHELATION with subcutaneous desferrioxamine or oral
desfeasirox from 2-3 yrs of age.
o Splenectomy may be effective if transfusion dependency ↑
o Bone marrow transplant→ Only cure but only from HLA identical sibling
c) ALPHA-THALASSAEMIA
• Individuals have 4 alpha globin genes so manifestation depends on how many
chains are affected→ a-T major aka Hb Barts hydrops fetalis caused by all 4 a-
chains lost→ Mid-trimester fetal hydrops (oedema and ascites) from fetal anaemia
- Autoimmune hemolytic anemia→ Usually there is a preceeding infection or antibiotic use ( ~2wks
before) leading to a acute onset of pallor, jaundice, fatigue/fainting, abdominal pain, splenomegaly,
dark urine (signs of hemolysis)
o Dx→ + Coombs test
o Tx→ Use steroids + immunosuppressants until negative coombs test
NORMAL HAEMOSTASIS
- Coagulation factors→ Produced mainly by liver which become activated by TISSUE FACTOR which is
exposed in vessel (endothelial) injury→ Exposed collagen triggers this.
- Coagulation inhibitors→ Circulate in plasma or are bound to endothelium and prevent widespread
coagulation once coagulation has been initiated.
- Fibrinolysis→ Limits fibrin deposition at injury site due to activity of PLASMIN.
- Platelets→ aggregate at site of vessel injury forming primary haemostatic plug → is stabilised by fibrin
- Blood vessels→Intact vascular endothelium secretes prostaglandin I2 and NO which inhibits platelet
aggregation. But damaged endothelium releases TF and procoagulants (collagen and vWF) but this is
controlled by inhibitors on endothelial surface like thrombomodulin, antithrombin and protein S)
Diagnostic approach
1) Identify features in clinical presentation:
Age of onset Neonate→ Haemophilia (intracranial or after circumcision)
Toddler→ haemophilia when starting to walk
Adolescent→ VW disease presents with menorrhagia
Family history Family tree, gender of affected relatives
Bleeding history Drug history (anticoagulants?) systemic disorders?, previous surgical procedures→ If
uncomplicated then bleeding is now acquired.
Pattern of bleeding Mucous membrane bleeding and skin haemorrhage→ Platelet disorder or VW disease
Bleeding into muscle/joint→ Haemophilia
2) Laboratory screening tests:
o PT measures the activity of factors I, II, V, VII and X→ Extrinsic pathway HEMOPHILIA A/B:
o aPTT measures activity of I,II,V,VIII,IX,X,XI and XII→ Intrinsic pathway PT= Normal
o Thrombin time (TT)→ Measures deficiency/dysfunction of fibrinogen (→Fibrin) aPPT= Prolonged
o D-Dimers → Tests for fibrin degradation products
o Biochemical tests→ Liver, renal function tests
- In neonate the levels of ALL clotting factors except factor VIII and fibrinogen are lower with preterm
infants have even lower levels→Their levels are compared with other healthy infants of same age
DIAGNOSIS
- FBC→ Low Hb, Thrombocytopenia (<150*109), WBC↑, Urate ↑ and LDH↑
o Evidence of leukemic blast cells on peripheral smear
o Clotting screen→ 10% of pt’s present with DIC→ Haemorrhagic or thrombotic complications
- Bone marrow biopsy → Examine for blast cells, hyperplasia etc.
- Lumbar puncture→ Identify disease (Blasts) in CSF
- X-RAY→ check for mediastinal mass (LN’s), Lytic bone lesions
- Immunological phenotyping → Subclassifies ALL into: Pre-B-Cell precursor & T-cell (15%) subtypes
o Chromosomal analysis→ Philadelphia chromosome (9:22)→ Poor prognosis
MANAGEMENT
- Intensity of therapy is adapted according to the risk (based on prognostic factors)
- Remission induction
o 1st Correct: Anaemia (Blood transfusion), risk of
bleeding (Platelet transfusion), infection
(Cotrimoxazole→ Prevent pneumocystis infection)
o Additional hydration + ALLOPURINOL given to
protect renal function against rapid cell lysis
o Chemotherapy + Steroids
o Remission= Eradication of blast cells and
restoration of bone marrow function
o Chemotherapy is continued over long time up to 3
years from Dx
- Intensification→ Block of intensive chemotherapy given to
consolidate remission→ Improves cure rates but at the
expense of increased toxicity.
- CNS→ Cytotoxic drugs don’t penetrate CNS well→
Leukemic cells here may still survive systemic Tx so → INTRATHECAL chemotherapy will prevent
CNS relapse
- Relapse
o High dose chemotherapy with/out total body irradiation followed by BONE MARROW
TRANSPLANT
- Prognosis → Very good with chemotherapy 95% success !
MEMORY ANCHOR
https://www.youtube.com/watch?v=Z4szXwfRMsU
- Lymphomas are malignant proliferation of lymphocytes which can accumulate in lymphoid organs but
can spill into peripheral blood
- Divided into Hodgkin and non-Hodgkin lymphoma (NHL)
o HL→ Reed-Sternberg cells (Multinucleate/ bi-lobed nuclei)→ Owl’s eye appearance
o NHL→ All lymphomas WITHOUT Reed-Sternberg cells
- NHL is more common in childhood, while Hodgkin lymphoma is seen more frequently in adolescence
HODGKIN LYMPHOMA
- Clinical presentation
o Painless lymphadenopathy → Mainly in the NECK (Cervical lymph nodes)→
Much larger and firmer than the benign lymphadenopathy seen in children.
▪ LN’s can become so large they may OBSTRUCT AIRWAYS
▪ Alcohol may induce PAIN
o Clinical history is insidious and systemic symptoms (B-symptoms→ Fever,
weight loss, sweating, pruritus) are in 25% of cases
- Diagnosis
o Bloods→ FBC, ESR, LDH↑ (↑Cell turnover), Urate ↑
o Lymph node biopsy
1. Nodular sclerosing = most common→ (+) Lacunar cells
2. Lymphocyte rich = best prog
3. Lymphocyte deplete = worst prog
4. Mixed cellularity→ Associated with EBV
▪ Staging (Ann-Arbor):
• I – confined to a single LN
• II – 2 or more nodal areas involved on the same side of diaphragm.
• III – involvement of nodes on both sides of diaphragm.
• IV – extra-nodal involvement (e.g. liver and BM).
• For each stage:
o A – no symptoms other than pruritis
o B – weight loss, night sweats and fever. Worse prog.
o Radiological assessment → Assess all nodal sites
o Bone marrow biopsy
- Management
o Chemotherapy +/- radiotherapy
▪ PET scan is used to monitor Tx response an guide further management
▪ Prognosis→ GOOD, 80% cured, even if disseminated (60%)→ Better than NHL
NON-HODGKIN LYMPHOMA
- All lymphomas without Reed-Sternberg cells
o NHL & T-cell malignancies (ALL) are both characterised by MEDIASTINAL mass +Bone Marrow
infiltration→ mediastinal mass can cause superior vena cava syndrome → Dyspnoea, facial
swelling, flushing and venous distension in the neck/chest/arms
o 75% Nodal disease
o 25% Extra-nodal:
▪ Skin involvement→ Sezary syndrome (T-cell)
▪ Oropharynx
▪ GUT:
• Gastric MALT→ MALTOMAS (Caused by H.pylori)
• Non-MALT gastric lymphomas
• B-Sx is less common than hodgkins lymphoma
- Diagnosis
o Bloods→ FBC, U&E, Urate↑, LDH↑
o Biopsy of bone marrow and LN’s
o Radiological assessment→ CT/MRI→ For nodal sites→ Chest, abdomen and pelvis
o Lumbar puncture→ CSF→ IF CNS signs
TYPES OF NHL LYMPHOMA
o Sx→ Hunger, Pallor, abdominal pain, sweatiness, light headed→ Lead to seizures/Coma
o Tx→ Simple sugars: oral glucose gel (Glucogel) via buccal mucosa
▪ Parents/teachers should have glucagon injection kit I.M admin→ After
hypoglycaemia give long acting carb e.g. slice of bread.
o Hypoglycaemic coma Tx→ Get IV access (intra-oral glucogel if IV access fails)
▪ Give 10% glucose 5ml/ kg IV with IM glucagon → If no return to consciousness:
• Check glucose
• IV dexamethasone
- Diabetic ketoacidosis (DKA)
o Presents as: Acetone breath, vomiting/dehydration, abdominal pain, Kussmal breathing,
shock state/coma Plus triad of DM (Polyuria,Glucosuria, Polydypsia)
o Investigations:
▪ Blood glucose >11.1mmol/L Blood ketones >3.0mmol/L cidosis <15mmol/L (HCO3-)
▪ Abnormal U&E, Cardiac monitor→ T-Changes of hypokalemia
▪ Evidence of precipitating cause→ Infection→ Blood/urine cultures
o Management:
▪ Fluids→ Dehydration corrected over 48 hrs (avoid cerebral oedema)
• Assess by monitoring fluid output and neurological state of patient
▪ Insulin→ After I.V fluid replacement until glucose levels ~14mmol then administer it
with glucose to avoid hypoglycaemia.
▪ Potassium→ Initially ↑ due to transcellular shift for H+ but it depletes when fluid +
insulin is given so monitor it with ECG
▪ Acidosis→ HCO3- should be avoided unless the child is in a state of shock. Acidosis
will fix itself with fluid and insulin therapy
▪ Re-establish oral fluids, subcutaneous insulin and diet→ Don’t stop I.V insulin until 1
hour after subcutaneous insulin has been given
▪ Identify and Tx the underlying cause
THYROID DISODERS
- During foetal development a small amount of thyroxine is transferred from the mother → fetus
hence maternal hypothyroidism can affect the developing brain of fetus
- The Foetal thyroid gland produces REVERSE T3 which is an inactive derivative of T3
o After birth there is a surge in TSH↑↑ and hence ↑T3 and T4↑→ TSH then reaches normal
adult level range within a week
o Preterm infants may have ↓T4 in first few weeks with normal TSH ranges (not high)
HYPOTHYROIDISM
In the NEONATE:
Congenital hypothyroidism
- Prolonged jaundice
• Lack of TH from birth
- Hypotonia
• If not managed → irreversible neurological defects and poor - Hyporeflexia
growth - Bradycardia
• 1/4000 births - Large protruding tongue
• Features: - Umbilical hernia.
o Poor feeding, lethargy, somnolence
o Constipation→ Don’t pass stool 5-7 times (<5)
o Jaundice (unconjugated) + Dry skin Cretinism
o Large fontanelles→ Don’t diffuse in time + Large tongue = hypothyroidism from
o Growth retardation/learning difficulties birth, untreated → mental
o Hoarse voice/cry and physical retardation.
o Nasal obstruction: flat nasal bridge - Short stature
o Narrow palpebral fissures, swollen eyelids - IQ
o Low temperature/cold intolerance
o Cardiomegaly, HR, pericardial effusion
o Refractory anaemia (macrocytic)
o Myxoedema:
▪ Coarse features
▪ Large head
▪ Non-pitting Oedema of extremities (mucopolysaccharidosis)
▪ Swollen eyes
• Causes:
o Maldescent of thyroid and Thyroid agenesis (absent thyroid)→ Most common
▪ In early fetal life the thyroid migrates from the base of the tongue (sublingual) to its
normal site below the larynx→ in maldescent thyroid, it remains as a lingual mass
o Dyshormonogenesis→ error of thyroid hormone synthesis→ In consanguineous couples
o Iodine deficiency
o Hypothyroidism due to ↓TSH→ Associated pituitary dysfunction with GH & ACTH↓ too
o Transient hypothyroidism, related to maternal Abs/ carbimazole
▪ Carbimazole can cross placenta but TH can’t; thus in maternal hyperthyroidism →
foetal hypothyroidism.
• Screening:
o Pinprick at birth (GUTHRIE TEST), measuring:
▪ T3/ T4/ TSH
▪ Thyroid auto-Ab
• Management:
o L-thyroxine should be started immediately after diagnosis to prevent neurodevelopment
delays
o Transient hypothyroidism (due to maternal) does not require treatment.
Acquired
• MOST COMMON = autoimmune thyroiditis (Hashimoto’s)→ Mainly in females→ Tx with thyroxine
o Abs vs thyroid peroxidase and thyroglobulin.
• Associated with: As well as other AI conditions e.g. vitiligo, RA
o Turner’s, Down’s syndrome
o Delayed puberty
- De-Quervains thyroiditis→ After viral→ Transient.
HYPERTHYROIDISM
- Result of Graves disease (AI thyroiditis) secondary to the production of thyroid-stimulating Ig
(TSI)→ Bind with TSH receptor→ Release of thyroid hormones
- Neonatal hyperthyroidism may occur if mother with thyrotoxicosis passes TSI transplacentally
- Clinical features: → are similar to adults but eye features are not as common
- Dx:
o TSH↓ but T3/T4↑, Anti-thyroid persoxismal Ab’s may be present → Leading to
hypothyroidism
- Tx:
o Carbimazole or propylthiouracil → Interfere with thyroid hormone synthesis
▪ S.E of neutropenia → Infections→ Sore throat, fever → Consult !!
o Beta-Blockers→ Symptomatic relief of anxiety, tremor, tachycardia
o Tx with meds continued for 2 years then stop but relapse occurs in 40-70% → Second
course of meds or→ RADIOIODINE treatment or surgery→ SUB-TOTAL THYROIDECTOMY
▪ Follow up thyroid replacement
ADRENAL DISORDERS
SHORT STATURE
- = height <2rd percentile→ The shorter the child there more likely there will be a pathological cause
- Correct for height using MPH.
- Causes:
o Familial→ Short children from short parents
o Constitutional delay in growth and puberty(CDGP)→ Final height becomes normal
o Psychological neglect (→GH)
o Small for gestational age & Premature birth & IUGR
o Endocrine:
▪ Hypothyroidism ↓height + ↑weight
▪ GH deficiency or IGF-1 deficiency
▪ Cushing’s / Corticosteroid excess
▪ GH deficiency: bitemporal homonymous hemianopia. DO insulin tolerance test:
should cause a rise.
• At birth → neonatal hypoglycaemia + jaundice
• Doll-like face.
• Grow normally for first 12 months
• MARKEDLY REDUCED BONE AGE
o Dysmorphic syndromes: → Absence of Short stature homeobox (SHOX) gene
▪ Turner’s, Noonan, Down’s syndrome
o Long-term illness→ Coeliac disease, Crohn’s disease, CKD, CF (malabsorption, infections, ↑
breathing), Congenital heart disease (due to increased work of breathing), Asthma, RA, IBD
o Skeletal dysplasia:
▪ Achondroplasia (AD dwarfism) → Disproportionate short stature
▪ Hypochondroplasia
o Nutritional → insufficiency food/restricted diets
DIAGNOSIS
- Height velocity chart throughout growth can help identify when growth failure occurred
o 2 measurements at least 6 months apart can help calculate height velocity in cm/yr
▪ Done in specialist clinic as they depend heavily on ACCURACY
▪ The height of the child must be compared with the WEIGHT centile and his/her
genetic expected height (Average parent height + 7cm if boy or -7 if girl). The 9th to
91st centile range of this estimate is +/- 10cm in a boy and +/-8.5cm in a girl
- X-RAY of the left hand and wrist for BONE AGE→ Delayed in CDGP, hypothyroidism, ↓GH
- FBC → Anemia in coeliac disease or crohns (also ↑CRP)
- Creatinine + U&E→ ↑ in CKD
- Calcium and phosphate→ Renal & bone disorders For GH:
- Karyotype→ Turners syndrome 45XO - Initial screen: IGF-1 (will be low)
- TFTs→ TSH↑ in primary hypothyroidism. - Then do insulin tolerance test,
- Serum IGF-1→ Will be low measuring GH and IGF-1 after 2h.
- Coeliac Ab screen
- Dexamethasone suppression test→ Cushings
http://www.rajeun.net/boneage.htm
l
TREATMENT
- GH deficiency→ biosynthetic GH subcutaneous injections daily→ Very expensive
o Very useful in prader-willi syndrome, CKD, SHOX def, IUGR and small for gestational age
** Red dot is the weight (lower) and height (upper) of a child who was born after IUGR**
o He is clearly below the 0.4th percentile for both weight + height ! making this guy more
underweight/shorter than 99.6% of all other kids born normally without IUGR.
NORMAL PUBERTY
Females Height grows 4cm/year at onset of
- ≥8 years. puberty then slows down to
1. Breast development = 1st sign 2cm/year after the onset of menses
a. Gonadal sex steroid secretion until puberty is complete
2. Pubic hair and rapid growth spurt + body odor
a. Adrenal androgen production
3. Menarche: 2.5 years after start of puberty; signals growth spurt is coming to an end
Males
- Testicular enlargement: pulses of pituitary gonadotrophin
- ≥9
1. 1st sign = testicular growth (>4ml)
2. Pubic hair growth: follows testicular enlargement. Usually between 10-14 years.
3. Penis enlargement: gonadal sex steroid secretion
4. Height spurt (later than F, greater magnitude) and body odor
- May be transient imbalance of testosterone/ oestrogen at the beginning → gynaecomastea.
Precocious puberty
1) Gonadotrophin DEPENDENT→ ‘Central/True precocious puberty’) (↑LH & ↑FSH)
o More common in girls→ Ovaries are sensitive to gonadotrophins from pituitary
o FSH, LH, hCG
-PP in o Premature activation of the hypothalamic-pituitary-gonadal axis, caused by:
females= ▪ Idiopathic/familial
Premature ▪ Abnormalities of CNS
onset of • CNS trauma or injury
normal • Meningoencephalitis
puberty • Tumours: Craniopharyngioma, Harmatomas (of hypothalamous)
-GD-PP in • Hydrocephalus
boys= ▪ Hyperthyroidism
usually o Management:
pathological ▪ GnRH pulses are required for normal gonadal function
▪ HIGH levels of GnRH → gonadotrophins (paradoxically)
▪ Thus treat with SC GnRH analogue until 11yo.
CAUSES
- Constitutional delay of growth and puberty/familial→ Most common → It’s a variation of
normal timing of puberty rather than a pathological condition.
o More common in boys→
▪ If worried, measure testicular volume (1st sign of puberty): if >4ml, they can be
reassured that they have entered puberty and the growth spurt will soon follow
▪ Tx not required unless wanted → Oxandrolone (weak anabolic steroid) helps
catch up growth but not secondary sexual characteristics and in older boys I.M
Testosterone causing catch up + secondary sexual characteristics
▪ In girls→ Estradiol can be given for several months to induce puberty
- Hypogonadotropic hypogonadism
o Systemic→ Cystic fibrosis, severe asthma, crohns disease, anorexia nervosa, starvation
o Hypothalamo-pituitary disorders→ Pituitary dysfunction, GH deficiency, intracranial
tumour, Kallmann syndrome (LH deficiency)
o Acquired hypothyroidism
- Hypergonadotropic hypogonadism
o Chromosomal abnormalities→ Kleinefelter syndrome (47XXY), Turner syndrome 45XO
o Steroid hormone enzyme deficiency
o Acquired gonadal damage→ Post-surgery, radiotherapy, trauma, AI
Ix of delayed puberty:
1. Wrist X-ray for bone age.
2. LH/ FSH.
N.B. bone age is an index of physiological maturation, and correlates with the onset of
secondary sexual characteristics better than chronological age in delayed puberty.
• BA delayed in GH deficiency + constitutional delay
• BA advanced in CAH + precocious puberty
CAUSES OF SEIZURES
FEBRILE SEIZURES
- An epileptic seizure accompanied by a fever in the absence of
intracranial infection, usually <20 mins→ Most common cause of seizures in childhood
- Genetic predisposition exists and the condition occurs in children between 6mo – 6yrs old
- Early in viral infection when the temperature rapidly rises → Tonic-Clonic seizure→ Febrile seizure
- Febrile seizures don’t cause brain damage but child has a ↑ risk of developing epilepsy (1-2%)
o ↑ Chance of developing epilepsy if it’s a complex febrile seizure (4-12%)
- Mx→ Tx the cause of the fever (viral) or( bacterial→ Meningitis→ Neck stiffness + photophobia
won’t be as apparent in a <18mo child so do infection screen (Blood culture, urine culture etc)
o If bacterial is cause→ Treat with antibiotics
- Antipyretics if very hot → Paracetamol syrup/rectum → Although no solid evidence it helps
- If seizure >5mins → Buccal midazolam or rectal diazepam or IV lorazepam
PAROXYSMAL DISODERS
- In Non-epileptic cases or if uncertain if epilepsy exists→ We must rule out/consider aka Non-
epileptic paroxysmal events aka FUNNY TURNS because epilepsies can be misdiagnosed.
- Blue Breath holding spells→ Blue when Angry/upset
o When child is upset→ Cries and holds breath in expiration and turns blue→ Can lead to
brief loss of consciousness but with full recovery→ Drug Tx is unhelpful→ Tx with behaviour
modification
- Reflex asystolic syncope (aka Anoxic seizures)→ Family Hx exists usually→ Pain or discomfort
specifically from minor head trauma, cold food (Ice cream), fright or fever→ child turns PALE and
falls to floor→ Hypoxia can induce a generalised tonic-clonic seizure
o Epidodes are due to cardiac Asystole from vagal inhibition→ Brief seizure + recovery
o Ocular compression can also lead to asystole and lead to asystole
- Syncope (transient loss of consciousness) → Hot + humid environment, long standing→ Child faints
- Migraine→ Can cause paroxysmal headache + unsteadiness/light headedness
- Benign paroxysmal vertigo→ Recurrent episodes of vertigo + nystagmus + imbalance → Associated
with viral labyrinthitis
- Other→ Cardiac arrythmias (prolonged QT-interval→ Associated with exercise), Tics, daydreaming,
pseudoseizures, Fabricated seizure (by parent), Induced illness (hypoglycaemia→seizure), Medically
unexplained seizure
- To identify these from epilepsies→ Detailed Hx (Video?), Physical, EEG’s
EPILEPSIES
- Most epilepsies are genetic (idiopathic) with a complex inheritance
- They are classified into:
1) Generalized: Discharge arises from BOTH hemispheres→ Absence, myoclonic, tonic,
tonic-clonic, atonic→ They can occur in a combination or in a sequence
2) Focal/Partial: Discharge arises from ONE or part of ONE hemisphere → Manifestation
depends on the part of brain where discharge originates and where it moves to:
a. Frontal seizure→ Involve motor or pre-motor cortex→ Clonic movements which
travels proximally (jacksonian march) or tonic seizure with both arms raised high
b. Temporal lobe seizures→ Auditory or sensory (Smell or taste) Phenomena + Lip-
smacking and plucking at ones clothing or feeling of déjà vu
c. Occipital seizure→ +Ve or -Ve visual phenomena
d. Parietal Lobe seizures→ Contralateral altered sensation
- Focal seizures, Consciousness can be maintained/LOC and can evolve into a generalised seizure
DIAGNOSIS
- Mainly based on the Hx from child and parent → Sometimes they video record the seizure
- ECG→ 12 lead ECG is done in all children with seizures → Rule out arrythmias e.g. long QT-Syndrom
- EEG: → Can however appear normal in 50% of time
o Ictal EEG→ If seizure is frequent enough to catch it→ To DIAGNOSE IT
o Inter-ictal EEG→ Done when epilepsy is DIAGNOSED→ Help categorise it and assess severity
o Additional techniques→ 24hr ambulatory EEG or 5 day video-telemetry EEG
- Brain imaging:
o Structural→ CT/MRI → Routinely done in childhood epilepsies
o Functional→ PET and SPET → Metabolically active cells identified
- Metabolic investigations→ Indicated if theres developmental arrest or regression or if seizure is
related with feeds or fasting periods
MANAGEMENT
- Not all epileptic seizures require anti-epileptic drugs and the decision to give should be based on
the seizure type, frequency and social and educational consequences of the seizures against the
possible unwanted side effects the drugs.
- Principles:
o Monotherapy at minimum dosages→ To prevent seizures without ADR’s
o Children with prolonged epileptic seizures >5 minutes with LOC are given rescue therapy to
keep with them→ Usually buccal midazolam
o Anti-epileptic drugs should be discontinues after 2 years of being seizure free but is given
indefinitely to young Pt’s with Juvenile absence epilepsy or juvenile myoclonic epilepsy
- S.E: Valproate→ Weight gain, hair loss, teratogenic; Carbamazepine→ Rash, ataxia, hyponatremia
- Other treatment options:
o Ketogenic diets
o Vagal nerve stimulation→ delivered with externally programmed stimulation wire
o Epileptic surgery→ in well-localised structural causes/epileptogenic zones e.g.
hemispherotomy→ disconnection of the hemisphere
- Teachers should be aware of condition and know how to manage, avoid baths or swimming alone
- Status epilepticus→ ES >30 mins or repeated ES for 30mins without recovery of consciousness
EPILEPSY SYNDROMES
1) Infantile spasms (West syndrome)
- Onset→ 3-12 Months
- Seizure pattern→ Flexion of head + trunk + limbs followed by extension of arms lasting 1-2s 20-30x
- Tx. With Vigabatrin + Corticosteoids
2) Lennox-Gastaut syndrome
- Onset→ 1-3 years
- Seizure pattern→ Multiple seizure types (atonic, absence, tonic) in sleep
- Poor prognosis
3) Childhood absence epilepsy
- Onset→ 4-12 years
- Seizure pattern→ Momentary unresponsiveness + motionless, may twitch eyelids or mouth <30s→
No recal of what happened
- 2/3 are female and episodes can be induced by hyperventilation→ Good prognosis
4) Benign Rolandic epilepsy (benign epilepsy with centro-temporal spikes)
- Onset→ 4-10 years
- Seizure pattern→ Tonic-clonic seizure in sleep or focal seizure with awareness of abnormal feeling
- May not require drugs, remits in adolescence
5) Panayiotopoulos syndrome (early- onset benign occipital epilepsy)
- Onset→ 1-5 years
- Seizure pattern→ Autonomic features (vomiting, head + eye deviation)
- Remits in childhood
6) Juvenile absence epilepsy
- Onset→ 10-20 years
- Seizure pattern→Absence and generalised tonic-clonic seizures with photosensitivity
- Remission unlikely but responds well to Tx
7) Juvenile myoclonic epilepsy
- Onset→ 10-20 years
- Seizure pattern→ Myoclonic seizure, generalised tonic clonic seizure and absence after waking
- Remission unlikely but responds well to Tx
CENTRAL MOTOR DISORDERS
There are three central movement control centres:
1) Motor cortex→ Lying along the PRECENTRAL gyrus→ Informaition from here passes down
the corticospinal (pyramidal) tract to link with the basal ganglia.
2) Basal ganglia + Deep grey matter structures → Store patterns of movement so that we don’t
put conscious effort into every movement we make.
3) Cerebellum→ Controls posture, balance, coordination and speech.
Disorders of these:
- Corticospinal (pyramidal) tract disorders→ Weakness + Pattern of ADDUCTION at shoulder,
FLEXION at elbow and PRONATION of forearm, ADDUCTION + INTERNAL ROTATION at hip,
FLEXION at hip +knee and PLANTAR FLEXION at the ankle with HYPERREFLEXIA + Extensor
plantar response → Think of the body position of a child with cerebral palsy/ stroke patient
- Basal ganglia disorders→ Difficulty initiating movement, Dyskinesia (movements are jerky),
chorea or writing movement problem.
- Cerebella disorders→ Ataxia, dysmetria, dysdiadokinesia, nystagmus and scanning dysarthria
Cerebral palsy
- Permanent disorder of movement and/or posture and motor function due to a non-progressive
abnormality in the developing brain.
• 2/1000 births→ Most common cause of motor impairment in children.
• Most common cause of major movement disorder in children.
• Non-progressive CNS lesions sustained <2yo: → If after 2yrs = Acquired brain injury
o → some/ all of :
▪ Delayed motor development
▪ Evolving CNS signs (non-progressive, but emerge over time)
▪ Epilepsy
▪ Hearing impairment
• Prognosis = 20yo if quadriplegic; longer if less affected.
• CAUSES:
o 80% = antenatal
▪ Vascular occlusion, cortical migration disorders or structural maldevelopment
▪ Genetic syndromes
▪ Congenital infection: rubella, CMV, toxoplasmosis
o Hypoxic-ischaemic damage during delivery:
▪ Ischaemia → periventricular leucomalacia
o Post-natal:
▪ Meningitis/ encephalitis/ encephalopathy
▪ Head trauma
▪ Intra-ventricular haemorrhage
▪ Symptomatic hypoglycaemia
▪ Hydrocephalus
▪ Hyperbilirubinaemia (kernicterus)
• Features:
o Although the cause/lesion is non-progressive, clinical manifestations emerge over time
o Abnormal tone/ posture
o Delayed milestones
o Slow head growth
o Speech and language delay
o Difficulty feeding, gagging and vomiting
o Abnormal gait/ tiptoe walking
o Asymmetrical hand function/ hand dominance <12 months
• Types:
1) Spastic (90%):
▪ = damage to pyramidal pathways (→ pyramidal weakness) (Upper motor neuron)
▪ General features: tone and reflexes, clasp knife, flexed hip and elbow, ankle
plantar flexion.
▪ Spastic hemiplegia:
• Arm>leg
• Fisting of affected hand + Flexed arm + Pronated forearm, Tiptoe walk on
affected side
▪ Spastic quadriplegia: → Most severe
• Opsthotonus Trunk (extensor posturing) + poor head control
• Associated with seizures and microcephaly + Intellectual impairment
• swallow → aspiration pneumonia
▪ Spastic diplegia:
• All 4 limbs but Legs>Arms (may appear normal)
• Associated with periventricular damage
Scissor walking
▪ Spastic monoplegia: paralysis of 1 limb, usually an arm
2) Dyskinetic/ athetoid(6%):
▪ Choreiform movements, Athetosis (fanning of fingers), Dystonia (simultaneous
contraction of agonist + antagonist giving twisting appearance
▪ Intellectually relatively unimpaired
▪ Basal ganglia damage from kernicterus
3) Ataxic(4%):
▪ Genetically determined
▪ Uncoordinated movements, intention tremor
• Associated impairment→ Visual impairment, epilepsy,
contractures, scoliosis
• Diagnose:
o Developmental assessment/ screening
o CT/ MRI head
o EEG
• Manage:
- Symptoms,
- Family/ educational support
- Physiotherapy
- Muscle relaxants:
o Botox to gastrocnemius (to reverse plantarflexion)
o Baclofen – used intrathecally to control spasticity.
- Selective dorsal rhizotomy (a proportion of the nerve roots in the spinal cord are selectively
cut to reduce spasticity)
PERIPHERAL MOTOR DISORDERS
CLINICAL SIGNS
- Any part of the Lower motor neurone pathway can be
affected in a neuromuscular disorder: (Picture on Rt)
- Clinical signs:
o Hypotonia (Floppiness)
o Muscle weakness
o Delayed motor milestones
o Unsteady/abnormal gait
o Muscle cramps→ metabolic myopathy
o +Ve GOWER’s SIGN→ Up to 3yrs of age its
NORMAL to go prone to rise to a standing
position when they’re originally in supine
position. If child has positive Gowers sign
>3years its highly likely there’s a
neuromuscular disorder.
- Its also important to differentiate myopathy from
neuropathy:
o Anterior horn cell defect→ Sign of denervation
presenting as weakness, loss of reflexes,
fasciculations and wasting of the muscle.
o Neuropathy→ Motor neuropathy= Weakness,
Sensory neuropathy= impaired perception of
pain, temperature or touch with loss of reflexes in either one
o Myopathy→ Weakness (Proximal), wasting and gait disturbances
o Neuromuscular junction→ End-plate Ach stores depleted→ Diurnal worsening
throughout the day leading to fatiguability
- Investigations
o Myopathy
▪ Plasma creatine kinase: ↑in Duchenne & Becker
muscular dystrophy
▪ Muscle biopsy
▪ DNA testing→ Abnormal genes
▪ US / MRI of muscles
o Neuropathy
▪ Nerve conduction studies
▪ DNA testing→ For abnormal genes
▪ Nerve biopsy
▪ EMG→ Differentiates myopathic from neuropathic
Different defects
• Anencephaly:
o Failure of development of most of the cranium and brain
o Die in utero/ shortly after
o Can be detected by antenatal USS→ Termination of pregnancy can be offered
o More commonly FEMALE.
• Encephalocele:
o Brain and meninges herniate through weakness in skull.
o Can be corrected surgically but usually underlying cerebral defects.
• Spina bifida occulta
o Failure of fusion of the vertebral arch
o Sometimes not noticed until born, if skin closed over → USS/ MRI.
o However may be overlying skin lesion, e.g. tuft of hair, lipoma, birth mark
o With growth, tethering of the cord → weakness and spasticity in lower limbs,
incontinence, constipation etc.
• Meningocele and myelomeningocele:
o Usually good prognosis following surgical repair
o Meningocele:
▪ Protrusion of meninges (filled with CSF) through a defect in the wall of the skull/
spine
o Myelomeningocele:
▪ Open spinal cord with meningeal cyst.
▪ Associated with:
• Variable paralysis/ weakness/ imbalance of legs→ Physiotherapy
• Sensory loss→ Skin care to avoid ulcers
• Bladder denervation (neuropathic bladder) → often retention. May
require intermittent catheterisation. Risk of recurrent UTI.
• Neuropathic bowel→ Regular toileting, laxatives and suppositories
• Sexual dysfunction
• Scoliosis→ Monitored, may require surgical tx
• Hydrocephalus from Arnold-Chiari malformation
Hydrocephalus (HC)
• = obstruction of CSF flow → Accumulation of CSF in brain→ dilation of ventricles (proximally)
o Non-communicating HC = obstruction within ventricles
▪ Congenital malformations:
• Aqueduct stenosis
• Atresia of the outflow of the 4th ventricle
• Chiari malformation→ Cerebellar tonsil herniates though foramen magna
▪ Acquired:
• Posterior fossa neoplasm or vascular malformation
• Intraventricular haemorrhage in pre-term
o Communicating HC= obstruction at arachnoid villi (Failure to reabsorb CSF)
▪ Sub arachnoid haemorrhage
▪ Meningitis → Pneumococcal, tuberculous
• Presentation:
o Disproportionately large circumference (IF sutures have not fused)
o Separated sutures→ Bulging anterior fontanelle + scalp veins becoming apparent
o Fixed downwards gaze (setting sun sign) → Advanced sign
• In suspected hydrocephalus:
o Cranial USS
o CT/ MRI
o Monitor head circumference on charts
• Mx:
o Insertion of ventriculoperitoneal shunt
o Risks: → Malfunctioning of shunt due to blockage:
▪ Infection from coagulase –ve staph [Staph epidermidis])
▪ Over drainage → low pressure headache
o Surgery to create a ventriculostomy is also possible but as alternative (2nd line)
- GLOBAL developmental delay (aka early developmental impairment) implies there’s a delay in
ALL skill fields→ Gross motor, fine motor, vision, hearing & speech, language, cognition,
social/emotional
- SPECIFIC developmental impairment is when one skill area is more delayed than others
HEARING IMPAIRMENT
- Any child with delayed language/speech, learning difficulties or behavioural problems should
test their hearing tested!!
1) Sensorineural HL→ Lesion in chochlea or auditory nerve→ usually presents at birth and is
irreversible
a. Genetics (mainly)→ Preterm
b. Perinatal→ Congenital infection, hypoxic ischemic encephalopathy, Hyper Br-emia
c. Postnatal→ meningitis/encephalitis, head injury
d. Tx→ Amplification or cochlear implant, Sit child at front of class, special deaf schools
2) Conductive HL→ Lesion in ear canal or middle ear→ Associate with otitis media + effusion
a. OM + Effusion (glue ear)→ Most common
b. Eustachian tube dysfunction→ Down Syn, Cleft palate
c. Dx→ Impedance audiometry tests
d. Tx→ Conservative (decongestants, Abx), amplification or surgery (Tympanostomy)
with/without removal of adenoids→ Associated with upper resp infections.
ACCIDENT PREVENTION
DROWNING
• Respiratory impairment → Hypoxaemia/ inadequate perfusion → acidosis, arrhythmia, shock
o Babies/Toddlers→ Baths, Swimming pools, Garden ponds
o Children→ Canals, Lakes, Sea
• Management:
o AB:
▪ Immobilise neck: there may be C-spine injury
▪ Airway may be obstructed with material from the water.
▪ If no gagging → intubate using Guedel.
o Undress of all wet clothes; warm using electric blanket.
• Respiratory arrest can occur up to 72h after, due to pulmonary oedema.
• May have aspirated water → 2o pneumonia.
BURNS & SCALDS
SYMPTOMS
- Soot in nasal/oral cavities ?
- Cough (With black sputum), Hoarseness, Stridor,
Dyspnea
- Blistering around mouth
- Scorched eyebrows or hair
- Circulation→ May be compromised due to fluid loss
from burns
- Confusion/ dizziness/ coma if brain
- Important to ask:
o Mechanism, Duration of exposure, LOC ?
o Environmental factors (closed or open)
INVESTIGATIONS
- ABG
- COHb→ Carboxyhaemoglobin
Lund & Browder chart
- FBC + crossmatch
- Bloods
- CHILD PROTECTION.
MANAGEMENT
- Burn First Aid
o Cool the area with cold running water for 20
minutes but avoid hypothermia
o Chemical burns→Irrigated
o Plastic (Cling film) applied on top to limit evaporation from burn area
o Pain relief→ Intranasal opiates
o Body Surface area calculated (Lund)→ Determines the need for admission/Fluid admin
o Burn depth assessment should be attempted
- Further management:
o Pain relief → I.V Morphine or Ketamine
o Maintaining circulation→ I.V Fluids (20ml/Kg) is required if:
▪ Infant → >10% Body burnt
▪ Child → >15% Body burnt
▪ Monitor urine output to assess adequacy of fluid replacement
• ~1ml/Kg/hr (Adults is 0.5ml/Kg/hr)
- Partial thickness burns >5% body SA should be referred to specialist (not <5%)
- All burns of face, ears, eyes, hands, feet, genitalia, perineum regardless of SA→ Specialist
- All burns, the possibility of inflicted injury should be considered → Child protection!
Assessment of Depth
POISONING
1. Accidental→ Common in young children→They consume small amounts→ Low risk of serious harm
2. Deliberate self harm/Experimentational→ Adolescents/young people
o Self harm is usually by ingestion of LARGE amounts of OTC meds e.g. aspirin etc
3. Iatrogenic→ Drug errors made by health professionals
4. Intentional→ By parents/carers→ Rare
TOXICITY MEDICINES HOUSEHOLD PRODUCT GARDEN
LOW Oral contraceptives, Most Antibiotics, Liquid soap & washing Animal faeces ☺,
topical hydrocortisone up liquid, lipstick, fish slugs, compost
food
HIGH Opiods, BB, TCA, Paracetamol, Iron, Bleach, oven cleaner, Pesticides,
Salicylates antifreeze Organophosphates,
mushrooms
- Chronic environmental poisoning→ Young children are at ↑ risk due to smaller bodies and their
developing brains→ Main problem is LEAD → Contamination of water supplies by mining/factories:
o Behavioural changes, ADHD developmental delay, severe cases→ Seizure/coma etc.
o Tx→ Prevent further exposure + CHELATION therapy for acute symptoms
Physical findings to help identify difference classes of drugs in OD→ If patient is UNRESPONSIVE
Jaundice + ↑ LFTs <24h
Hepatomegaly >24h
Opiates
o Bradycardia, hypotension,
pinpoint pupils, nausea,
respiratory depression →
pH
o Naloxone IV 10ug/kg
Beta- Blockers
o Hypotension, bradycardia,
heart block, HF
Reye’s syndrome!! →
Encephalopathy days
o Atropine, glucagon (glucagon
after febrile illness
not effective if concurrent
alcohol)
Cocaine
o Mydriasis, seizures,
hyperthermia, metabolic
acidosis, rhabdomyolysis
o 1st line = benzodiazepines
o Chest pain: benzodiazepines +
GTN
Present DRUNK without
smelling of alcohol
o HTN: benzodiazepines +
sodium nitroprusside
Ecstasy
o Agitations, anxiety, confusion,
ataxia, tachycardia,
hypotension, hyponatraemia,
hyperthermia, rhabdomyolysis
Correct acidosis with
o Mx:
fluids and BICARBONATE
▪ Supportive
▪ Dantrolene if severely
hyperthermic
Immunodeficiency may be:
1. Primary(uncommon): Genetically determined defect in the immune system
2. Secondary: cancer, immunosuppressive agents (Chemo/Steroids), HIV infection, splenectomy,
nephrotic syndrome, Sickle cell, etc.
PRESENTATION OF IMMUNODEFICIENCY
- Recurrent (proven) bacterial infections
- Severe infections (e.g. meningitis, osteomyelitis, pneumonia)
- Infections are unusually severe or chronic or fail to respond to regular treatment
- Infections by an unexpected / opportunistic pathogen or if child has immunization against it
- Severe or long-lasting warts, generalized molluscum contagiosum
- Complications following live vaccinations (e.g. disseminated BCG)
- Abscesses of internal organs; recurrent skin abscesses
- Prolonged or recurrent diarrhoea (often combined with faltering growth).
HIV in children
• Transmitted from mother:
o Intrapartum
o Breastfeeding
• HIV +ve mother:
o Start HAART as soon as diagnosed in pregnancy
o C-section if detectable viral load (>50)
o Zidovudine to baby for 4 weeks
o No breastfeeding.
• Diagnosis:
o Ab detected in children >18mo
▪ (If +ve mother, they can only be declared as HIV –ve after a –ve test at 18mo)
▪ When younger: will still have maternal Ab present
o Therefore more sensitive to do viral PCR
▪ 2 -ve PCRs in the first 3 months of life, >2 weeks after completion of post-natal
anti-retroviral therapy = infant –ve.